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Summary 
In their natural habitat bacteria are exposed to many environmental threats. Besides rapidly 
changing physicochemical parameters and an almost constant lack of nutrients, they also 
have to deal with the presence of antimicrobial compounds produced by competing 
organisms. The bacterial cell envelope is the interface between the cytoplasm and the 
environment. Its integrity is crucial for survival, which makes it a preferred target for 
antibiotics. In order to deal with cell envelope impairing agents and conditions before 
severe damage actually occurs, bacteria developed a number of signal transducing systems 
that enable them to sense the presence of antibiotics and respond appropriately by 
differential gene expression. Two different signal transducing principles orchestrate such 
responses: two-component systems (TCSs) and extracytoplasmic function (ECF) σ factors. 
The response of the Gram-positive model organism Bacillus subtilis to cell wall antibiotics 
has been studied extensively and involves four TCS (LiaRS, BceRS, PsdRS and YxdJK) 
and at least three ECF σ factors (σW, σM and σX). In the context of this thesis, we 
determined cell envelope stress responses with a focus on ECF σ factors. 
In the first part of this work, we investigated and compared the response of B. subtilis to 
the cyclic lipopeptide antibiotics daptomycin and friulimicin B, which are both active 
against even multi-resistant Gram-positive pathogens. Genome-wide in-depth expression 
profiling at both the transcriptome and proteome level revealed that both antibiotics trigger 
an ECF σ factor-dependent response involving primarily σM and σV. This response was 
more strongly induced by friulimicin B than by daptomycin. In contrast, daptomycin 
exclusively and strongly induced the LiaRS TCS. These expression signatures indicate that 
both antibiotics act via completely different mechanisms of action, although they are 
structurally similar and generally interfere with cell envelope integrity. This demonstrates 
the great potential and specificity of global expression profiling as a powerful approach to 
characterize the mechanism of action of novel antibiotics or even differentiate between 
chemically related compounds. 
In the second part, we determined the transcriptional response of B. subtilis to 
rhamnolipids, which are industrially important biosurfactants produced by Pseudomonas 
aeruginosa. Rhamnolipids also display antimicrobial activity by interfering with the 
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integrity of biological membranes. A genome-wide DNA microarray analysis of B. subtilis 
after treatment with rhamnolipids revealed for the first time that a single antimicrobial 
compound is able to induce two normally independent stress responses: the cell envelope 
stress response, in this case represented by the LiaRS TCS and the ECF σ factor σM, and 
the secretion stress response mediated by the CssRS TCS. Moreover, the LiaRS TCS and 
σ
M have a protective function against damage caused by rhamnolipids, while the role of 
CssRS in this response is still unclear.  
Finally, we characterized a novel group of ECF σ factors with unique features, namely 
ECF41, which was identified in the context of a comprehensive classification of this 
protein family. A detailed bioinformatics analysis revealed a wide distribution of ECF41 σ 
factors with about 400 proteins from ten different bacterial phyla. This group shows an 
unusual but highly conserved genomic context. Obvious anti-σ factors are missing in the 
direct vicinity of the genes encoding the ECF41 σ factors. Instead, the ECF41 genes are 
associated with genes encoding carboxymuconolactone decarboxylases, oxidoreductases or 
epimerases. These transcriptional units represent the only targets and are often preceded by 
a highly conserved promoter motif recognized by the corresponding ECF41 σ factor, which 
has been experimentally demonstrated for both Bacillus licheniformis and Rhodobacter 
sphaeroides. Moreover, the ECF41 proteins harbor a large C-terminal extension, which is 
not present in other ECF σ factors. We demonstrated that this extension is clearly involved 
in regulation of ECF41 σ factor activity and possibly functions as a fused anti-σ factor-like 
domain. 
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Zusammenfassung 
Bakterien sind in ihrer natürlichen Umgebung einer Vielzahl von schädlichen 
Umwelteinflüssen ausgesetzt. Neben schnell wechselnden physikalisch-chemischen 
Parametern und einem fast ständigen Nährstoffmangel stellen auch antimikrobielle 
Substanzen, welche von konkurrierenden Organismen produziert werden, eine große 
Herausforderung dar. Die bakterielle Zellhülle ist die Verbindung zwischen dem 
Cytoplasma und der Umgebung und ihre Integrität ist essentiell für das Überleben der 
Zelle, was sie zu einem bevorzugten Angriffspunkt für Antibiotika macht. Es ist daher 
wichtig, bereits auf zellhüllschädigende Substanzen und Bedingungen zu reagieren bevor 
die Zelle ernsthaft gefährdet ist. Daher haben Bakterien eine Vielzahl von 
signaltransduzierenden Systemen entwickelt, welche es ermöglichen Antibiotika 
wahrzunehmen und angemessen darauf zu reagieren. Zwei verschiedene Prinzipien der 
Signaltransduktion vermitteln solche Reaktion: Zweikomponentensysteme und 
extracytoplasmic function (ECF) σ-Faktoren. Die Antwort des Gram-positiven 
Modellorganismus Bacillus subtilis auf Zellwandantibiotika wurde bereits ausführlich 
untersucht und umfasst vier Zweikomponentensysteme (LiaRS, BceRS, PsdRS and 
YxdJK) und mindestens drei ECF σ-Faktoren (σW, σM and σX). Im Rahmen dieser 
Doktorarbeit haben wir solche Zellhüllstress-Antworten mit einem besonderen Fokus auf 
ECF σ-Faktoren untersucht. 
Im ersten Teil dieser Arbeit haben wir die Antwort von B. subtilis auf die zyklischen 
Lipopeptid-Antibiotika Daptomycin und Friulimicin B, welche beide sogar gegen multi-
resistente Gram-positive Pathogene wirksam sind, untersucht und verglichen. Genom-
weite Expressionsanalysen sowohl auf Ebene des Transkriptoms als auch des Proteoms 
zeigten, dass beide Antibiotika eine ECF σ-Faktor-abhängige Antwort induzieren, welche 
hauptsächlich von σM und σV vermittelt wird. Diese Induktion ist sehr viel stärker für 
Friulimicin B als für Daptomycin. Im Gegensatz dazu induziert ausschließlich Daptomycin 
das LiaRS Zweikomponentensystem. Diese Unterschiede in den Expressionsprofilen 
deuten an, dass beide Antibiotika spezifische und komplett verschiedene 
Wirkmechanismen aufweisen, obwohl sie strukturell sehr ähnlich sind und generell die 
Zellhüllintegrität beeinträchtigen. Dies veranschaulicht das große Potential sowie die 
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Spezifität der Analyse solcher Expressionsprofile als einen Ansatz für die 
Charakterisierung neuer Antibiotika oder sogar der Differenzierung zwischen chemisch 
sehr ähnlichen Substanzen. 
Im zweiten Teil haben wir die transkriptionelle Antwort von B. subtilis auf Rhamnolipide 
untersucht, welches von Pseudomonas aeruginosa produzierte und industriell wichtige 
Biotenside sind. Rhamnolipide beeinträchtigen die Integrität von biologischen Membranen 
und weisen somit auch antimikrobielle Eigenschaften auf. Eine auf DNA-Microarrays 
basierende Transkriptom-Analyse von B. subtilis nach Behandlung mit Rhamnolipiden 
zeigte erstmals, dass eine einzige antimikrobiell wirksame Substanz zwei normalerweise 
unabhängige Stressantworten induziert: die Zellhüllstress-Antwort, in diesem Fall vertreten 
durch das Zweikomponentensystem LiaRS und den ECF σ-Faktor σM, und die 
Sekretionsstress-Antwort vermittelt durch das Zweikomponentensystem CssRS. LiaRS und 
σ
M zeigen eine schützende Funktion gegenüber Schädigungen verursacht durch 
Rhamnolipide, während die Rolle des CssRS Zweikomponentensystems in dieser Antwort 
bisher unklar ist.  
Zum Schluss haben wir eine neue Gruppe von ECF σ-Faktoren (ECF41) charakterisiert, 
welche einzigarte Merkmale aufweist und im Rahmen einer umfassenden Klassifizierung 
dieser Proteinfamilie identifiziert wurde. Eine detaillierte bioinformatische Analyse lässt 
eine weite Verbreitung dieser ECF41 σ-Faktoren mit etwa 400 Proteinen aus zehn 
verschiedenen bakteriellen Phyla erkennen. Außerdem weist diese Gruppe einen 
ungewöhnlichen, jedoch stark konservierten genomischen Kontext auf.  Es gibt keinen 
offensichtlichen Anti-σ-Faktor in direkter genomischer Nähe der ECF41 σ-Faktor-
kodierenden Gene. Stattdessen sind sie mit Genen assoziiert, welche entweder 
Carboxymuconolacton-Decarboxylasen, Oxidoreduktasen oder Epimerasen kodieren. 
Diese transkriptionellen Einheiten stellen die einzigen ECF41-abhängigen Zielgene dar 
und besitzen ein stark konserviertes Promotor-Motiv, welches von den dazugehörigen 
ECF41 σ-Faktoren erkannt wird, wie experimentell in Bacillus licheniformis und 
Rhodobacter sphaeroides gezeigt werden konnte. Darüber hinaus haben die ECF41-
Proteine eine große C-terminale Erweiterung, die in keinen anderen ECF σ-Faktoren 
vorkommt. Diese Erweiterung ist wesentlich an der Regulation der ECF41 σ-Faktoren 
beteiligt und fungiert möglicherweise als eine fusionierte Anti-σ-Faktor-ähnliche Domäne. 
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Chapter 1 
Introduction 
Bacteria are very adaptable organisms and inhabit almost every possible habitat. The soil is 
a densely populated ecosystem with an enormous diversity of microorganisms. Microbial 
life in this environment is characterized by high competition between different organisms, 
lack of nutrients and rapidly changing physicochemical parameters, such as temperature, 
oxygen concentration or moisture. To survive in such a complex and life-threatening 
habitat, bacteria have to constantly monitor their environment and respond to changes 
before their vitality is seriously endangered. Therefore, they developed a number of signal 
transducing systems to orchestrate these responses and enable survival even under severe 
stress conditions (Paul & Clark, 1996, Storz & Hengge-Aronis, 2000). 
1.1 The bacterial cell envelope  
The bacterial cell envelope, which includes the membrane(s) and other components 
surrounding the cytoplasm, is an essential and complex multilayered structure. Its integrity 
and functionality is crucial for survival and has to be maintained at any time. The cell 
envelope counteracts the high internal osmotic pressure, gives the cell its shape and 
protects it from environmental threats, but it also serves as a selective barrier for nutrients 
and other molecules. Besides these mere physical characteristics, the cell envelope also 
constitutes an important communication interface between the cell and its surroundings. It 
contains a number of different sensory systems allowing the cell to monitor and respond to 
environmental changes (Dijkstra & Keck, 1996, Silhavy et al., 2010). 
Based on their cell envelope structure and according staining behavior, bacteria can be 
classified into two major groups: the Gram-positives and Gram-negatives (Fig. 1.1) 
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(Popescu & Doyle, 1996). The interior layer of the cell envelope, the inner or cytoplasmic 
membrane, is identical in both groups. It is a phospholipid bilayer containing integral 
membrane proteins, which are often involved in essential processes like energy production 
or transport. However, the outer layers of the cell envelopes of Gram-positive and Gram-
negative bacteria differ significantly and are therefore introduced in detail in the following 
paragraphs. 
 
Figure 1.1. Composition of the Gram-positive and Gram-negative cell envelope. CAP, covalently 
attached protein; IMP, integral membrane protein; LP, lipoprotein; LPS, lipopolysaccharide; LTA, 
lipoteichoic acid; OMP, outer membrane protein; WTA, wall teichoic acid. The figure is taken from (Silhavy 
et al., 2010). 
The outer layer of the Gram-positive cell envelope consists of a multi-layered 
peptidoglycan sacculus, also called cell wall, which can achieve a thickness of up to 50 
nm. This allows the Gram-positive cell to withstand turgor pressures in the order of 20 atm 
(in contrast to 2-5 atm in the case of the single-layered peptidoglycan of Gram-negative 
bacteria (see below)). The overall structure of peptidoglycan can be best described as a 
fisherman’s net, giving the sacculus both enormous strength and flexibility (Delcour et al., 
1999). Another major component of most Gram-positive cell walls are teichoic acids, 
which are polymers of glycerol- or ribitol-phosphate units. They can be either covalently 
attached to the peptidoglycan (wall teichoic acids) or anchored in the cytoplasmic 
membrane (lipoteichoic acids) (Delcour et al., 1999, Neuhaus & Baddiley, 2003). Teichoic 
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acids are responsible for the overall negative net charge of the Gram-positive cell surface 
and can serve as a phosphate reservoir or scavengers of cations (Hughes et al., 1973). 
The composition of the Gram-negative cell envelope is more complex. In addition to a 
thin, often single-layered peptidoglycan sacculus, Gram-negative bacteria contain an outer 
membrane. In contrast to the cytoplasmic membrane, this outer membrane is an 
asymmetrical bilayer composed of phospholipids and lipopolysaccharides at the inner and 
outer leaflet, respectively. Lipopolysaccharides are glycolipids consisting of a hydrophobic 
membrane anchor, termed lipid A, and a covalently attached core oligosaccharide, which is 
often extended by a repeating oligosaccharide, called O-antigen (Bos et al., 2007). 
Lipopolysaccharides can play a role in pathogenicity since they are responsible for the 
endotoxic shock caused by Gram-negative bacteria (Raetz & Whitfield, 2002). Two kinds 
of proteins are associated with the outer membrane: lipoproteins attached to the inner 
leaflet and integral outer membrane proteins with a cylindrical β-barrel conformation. 
While the function of most lipoproteins is still unknown, the integral outer membrane 
proteins often facilitate the passive diffusion of small molecules (Bos et al., 2007, Silhavy 
et al., 2010). The viscous space between the outer and inner membrane is called periplasm. 
It contains a high concentration of different kinds of proteins, for example periplasmic 
binding proteins involved in sugar and amino acid transport or chaperones functioning in 
envelope biogenesis (Silhavy et al., 2010). 
The cell envelopes of some bacteria contain additional components, such as proteinaceous 
structures called S-layers (Sleytr et al., 1993) or extracellular matrices involved in biofilm 
formation (Branda et al., 2005). The Corynebacterineae, including the important pathogen 
Mycobacterium tuberculosis, are generally classified as Gram-positive bacteria, but they 
have a very complex and unusual cell envelope containing  arabinogalactan and covalently 
attached mycolic acids, giving them a waxy appearance and high antibiotic tolerance 
(Dover et al., 2004). 
1.2 Cell wall biosynthesis  
Peptidoglycan is an essential and specific component of the cell envelope of almost all 
bacteria. Its main function is the maintenance of cell shape and integrity. Any degradation 
of the cell wall or inhibition of its biosynthesis consequently results in cell lysis (Vollmer 
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et al., 2008). Although the exact chemical composition of peptidoglycan varies from 
species to species, the main elements are linear glycan strands connected by short peptides. 
The glycan strands consist of alternating N-acetyl-muramic acid and N-acetyl-glucosamine 
molecules linked by β-(1,4)-glycosidic bonds. These glycan strands are crosslinked by a 
pentapeptide bridge attached to N-acetyl-muramic acid, which consequently leads to the 
characteristic net-like structure. Although the bacterial cell wall has been extensively 
studied for decades, even central questions regarding its architecture still remain mostly 
unanswered. One controversy is the orientation of the peptidoglycan components relative 
to the surface and axis of the cell. Two mutually exclusive models are being discussed: the 
“layered” model, in which both the glycan strands and peptides run parallel to the 
cytoplasmic membrane, and the “scaffold” model, in which the glycan strands run 
perpendicular and the peptides parallel to the membrane (Vollmer & Seligman, 2010). 
Another controversial aspect concerns the complexity of the Gram-positive cell envelope. 
Instead of a homogenous cell wall layer, cryo-electron microscopy revealed an inner wall 
zone with low-electron density and an outer wall zone with high-electron density in both 
Bacillus subtilis and Staphylococcus aureus. The outer zone seems to represent the actual 
cell wall consisting of peptidoglycan, while the inner zone can be interpreted as an extra-
protoplasmatic compartment similar to the periplasmic space of Gram-negative bacteria 
(Matias & Beveridge, 2005, Matias & Beveridge, 2006). These data emphasize our limited 
understanding of bacterial cell envelope composition and peptidoglycan architecture, and 
future research might significantly change our current view of these fundamental 
structures. 
The biosynthesis of peptidoglycan can be divided into three sections (Fig. 1.2): (i) 
synthesis of cell wall precursors in the cytoplasm, (ii) membrane-anchored assembly of 
these precursors and transport through the cytoplasmic membrane, and (iii) incorporation 
of new peptidoglycan units into the existing cell wall. Starting point of the cell wall 
biosynthesis is UDP-activated N-acetyl-glucosamine, which comes from the central carbon 
metabolism. N-acetyl-glucosamine is converted to N-acetyl-muramic acid in a two-step 
reaction catalyzed by MurA and MurB. Thereafter, the first three amino acids of the 
pentapeptide, classically consisting of alternating L- and D-amino acids, are added 
successively by the ligases MurC, MurD and MurE. The last two residues of the 
pentapeptide are first united and then attached as a dipeptide. The corresponding enzymes 
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are the ligases Ddl and MurF. The resulting N-acetyl-muramic acid pentapeptide is 
coupled to the lipid carrier undecaprenol-monophosphate at the interior side of the 
cytoplasmic membrane by the translocase MraY. The resulting complex is called lipid I. 
Subsequent addition of N-acetyl-glucosamine by the glycosyltransferase MurG results in 
lipid II, which is comprised of the complete peptidoglycan subunit linked via a 
pyrophosphate to the lipid carrier. The cell wall precursor is then translocated by a flippase 
to the exterior side of the cytoplasmic membrane and incorporated into the existing 
peptidoglycan through transglycosylation and transpeptidation. The remaining 
undecaprenol-pyrophosphate is dephosphorylated and transferred to the interior side of the 
membrane to be available for binding and transfer of another cell wall precursor. The steps 
of cell wall biosynthesis involving the lipid carrier undecaprenol are called lipid II cycle 
(Delcour et al., 1999, Foster & Popham, 2002, Mohammadi et al., 2011).   
 
Figure 1.2. Cell wall biosynthesis and its inhibition by antimicrobial compounds. Important steps of the 
cell wall biosynthesis are shown schematically, their cellular location is indicated below. Cell wall antibiotics 
mentioned in the text are given and placed next to their biological target. Antibiotics in blue sequester the 
substrate of a given step, antibiotics in red inhibit the corresponding enzyme. Daptomycin and rhamnolipids 
as compounds that target the cytoplasmic membrane are displayed in black. The curved line represents the 
lipid carrier undecaprenol, the ovals amino acids. Abbreviations: GlcNac, N-acetyl-glucosamine, MurNac; 
N-acetyl-muramic acid; UDP, uridine diphosphate; UMP, uridine monophosphate; P, phosphate group; Pi, 
inorganic phosphate. Names of amino acids are shown as three-letter code. This figure is taken from (Jordan 
et al., 2008), with modifications.  
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Although a functional peptidoglycan layer seems to be important for cell integrity and 
growth, cell wall-deficient bacteria, so-called L-forms, have been discovered (Dienes, 
1947, Klieneberger, 1935). Since then, L-forms of many different bacterial species have 
been generated and successfully cultured in osmotically protective media. Naturally 
occurring L-forms can also be isolated from human samples and their contribution to a 
variety of diseases has been discussed. In this context, loss of the cell wall in the course of 
L-form formation can be viewed as a neat survival strategy to escape cell wall active 
antibiotics (Wyrick & Rogers, 1973, Glover et al., 2009, Domingue GJ & Woody, 1997). 
1.3 Cell wall antibiotics 
The cell wall and its biosynthesis are preferred targets for antibiotics and almost every step 
is inhibited by at least one of these compounds (Schneider & Sahl, 2010). Important 
antibiotics as well as their site of interference with cell wall biosynthesis are shown in Fig. 
1.2. Although many of them target the later lipid-linked steps, two antibiotics that 
intervene with synthesis of cell wall precursors in the cytoplasm have been developed for 
clinical use and are actually used for treatment of infections in humans. Fosfomycin is a 
broad-spectrum antibiotic that inhibits the first step of cell wall biosynthesis, which is the 
formation of UDP-N-acetyl-glucosamine catalyzed by MurA. This reaction requires 
phosphoenol pyruvate as a cofactor. Fosfomycin is a structural analogue of this cofactor 
and inactivates MurA by covalently binding to an active cysteine residue (Kahan et al., 
1974). Resistance can be gained by enzymatic inactivation of fosfomycin catalyzed by 
metalloglutathione or metallothiol transferases (Bernat et al., 1997, Cao et al., 2001), 
enhanced expression of MurA or alterations in fosfomycin uptake systems (Horii et al., 
1999). 
D-cycloserine prevents completion of the pentapeptide responsible for the net-like 
structure of peptidoglycan. It inhibits two enzymes: the D-alanine racemase, which 
converts L-alanine to D-alanine, and the D-alanine/D-alanine ligase, which forms the 
corresponding dipeptide (Lambert & Neuhaus, 1972, Neuhaus & Lynch, 1964). Resistance 
can be achieved either by removal of the antibiotic with an efflux pump or overexpression 
of the target proteins (Feng & Barletta, 2003, Matsuo et al., 2003). 
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The lipid II cycle is the target of a conspicuously large number of antibiotics (Fig. 1.2). 
One reason for this might be the location at the exterior of the cell and therefore easy 
accessibility of the target for the antibiotic. But also the lipid-anchored steps occurring at 
the inside of the cytoplasmic membrane are inhibited. Tunicamycin inhibits formation of 
lipid I catalyzed by the translocase MraY, but it is not suitable for therapeutic use due to 
inhibition of mammalian glycoprotein biosynthesis. Tunicamycin is structurally similar to 
UDP-activated sugars and therefore blocks the MraY reaction in bacteria (Brandish et al., 
1996). 
Vancomycin, the most medically relevant drug within the large group of glycopeptide 
antibiotics, binds tightly to the terminal D-alanyl-D-alanine of the peptide chain of lipid II 
at the outside of the cell and thereby inhibits the crosslinking (Kahne et al., 2005). Use of 
an alternative dipeptide terminus composed of D-alanyl-D-lactate significantly reduces the 
affinity of vancomycin and results in vancomycin resistance (Walsh et al., 1996). Some 
bacteria naturally use this alternative dipeptide. Therefore, it is not surprising that the 
genetic information for this resistance mechanism was transferred to clinically relevant 
bacteria, for example resulting in vancomycin-resistant S. aureus (VRSA). Vancomycin is 
clinically used as a last resort antibiotic reserved for treatment of serious infections with 
(often multi-resistant) Gram-positive bacteria, but resistance to it becomes more and more 
common (Weigel et al., 2003). 
A new antibiotic for treatment of vancomycin-resistant enterococci, which has been 
already developed into phase III of clinical trials, is ramoplanin, a non-ribosomally 
synthesized lipoglycodepsipeptide antibiotic. The exact mechanism of action (MOA) of 
ramoplanin is not yet completely understood. Inhibition of both the formation of lipid II, 
catalyzed by the glycosyltransferase MurG, and the transglycosylation step of cell wall 
biosynthesis have been suggested as possible targets. Further research indicated that 
binding of lipid II and blocking of transglycosylation is the biologically more relevant 
inhibition mechanism (Breukink & de Kruijff, 2006, Fang et al., 2006, Walker et al., 
2005). 
The phosphoglycolipid antibiotic moenomycin directly inhibits the enzyme catalyzing the 
transglycosylation step. It displays biological activity against various Gram-positive 
bacteria including methicillin- and vancomycin-resistant enterocooci, but it was not further 
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developed into a drug for treatment of infections in humans due to suboptimal 
pharmacokinetic properties (Ostash & Walker, 2010). 
Daptomycin is one of only a few antibiotics that have been approved for clinical use within 
the last decade. This lipodepsipeptide antibiotic is used for treatment of infections caused 
by Gram-positive pathogens and is effective against methicillin-resistant S. aureus 
(MRSA) and vancomycin-resistant enterococci (Baltz et al., 2005). Daptomycin interferes 
with cell envelope integrity, but its mechanism of action is not yet fully understood and a 
defined molecular target within the cell wall biosynthesis pathway has not been identified 
(Schneider et al., 2009). Initial investigations proposed inhibition of lipoteichoic acid 
biosynthesis (Canepari & Boaretti, 1996), but the currently accepted model considers the 
binding to and Ca2+-dependent integration into the cytoplasmic membrane. Subsequent 
oligomerization and pore formation may lead to leakage of ions from the cytoplasm, arrest 
of macromolecular biosynthesis and finally cell death (Silverman et al., 2003). Recent 
studies challenge this model and suggest that binding of Ca2+ ions leads to initial formation 
of micelles in solution accompanied by conformational changes of daptomycin. In close 
proximity to the cytoplasmic membrane, these micelles dissociate and daptomycin may 
insert into the phospholipid bilayer leading to the already mentioned effects (Straus & 
Hancock, 2006). Although daptomycin was introduced to the market only recently, first 
cases of resistance in the clinical environment as well as cross-resistance between 
vancomycin and daptomycin have been reported (Enoch et al., 2007, Hidron et al., 2008, 
Patel et al., 2006). These observations underline the alarmingly rapid resistance 
development and urgent need for the marketing of antibiotics with novel MOAs.  
A promising candidate for such a novel antibiotic is the lipopeptide friulimicin B, which 
has already entered clinical development. Friulimicin B is structurally similar to 
daptomycin and also active against multi-resistant Gram-positive bacteria (Aretz et al., 
2000, Vertesy et al., 2000), but shows a completely different MOA. Instead of impairing 
membrane integrity, it specifically forms a complex with undecaprenol-monophosphate 
and thereby prevents formation of a functional cell envelope in Gram-positive bacteria 
(Schneider et al., 2009). 
Lantibiotics are post-translationally modified peptide antibiotics, which contain the 
unusual amino acid lanthionine as their name-giving feature. Their MOA involves lipid II-
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binding, which is sometimes followed by pore formation. Lantibiotics of group A, 
including nisin, use lipid II as a docking molecule: they first specifically bind to lipid II 
and then form pores, thereby combining inhibition of cell wall biosynthesis with 
membrane permeabilization. In contrast, lantibiotics of group B, for example mersacidin, 
exert their antibacterial activity only by binding lipid II without subsequent pore formation. 
Resistance against these positively charged antibiotics can for example be achieved by 
lowering the overall negative net-charge of the Gram-positive cell envelope by D-alanine 
insertion into teichoic acids (Breukink & de Kruijff, 2006, Schneider & Sahl, 2010).  
Bacitracin is a non-ribosomally synthesized cyclic dodecylpeptide antibiotic primarily 
active against Gram-positive bacteria. It is produced as a mixture of up to 50 different 
congeners (Kang et al., 2001) and requires a divalent metal ion for its biological activity 
(Ming & Epperson, 2002). Bacitracin presumably binds to undecaprenol-pyrophosphate, 
which is released during the transglycosylation reaction. This complex formation prevents 
dephosphorylation of the lipid carrier and thus completion of the lipid II cycle (Stone & 
Strominger, 1971, Storm & Strominger, 1973). Resistance against bacitracin can be 
achieved by removal of the antibiotic by specific transporters (Mascher et al., 2003, Ohki 
et al., 2003a), de novo synthesis of undecaprenol-monophosphate (Cain et al., 1993, 
Chalker et al., 2000), expression of alternative undecaprenol-pyrophosphate phosphatases 
(Bernard et al., 2005, Cao & Helmann, 2002, Ohki et al., 2003b) or exopolysaccharide 
production (Pollock et al., 1994, Tsuda et al., 2002). 
Incorporation of the newly synthesized peptidoglycan units into the existing cell wall is 
targeted by the clinically most important class of antimicrobial compounds, the β-lactam 
antibiotics. Their characteristic feature is a β-lactam ring, which structurally mimics the D-
alanyl-D-alanine terminus of the pentapeptide of peptidoglycan units. Consequently, they 
are recognized by the active site of transpeptidases (which are therefore also called 
penicillin binding proteins), and block the crosslinking of glycan chains catalyzed by these 
enzymes (Strominger & Tipper, 1965). The most important resistance mechanism is the 
synthesis of β-lactamases, which hydrolyze the β-lactam ring and thereby inactivate the 
antibiotic (Ghuysen, 1991). Other resistance strategies are the removal of the antibiotic 
from its active site by efflux pumps (Poole, 2005) or the synthesis of altered penicillin 
binding proteins that maintain their physiological function but show decreased affinity to 
the harmful antibiotic (Dowson et al., 1994, Hakenbeck, 1999). 
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Besides these classical and often clinically relevant antibiotics, a variety of other secondary 
microbial metabolites display biological activity (Berdy, 2005). One example for such 
bioactive secondary metabolites are biosurfactants, which are surface-active molecules 
commercially used for bioremediation processes, as components of cosmetic products or 
detergents (Banat et al., 2000). Some of these biosurfactants, such as rhamnolipids, also 
have antimicrobial properties and could therefore be of interest for therapeutic 
applications. The antimicrobial activity of rhamnolipids is based on cell surface 
modifications like an increase in hydrophobicity and membrane permeability (Lang et al., 
1989, Vasileva-Tonkova et al., 2011). 
1.4 Regulatory networks orchestrating cell envelope stress 
responses  
The presence of antibiotics produced by competing organisms and abiotic stresses like 
suboptimal temperature or pH necessitate the development of signal transducing systems. 
These systems allow the sensing of extracellular stimuli and transfer of the signal through 
the membrane to the cytoplasm, where an appropriate response, usually in the form of 
differential gene expression, is triggered. 
The sensing of and response to cell envelope stress is mediated by two different modes of 
signal transduction: two-component systems (TCSs) and extracytoplasmic function (ECF) 
σ factors. Both systems consist of two proteins: a membrane-anchored sensor (histidine 
kinase (HK) or anti-σ factor, respectively) and a cytoplasmic transcriptional regulator 
(response regulator (RR) or ECF σ factor, respectively). In the absence of an inducing 
stimulus, the regulator is usually kept inactive. Upon perception of a cell envelope stress 
signal by the sensor protein, the regulator becomes activated and mediates the cellular 
response by modifying gene expression (Jordan et al., 2008). The mechanism of signal 
transduction of TCSs and ECF σ factors will be presented in detail in sections 1.5 and 1.6. 
The regulatory networks orchestrating cell envelope stress responses in Escherichia coli 
and B. subtilis are well investigated and will be introduced in the following sections. 
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1.4.1 Cell envelope stress response of Escherichia coli 
The cell envelope stress response of the Gram-negative model bacterium E. coli is 
orchestrated by two TCSs, one ECF σ factor and the phage shock protein system. These 
signal transducing systems partly overlap with regard to their inducing conditions and 
regulons (Rowley et al., 2006, Ruiz & Silhavy, 2005).  
The first TCS, BaeRS, is induced upon exposure to cell envelope stresses in form of 
indole, flavonoids, spheroplast formation or misfolded proteins and controls expression of 
three operons, one of these including the genes encoding the TCS. The other gene products 
are multidrug efflux pumps and a periplasmic protein of unknown function (Leblanc et al., 
2011, Raffa & Raivio, 2002). The second TCS, CpxAR, is induced by various signals 
including alkaline pH, misfolded periplasmic proteins or abnormalities in the inner 
membrane, for example changes in lipid composition. The RR CpxR directly controls 
expression of about 100 operons, some of which are also part of the σE regulon (De Wulf et 
al., 2002, Ruiz & Silhavy, 2005).  
The main signal for activation of the ECF σ factor σE is the accumulation of misfolded 
proteins in the cell envelope, which can be caused for example by heat or ethanol. It 
controls a large regulon of about 50 transcriptional units including genes encoding 
chaperones and proteases involved in cell envelope maintenance (Ades, 2004, Rhodius et 
al., 2006). 
The PspA-mediated phage shock protein response is triggered by a variety of stress 
conditions, including mislocalization of envelope proteins, high temperature, presence of 
proton ionophores and the name-giving filamentous phage infection. The physiological 
role of the phage shock protein response is still unclear, but a function in maintenance of 
membrane integrity and proton-motive force has been discussed (Ades, 2004, Darwin, 
2005, Kleerebezem et al., 1996, Rhodius et al., 2006). 
1.4.2 Cell envelope stress response of Bacillus subtilis 
The cell envelope stress response network of the Gram-positive model organism B. subtilis 
is more complex than that of E. coli and involves four TCSs and at least three ECF σ 
factors (Fig. 1.3). The TCSs can be further divided into two subgroups: the cell envelope 
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stress sensing TCS LiaRS and three paralogous TCSs genetically and functionally linked to 
ABC transporters.  
 
Figure 1.3. Graphical overview of the regulatory network orchestrating the cell envelope stress 
response of B. subtilis. ECF σ factors and the corresponding anti-σ factors are illustrated in green, TCSs 
associated with ABC transporters in blue and the LiaRS system in red. Transmembrane sensor proteins are 
shown on top, the regulators below and the corresponding target genes at the bottom. Arrows indicate 
regulation, dotted lines cross-regulation. Antibiotics inducing these systems are displayed above the graphic. 
Abbreviations: BAC, bacitracin; CAP, cationic antimicrobial peptides; CEP, cephalosporin; DAP, 
daptomycin; FOS, fosfomycin; FRI, friulimicin B; LAN, lantibiotics; MOE, moenomycin; RAM, 
ramoplanin; VAN, vancomycin; CM, cytoplasmic membrane. The figure is taken from (Jordan et al., 2008), 
with modifications. 
The LiaRS TCS strongly responds to a wide variety of cell wall antibiotics, especially 
compounds interfering with the lipid II cycle, such as bacitracin, vancomycin, ramoplanin 
or cationic antimicrobial peptides (Mascher et al., 2004, Pietiäinen et al., 2005). Induction 
can also be observed upon exposure to ethanol, detergents, organic solvents and alkaline 
shock (Mascher et al., 2004, Petersohn et al., 2001, Wiegert et al., 2001). Moreover, the 
LiaRS TCS is activated without any external stimulus at the onset of stationary phase, 
albeit to a much weaker extent compared to antibiotic induction (Jordan et al., 2007). The 
TCS is genetically and functionally linked to a third protein, LiaF, thereby actually 
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constituting a three-component system. This membrane protein acts as a strong inhibitor of 
LiaRS-mediated signal transduction (Jordan et al., 2006). The RR LiaR regulates 
expression of the liaIHGFSR operon. Basal expression of the last four genes, encoding the 
three-component system and the putative membrane-anchored protein LiaG, is ensured by 
a weak constitutive promoter upstream of liaG. Activation of LiaR strongly upregulates 
expression from a promoter upstream of liaI, resulting in the synthesis of two transcripts: a 
major transcript consisting of liaIH and a transcript including the whole operon (Mascher 
et al., 2004).  
Deletion of the inhibitory protein LiaF, which results in a constitutive active RR LiaR, 
induces transcription of two additional loci, yhdYZ-yhdA and ydhE. Although all three 
transcripts expressed under these artificial conditions are preceded by a putative LiaR 
binding site, only expression of liaIH seems to be biologically relevant (Jordan et al., 2006, 
Wolf et al., 2010). LiaH is a phage shock protein homologue and forms large oligomeric 
rings (Wolf et al., 2010), which has been also described for the homologous proteins PspA 
of E. coli and  Vipp1 of Arabidopsis thaliana (Aseeva et al., 2004, Hankamer et al., 2004). 
LiaI is a small membrane protein possibly interacting with LiaH. The physiological role of 
the lia system in B. subtilis is still unclear and only a very few phenotypes associated with 
LiaH have been discovered, including resistance against the cell wall antibiotics 
daptomycin and enduracidin and some oxidative stress agents. It has been suggested that 
the LiaFSR system coordinates a phage shock protein response in B. subtilis and, 
presumably, other Firmicutes bacteria (Wolf et al., 2010). 
The remaining three TCSs involved in orchestrating the cell envelope stress response in B. 
subtilis (Fig. 1.3) are genetically linked to genes encoding ABC transporters, thereby 
forming efficient detoxification modules. The best understood example of these modules is 
the BceRS-BceAB system, which responds to the presence of bacitracin and, to a lesser 
extent, the lantibiotics actagardine and mersacidin as well as the defensin plectasin (Ohki 
et al., 2003a, Staroń et al., 2011). Activation of the RR BceR results in increased 
expression of the ABC transporter BceAB, which functions as a resistant determinant and 
facilitates removal of the antibiotic from its active site (Mascher et al., 2003, Ohki et al., 
2003a). However, BceAB is also crucial for stimulus perception, since the HK BceS alone 
is not sufficient for bacitracin sensing (Bernard et al., 2007, Rietkötter et al., 2008). 
Phylogenetic analysis of BceRS-BceAB-like systems in Firmicutes bacteria revealed a 
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tight evolutionary correlation and suggests a common novel signaling and resistance 
mechanism, possibly involving a sensory complex composed of the HK and ABC 
transporter (Dintner et al., 2011).  
The PsdRS-PsdAB module responds to and mediates resistance against the lipopeptide 
antibiotic enduracidin and the lantibiotics nisin, subtilin, actagardine and gallidermin 
(Staroń et al., 2011). Noteworthy, all these compounds are peptide antibiotics interacting 
with lipid II. Weak induction has also been observed for bacitracin, but it has been shown 
to be due to cross-activation of the RR PsdR by the paralogoues BceRS system (Mascher 
et al., 2003, Rietkötter et al., 2008). 
Only little is known about the third module, YxdJK-YxdLM. As is also true for the other 
systems, expression of yxdLM encoding the ABC transporter is dependent on the RR YxdK 
(Joseph et al., 2004). The only inducer identified so far is the human cationic antimicrobial 
peptide LL-37 (Pietiäinen et al., 2005, Staroń et al., 2011). Since it is unlikely that B. 
subtilis, naturally inhabiting the soil, has evolved systems specifically responding to 
human peptides, a biologically relevant inducer of this module still has to be identified. 
The genome of B. subtilis encodes seven ECF σ factors, of which at least three (σW, σM and 
σ
X) are involved in orchestrating the cell envelope stress response. With regard to its signal 
transducing mechanism and physiological function best investigated ECF σ factor of B. 
subtilis is σW. As is typical for ECF σ factors, the sigW gene is transcribed together with its 
anti-σ factor, rsiW, from an autoregulated promoter. σW is activated by cell wall antibiotics 
such as vancomycin, cephalosporin C or D-cycloserine (Cao et al., 2002b), the mammalian 
cationic peptides LL-37 and PG-1 (Pietiäinen et al., 2005) as well as alkaline shock 
(Wiegert et al., 2001), but it is not required for resistance against these compounds and 
conditions. Its regulon was identified using a combination of different approaches 
including in silico promoter search (Huang et al., 1999), in vivo DNA microarray analysis 
and an in vitro technique called ROMA (Run-Off transcription/Microarray Analysis) (Cao 
et al., 2002a, MacLellan et al., 2009a). Altogether, σW recognizes ~30 promoters 
controlling expression of about 60 genes, many of which encode membrane proteins, 
transporters, small peptides or proteins involved in detoxification. Thus, it has been 
postulated that σW mediates an antibiosis stress response including production of and 
protection against antibiotics (Butcher & Helmann, 2006). Indeed, increased expression of 
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the fosB gene, which is part of the σW regulon, provides resistance against fosfomycin (Cao 
et al., 2001). A sigW mutant is also more sensitive to a wide variety of antimicrobial 
compounds produced by competing Bacillus species. Moreover, systematic deletion of all 
σ
W regulon members identified genes directly conferring resistance against antibiotics, for 
example sdpI against the antimicrobial protein SdpC and the yqeZ-yqfAB operon against 
sublancin (Butcher & Helmann, 2006). 
The gene encoding σM is co-transcribed with yhdLK, which function as negative regulators 
of σM activity (Horsburgh & Moir, 1999). σM is induced under acid, heat, salt and 
superoxide stress as well as upon exposure to cell wall antibiotics like bacitracin, 
vancomycin and fosfomycin (Mascher et al., 2003, Thackray & Moir, 2003, Cao et al., 
2002b). A comprehensive analysis including several complementary approaches identified 
almost 60 genes organized in 30 operons to be direct targets of σM under conditions of 
antibiotic stress. The functions of these genes are very diverse and include gene regulation, 
cell envelope related functions like cell wall synthesis, shape determination and cell 
division, DNA monitoring and repair as well as detoxification (Eiamphungporn & 
Helmann, 2008). For example, bacitracin-induced expression of bcrC, conferring 
resistance against this antibiotic, is dependent on σM, although the corresponding promoter 
is also recognized by σW (Cao & Helmann, 2002). Furthermore, resistance to paraquat, a 
superoxide-generating agent, can be also attributed to σM, which directly controls 
expression of yqjL encoding a putative hydrolase (Cao et al., 2005). Analysis of the σM 
regulon also revealed indirect effects of antibiotic induction. Among the genes controlled 
by σM is spx encoding a transcription factor, which in turn regulates expression of several 
antibiotic-inducible genes. Thereby, σM indirectly controls expression of the Spx regulon 
(Eiamphungporn & Helmann, 2008).  
The gene of the third ECF σ factor, σX, forms an operon with rsiX, encoding the 
corresponding anti-σ factor, and is transcribed during logarithmic and early stationary 
growth phase (Huang et al., 1997). σX controls expression of about ten operons encoding 
proteins involved in cell envelope composition, surface metabolism and cell division (Cao 
& Helmann, 2004). Based on these functions, it has been suggested that σX generally 
regulates modification of the cell envelope. The products of the σX target operon 
dltABCDE introduce positively charged amino acids into teichoic acids, thereby reducing 
the negative net charge of the cell wall. These changes in cell surface charge consequently 
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affect both autolysis and resistance to cationic antimicrobial peptides. Indeed, a sigX 
mutant strain shows increased autolysis and is more sensitive to nisin (Cao & Helmann, 
2004), thereby supporting the hypothesis that σX plays a role in cell surface modification.  
ECF σ factors control expression of often large regulons with a significant regulatory 
overlap (Mascher et al., 2007, Qiu & Helmann, 2001). A stimulus does not always activate 
a single ECF σ factor, which mediates a proper response by upregulation of a specific 
regulon. Rather, the ECF response is more complex and often involves several ECF σ 
factors controlling distinct but overlapping sets of genes. Therefore, it is not surprising that 
mutations in single ECF-encoding genes do not always lead to obvious phenotypes. While 
single mutations do not affect antibiotic susceptibility, simultaneous deletion of σW, σM and 
σ
X revealed increased sensitivity against cell wall antibiotics such as D-cycloserine, nisin 
and cephalosporin C (Mascher et al., 2007). 
1.5 Signal transducing mechanisms orchestrating cell envelope 
stress responses 
Bacterial signal transducing systems consist of at least two domains: an input or sensor 
domain, which detects the signal, and an output or effector domain, which orchestrates the 
cellular response. These two domains can be located on one polypeptide chain, as is true 
for one-component systems, or separated on two different proteins (Fig. 1.4). The principle 
of two co-operating proteins, which is represented by TCSs and ECF σ factors, enables 
transmembrane signaling. This includes the sensing of an extracellular stimulus and 
transfer of the signal through the membrane to the cytoplasm, where the effector mediates 
a proper cellular response, usually in the form of differential gene expression.  
1.5.1 One-component systems 
One-component systems are the simplest and most widely distributed form of bacterial 
signal transduction, in which the input and output domains are fused on a single 
polypeptide chain. The input domain perceives a signal and then modulates activity of the 
output domain, which usually functions as a transcriptional regulator. This regulator either 
activates or represses transcription of its target gene(s), whose number can vary from a 
single gene up to several hundred (Ulrich et al., 2005). Classical examples for such 
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transcriptional regulators are the E. coli lac repressor LacI (Lewis et al., 1996) or the 
cAMP receptor protein (CRP) (Kolb et al., 1993).  
 
Figure 1.4. Overview of signal transducing systems in bacteria. The modular structure of one-component 
systems, TCSs and ECF σ factors as well as their basic signal transducing mechanism are shown 
schematically. See text for details. This figure is taken from (Staroń & Mascher, 2010a).  
1.5.2 Two-component systems 
While one-component systems are predominantly designed to respond to intracellular 
signals, TCSs are suitable for transmembrane signaling. A classical TCS consists of two 
different proteins: a sensor protein, which functions as a HK, and an effector protein, the 
RR. Both proteins contain at least two domains and the signal transduction is based on 
phosphotransfer reactions. The HK senses a specific stimulus with its N-terminal input 
domain, which results in an intramolecular conformational change and 
autophosphorylation of a conserved histidine residue within the C-terminal transmitter 
domain. Subsequently, this phosphate group is transferred to a conserved aspartate residue 
within the N-terminal receiver domain of the RR. The cellular response is then mediated 
by the C-terminal effector domain of the activated RR and usually involves protein-DNA 
interaction leading to differential gene expression. The whole system is set back to the pre-
stimulus state by dephosphorylation of the RR, catalyzed either by an external 
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phosphatase, the corresponding HK or the RR itself (Mascher et al., 2006, Stock et al., 
2000).  
Depending on their architecture, HKs can be divided into three main groups, which 
perceive either an extracellular, a cytoplasmic or a membrane-associated stimulus. The 
largest group contains the extracellular-sensing HKs, typically detecting the presence of 
solutes or nutrients. These kinases are transmembrane proteins with at least two 
transmembrane helices flanking a large extracellular sensory domain. The kinase domain is 
located in the cytoplasm, which necessitates signal transduction through the membrane 
(Mascher et al., 2006). One of the best investigated HKs, EnvZ from E. coli, belongs to 
this group. Together with its cognate RR OmpR, this TCS plays a central role in the 
adaptation to changes in extracellular osmolarity, although the periplasmic domain of 
EnvZ does not seem to be essential for sensing the corresponding signal (Leonardo & 
Forst, 1996, Tanaka et al., 1998). 
The second-largest group contains the cytoplasmic-sensing HKs. These are membrane-
anchored or soluble proteins, in which both the sensory and kinase domain are located in 
the cytoplasm. Signals sensed by these kinases are mainly cytoplasmic solutes or proteins 
reporting the physiological state of the cell (Mascher et al., 2006). Well-understood 
examples of this group are KinA, involved in sporulation of B. subtilis (Msadek, 1999), 
and CheA, which regulates chemotaxis in proteobacteria (Bilwes et al., 2003). 
The third and very diverse group is formed by HKs that possess two to 20 transmembrane 
regions, which are connected by very short intra- or extracellular linkers. An obvious 
sensory domain is missing in these proteins, suggesting that the stimulus sensed by these 
kinases is within or associated with the membrane interface. Such stimuli could be loss of 
cell envelope integrity, ion gradients, change of mechanical parameters such as turgor 
pressure or signals derived from other transmembrane proteins. HKs of TCSs orchestrating 
the cell envelope stress response in B. subtilis, such as LiaRS or BceRS, belong to this 
group (Mascher, 2006, Mascher et al., 2006).  
The examples mentioned above demonstrate the enormous variety of signals that can be 
sensed by TCSs. However, not only the input but also the output can vary depending on the 
effector domain of the RR. About two-thirds of all known RRs contain a DNA-binding 
domain, thereby functioning as transcriptional regulators. But they can also have 
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enzymatic, RNA-, ligand- or protein-binding domains, enabling almost unlimited 
variations in the response mediated by these proteins (Galperin, 2006, Galperin, 2010).   
The modularity of both the HK and the RR further increases the flexibility of TCSs. The 
signal transducing process does not necessarily have to lead from a single HK to a single 
RR. Rather, the modular architecture enables modifications such as amplification, 
branching of pathways or even integration of different signals into one cascade, thereby 
leading to the same output (Gao & Stock, 2009). 
1.5.3 Alternative σ factors and the extracytoplasmic function protein family 
Another possibility to control gene expression at the level of transcription initiation is the 
use of σ factors, which constitute an essential component of the RNA polymerase (RNAP). 
Transcription is a complex and highly coordinated process. The bacterial RNAP consists of 
a core complex with a subunit stoichiometry of α2ββ’ω. This core enzyme is capable of 
transcription elongation and termination. Promoter recognition and transcription initiation 
additionally require the σ factor, which binds to the core enzyme and recruits the resulting 
RNAP holoenzyme to an appropriate promoter. Therefore, σ factors can be considered as 
specificity factors providing a fundamental mechanism for orchestrating differential gene 
expression (Burgess & Anthony, 2001). 
All bacteria contain a primary (or housekeeping) σ factor, which is responsible for general 
expression of most genes. In addition, most bacteria - especially those living in complex 
habitats - contain alternative σ factors, which are only activated under certain conditions. 
They compete with and eventually replace the primary σ factor, thereby redirecting RNAP 
to initiate transcription from a specific set of alternative promoters. In the absence of a 
stimulus, alternative σ factors are kept inactive by a cognate anti-σ factor through direct 
protein-protein interaction (Brown & Hughes, 1995, Helmann, 2010, Helmann & 
Chamberlin, 1988).  
Bacterial σ factors can be divided into two major groups: the σ70 and the σ54 protein family 
(Gruber & Gross, 2003, Helmann & Chamberlin, 1988). The σ54-like proteins are unique 
transcriptional activators and do not show any sequence homology to other σ factors. 
Although they are widely distributed, not every bacterium harbors a σ54 protein and, if 
present, usually no more than one σ54-encoding gene is found in a genome (Buck et al., 
2000). In contrast, every bacterium contains at least one, but often several (up to 63 in 
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Streptomyces coelicolor) proteins of the σ70 family, which is named after the prototypical 
primary σ factor of E. coli. Based on their domain architecture, the proteins of this family 
can be divided into four phylogenetic groups, often correlating with specific functions. 
Group 1 contains the essential primary σ factors, such as the name giving σ70 of E. coli or 
σ
A of B. subtilis, which are composed of four distinct domains (designated regions σ1 
through σ4) as well as a non-conserved region (NCR) adjacent to σ2. Proteins of group 2 
have the same domain architecture and are therefore closely related to group 1 σ factors, 
but they are not essential for growth. The most extensively studied example of this group is 
σ
S, the master regulator of the general stress response in E. coli. Proteins of group 3 lack 
both the σ1 domain and the NCR. They are more divergent in sequence than proteins of 
group 1 and 2 and can be further divided into clusters correlating with specific functions, 
including flagella biosynthesis, sporulation and heat shock response. Group 4 is the 
numerically largest and most diverse group and contains the proteins of the ECF family, 
named after their function in response to extracellular stimuli (Gruber & Gross, 2003, 
Helmann & Chamberlin, 1988, Paget & Helmann, 2003).  
The ECF σ factors are the smallest proteins of the σ70 family and contain only two of the 
four conserved domains, σ2 and σ4 (Fig. 1.5 A), which are sufficient for all σ factor 
functions, e.g. interaction with RNAP and recognition of specific target promoters. Each 
domain can be further subdivided into distinct regions. Domain σ2 comprises regions 2.1 to 
2.4. The first two of these regions are important for RNAP core binding, while region 2.4 
recognizes the -10 element of promoter DNA. Region 2.3 is involved in promoter melting. 
Domain σ4 also interacts with RNAP and is involved in recognition and binding of the -35 
promoter element, primarily via the helix-turn-helix motif of region 4.2 (Gruber & Gross, 
2003). The classical promoter region recognized by the primary σ factor consists of two 
highly conserved regions, the -10 (‘TTGACA’) and the -35 (‘TATAAT’) region 
(Helmann, 1995). In contrast, the ECF σ factors recognize alternative promoter sequences, 
often characterized by a highly conserved ‘AAC’ motif in the -35 and ‘CGT’ in the -10 
region (Fig. 1.5 B) (Helmann, 2002, Lane & Darst, 2006).  
ECF σ factors can be easily recognized due to their domain architecture and consequently 
smaller size compared to other σ factors. They are widely distributed within the bacterial 
kingdom and bacteria contain an average of six ECF genes per genome. Only a very few 
organisms, mostly obligate symbionts or pathogens with very small genomes, do not 
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harbor any ECF σ factor at all. A classification based on sequence similarities and genomic 
context conservation identified more than 40 distinct groups of ECF σ factors (Staroń et 
al., 2009). The two predominant groups contain the RpoE-like and FecI-like proteins, 
whose signal transducing mechanisms have been well studied in E. coli. Another large 
group includes ECF σ factors associated with cytoplasmic-sensing anti-σ factors, which 
also have been investigated experimentally. In addition to these well characterized types of 
ECF σ factors, the classification identified a number of novel groups with unique features 
and so far unknown signaling mechanisms (Staroń et al., 2009). An overview of already 
well-established ECF-dependent signal transduction as well as possible novel types of 
signal transducing mechanisms is given in the following section. 
 
Figure 1.5. Domain architecture and target promoters of ECF σ factors. (A) Domain architecture of ECF 
σ factors with domains σ2 and σ4 as well as according subregions are shown schematically. C and N 
correspond to the C- and N-terminus. Interactions of subregions 2.4 and 4.2 with the target promoter -10 and 
-35 region, respectively, are indicated by arrows. (B) Weblogo of typical ECF-dependent target promoters. 
The weblogo was generated using the WebLogo tool (Crooks et al., 2004) available at 
http://weblogo.berkeley.edu. It graphically represents a position weight matrix and illustrates the degree of 
conservation for each nucleotide. The matrix is based on the shown autoregulated promoters of the seven 
ECF σ factors from B. subtilis (Butcher et al., 2008). 
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1.6 Mechanisms of ECF σ factor activation 
In general, the activity of an ECF σ factor is controlled by a cognate anti-σ factor, often 
consisting of a cytoplasmic and an extracellular domain linked by one transmembrane 
helix. In the absence of a stimulus, the anti-σ factor tightly binds the ECF σ factor with its 
inhibitory cytoplasmic domain, thereby preventing RNAP interaction and promoter 
recognition. In the presence of a suitable stimulus, the anti-σ factor gets inactivated. This 
results in the release and subsequent activation of the ECF σ factor, which then substitutes 
the primary σ factor and initiates transcription from alternative promoters (Helmann, 
2002). While the ECF σ factors show a highly conserved domain structure, the 
composition of anti-σ factors is very diverse. Some of them contain a so-called anti-sigma 
domain (ASD), but other anti-σ factors are comprised of domains of unknown function. 
Consequently, the mechanisms of stimulus perception and subsequent ECF σ factor 
activation also differ significantly. The few already well-investigated examples 
demonstrate an enormous mechanistic diversity (Fig. 1.6) and there is still a great potential 
for the identification of completely novel ECF-dependent signal transducing mechanisms 
(Staroń et al., 2009).  
1.6.1 Regulated proteolysis of transmembrane anti-σ factors 
The best understood mechanism of ECF σ factor activation is regulated intramembrane 
proteolysis (RIP), in which an environmental stimulus results in complete proteolytic 
degradation of a transmembrane anti-σ factor (Fig. 1.6 A). The first step of RIP, called site-
1 proteolysis, comprises the proteolytic processing of the extracytoplasmic part of the anti-
σ factor. This step is necessary to make the anti-σ factor accessible for site-2 proteolysis, 
which represents the actual intramembrane cleavage event. The family of peptidases 
catalyzing this key step of RIP has been named intramembrane cleaving proteases (I-
CLiPs). The complex of the remaining anti-σ/ECF σ factor is then released to the 
cytoplasm, where the anti-σ factor is completely degraded by additional proteases, leading 
to a free and thereby activated σ factor (Heinrich & Wiegert, 2009).  
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Figure 1.6. Examples of ECF-dependent signal transduction. See text for details. This figure is taken 
from (Staroń & Mascher, 2010a). 
The best investigated ECF σ factors regulated by RIP are σE of E. coli and σW of B. 
subtilis. σE forms a complex with its transmembrane anti-σ factor RseA and the 
periplasmic protein RseB, which has an additional inhibitory function. The cascade leading 
to active σE is triggered by misfolded outer membrane proteins. A conserved peptide at the 
C-terminus, which is only exposed when these outer membrane proteins are not folded 
properly, binds to and activates the membrane-anchored serine protease DegS. Active 
DegS is responsible for site-1 proteolysis and removes the C-terminal part of RseA, 
thereby making it a substrate for the membrane-embedded RseP protease. This site-2 
protease cleaves RseA within the membrane and the remaining complex of processed 
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RseA and σE is released into the cytoplasm. Site-2 clipped RseA presents a C-terminal 
proteolytic tag, which is recognized by cytoplasmic proteases such as ClpXP. Subsequent 
complete degradation of RseA results in a free and active σE able to start transcription of 
corresponding target genes, including its own autoregulated operon rpoE-rseABC (Ades, 
2008, Ades, 2004). 
σ
W from B. subtilis is kept inactive by direct interaction with the N-terminal part of the 
transmembrane anti-σ factor RsiW. The proteolytic cascade leading to activation of σW 
basically resembles the σE/RseA system described above. Nevertheless, there are some 
remarkable differences and the proteases involved can be grouped into two proteolytic 
modules. Module I consists of the proteases PrsW and Tsp. Site-1 proteolysis is mediated 
by PrsW, but the exact molecular signal activating this protease is still unknown. In 
contrast to E. coli DegS, which is a classical serine protease, PrsW belongs to a 
superfamily of probably membrane-embedded metalloproteases. Further C-terminal 
degradation of site-1 processed RsiW by the tail-specific protease Tsp is crucial for RsiW 
to become a substrate for module II, which consists of RasP and cytoplasmic proteases like 
ClpXP. As in E. coli, site-2 proteolysis, which is catalyzed by RasP, uncovers a proteolytic 
tag recognized by ClpXP. Complete degradation of the anti-σ factor leads to activation of 
σ
W and consequently expression of sigW-rsiW and other target genes (Heinrich et al., 2009, 
Heinrich & Wiegert, 2006, Heinrich & Wiegert, 2009). 
1.6.2 Conformational change of soluble anti-σ factors 
Anti-σ factors are not necessarily transmembrane proteins. Instead, they can also be 
soluble proteins, thereby sensing cytoplasmic stimuli. Their inactivation and therefore 
release of the ECF σ factor is based on an intramolecular conformational change (Fig. 1.6 
B). The best understood example for such an anti-σ factor is ChrR of Rhodobacter 
sphaeroides controlling activity of the ECF σ factor σE, which is responsible for the 
cellular response to singlet oxygen (Anthony et al., 2004, Anthony et al., 2005). ChrR is 
comprised of two domains: an N-terminal ASD domain and a C-terminal cupin-like 
domain (CLD). In contrast to other ASD-containing anti-σ factors, ChrR requires Zn2+ ions 
for its inhibitory function. Therefore, ChrR and similar cytoplasmic-sensing anti-σ factors 
are members of the so-called ZAS (Zn2+ anti-σ) family. In the absence of singlet oxygen, 
ChrR binds σE with its ASD. While this domain is sufficient to inhibit activity of the ECF 
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σ factor, the transcriptional response to singlet oxygen requires the CLD. Singlet oxygen 
causes dissociation of the σE/ChrR complex, resulting in expression of its autoregulated 
operon rpoE-chrR and cycA, encoding the periplasmic electron carrier cytochrome c2 
(Greenwell et al., 2011, Newman et al., 2001, Newman et al., 1999). 
Another example for an anti-σ factor of the ZAS family is RsrA of S. coelicolor, which 
regulates the activity of σR. Like ChrR, RsrA coordinates a Zn2+ ion and forms a complex 
with σR. The Zn2+ ion is released in the presence of thiol-oxidative stress, resulting in 
formation of a disulfide bond between two histidine residues and consequently a 
conformational change that releases and therefore activates σR (Zdanowski et al., 2006, 
Kang et al., 1999). Many of the σR-dependent target genes encode proteins involved in 
counteracting thiol-oxidative stress, such as thioredoxins, and proteins involved in 
biosynthesis of thiol-containing compounds like cysteine and molybdopterin (Paget et al., 
2001). 
1.6.3 Transcriptional activation involving a two-component system 
The signal transducing mechanism leading to activation of an ECF σ factor not always 
involves an anti-σ factor. Instead, the ECF σ factor can also form a functional module with 
a TCS (Fig. 1.6 C), as has been shown for σE from S. coelicolor. Here, transcription of the 
ECF σ factor, which is required for normal cell envelope integrity, is controlled by the 
TCS CseBC. CseC is a membrane-anchored HK that perceives the signal and 
phosporylates the cognate RR CseB. The signal sensed by CseC has yet to be identified, 
but it most likely arises from cell envelope damage, since σE is activated by a wide range 
of unrelated cell wall antibiotics. The activated RR CseB induces transcription of sigE, the 
structural gene encoding the ECF σ factor. This leads to an increase in the cellular 
concentration of σE, which, in turn, replaces other σ factors and redirects expression to its 
target genes. In addition to primarily monocistronic transcription, sigE is also part of a 
larger operon including the genes encoding CseA and the TCS CseBC. CseA is a 
lipoprotein localized at the outside of the cytoplasmic membrane, which somehow 
influences CseBC activity, but the specific function and mechanism is still unclear (Hong 
et al., 2002, Hutchings et al., 2006, Paget et al., 1999). 
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1.6.4 Partner switching mechanism 
The signal transduction pathway leading to an active ECF σ factor can be even more 
complex involving both an anti-σ factor and a specialized TCS (Fig. 1.6 D). Such an 
unusual and elaborate cascade mediates the general stress response of α-proteobacteria. 
The best-understood and name-giving example is EcfG from Methylobacterium extorquens 
(Francez-Charlot et al., 2009), but the signal transducing mechanism has been also 
investigated in other α-proteobacteria including Bradyrhizobium japonicum, Sinorhizobium 
meliloti, Caulobacter crescentus and Rhizobium etli (Alvarez-Martinez et al., 2007, Bastiat 
et al., 2010, Gourion et al., 2009, Martinez-Salazar et al., 2009, Sauviac et al., 2007). 
Besides the actual EcfG-like σ factor, the cascade usually involves three additional 
proteins: a NepR-like anti-σ factor, a PhyR-like RR and often a HK. The structural genes 
encoding these proteins are organized in a well-defined but variable locus (Staroń et al., 
2009). NepR-like anti-σ factors are small soluble proteins that bear no sequence similarity 
to other anti-σ factors. The PhyR-like proteins are unusual RRs with specialized domain 
architecture. In contrast to other RRs, PhyR-like proteins carry the receiver domain at the 
C-terminus. The N-terminal output domain shows high sequence similarity to ECF σ 
factors, especially to EcfG-like proteins. Nevertheless, important residues for DNA 
binding are missing, indicating that PhyR-like RRs do not function directly as 
transcriptional regulators. Rather, PhyR-like RRs mimic EcfG-like proteins and function as 
anti-anti-σ factors. As an additional component, genes encoding HKs are often located in 
close vicinity of the EcfG-like σ factors. These HKs are very diverse in sequence and 
domain architecture and can be either periplasmic- or cytoplasmic-sensing proteins. The 
only specific feature can be found within the phosphotransfer domain. HKs linked to EcfG-
like σ factors carry one of two very similar domains predominantly found in α-
proteobacteria, thereby distinguishing them from other HKs (Francez-Charlot et al., 2009, 
Herrou et al., 2010, Staroń & Mascher, 2010b, Staroń & Mascher, 2010a). 
In the absence of a stimulus, NepR-like anti-σ factors bind EcfG-like σ factors, thereby 
keeping them inactive. An appropriate stimulus, such as heat and osmotic stress or carbon 
and nitrogen starvation, is most probably sensed by the associated HK, leading to 
phosphorylation and thereby activation of the PhyR-like RR. Activated PhyR-like proteins 
function as anti-anti-σ factors and release of the σ factor from the anti-σ factor occurs via a 
Chapter 1 
27 
partner switching mechanism. The ECF σ factor-like domain of phosphorylated PhyR has 
high affinity for the NepR-like anti-σ factors, thereby replacing EcfG-like proteins. This 
allows the ECF σ factors to associate with RNA polymerase and initiate transcription of 
stress-related gene (Francez-Charlot et al., 2009, Francez-Charlot et al., 2010). 
1.6.5 Activation involving protein-protein interactions 
Stimulus perception can also be achieved by direct interaction of the anti-σ factor with 
other proteins usually not involved in signal transduction (Fig. 1.6 E). The best 
investigated example for such a mechanism is the FecI-FecR pair, which regulates iron 
acquisition in E. coli. The signal transducing cascade communicating the presence of ferric 
citrate from the outside of the cell to the cytoplasm involves the outer membrane 
transporter protein FecA, which serves as a signal receiver and outer membrane 
transmitter. In the absence of ferric citrate, the anti-σ factor FecR binds the ECF σ factor 
FecI with its N-terminal ASD, thereby keeping FecI inactive. Is ferric citrate present in the 
environment, it is bound by FecA and the signal is transferred by direct protein-protein 
interaction from the periplasmic N-terminal domain of FecA to the periplasmic C-terminus 
of the anti-σ factor FecR. This signal is transmitted by an unknown mechanism through the 
inner membrane, resulting in activation of FecI, which initiates transcription of the 
fecABCDE operon, encoding a ferric citrate uptake system. Contradictory to the anti-σ 
factor paradigm, FecR remains intact after signal transduction and is even required for full 
FecI-dependent transcription, thereby acting as both an anti-σ factor and mediator of σ 
factor activity. Transcription of the fecIR operon, encoding the ECF σ and anti-σ factor, 
respectively, is not autoregulated. Instead, its expression is controlled by the Fur repressor, 
whose inhibitory function is abolished at low intracellular iron concentrations. This ensures 
the presence of the regulatory components when iron is limited, while expression of the 
corresponding uptake system additionally requires the availability of the specific substrate 
(Braun & Mahren, 2005, Braun et al., 2006). 
1.6.6 Novel types of ECF-dependent signal transducing mechanisms 
In addition to these well-established ECF σ factor-dependent signal transducing 
mechanisms described above, the comprehensive classification of ECF σ factors by Staroń 
and colleagues identified a number of novel groups with unique features (Fig. 1.6 F). Most 
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of them have not been intensively studied, but initial characterization of some proteins as 
well as data derived from sequence and genomic context analyses indicate the discovery of 
yet completely unknown signaling modules and mechanisms. Some of these ECF σ factors 
are associated with unusual anti-σ factors, either carrying domains of unknown function or 
having a special architecture, for example regarding the number of transmembrane regions. 
Other ECF σ factors are genomically linked to completely unrelated proteins like sensor 
kinases or enzymes. Moreover, in some cases the ECF σ factor itself contains additional 
domains, while an obvious anti-σ factor is missing (Staroń et al., 2009). 
1.7 Aims of this work 
The response to cell envelope stress is orchestrated by two signal transducing principles: 
TCSs and ECF σ factors, both consisting of an often membrane-anchored sensor protein 
and a cytoplasmic regulator, which mediates the cellular response in form of differential 
gene expression. These systems allow the sensing of and response to cell envelope-related 
stimuli, which could be the presence of harmful compounds like antibiotics or a general 
loss of cell envelope integrity (Jordan et al., 2008). 
One aim of this work was to elucidate the response of the Gram-positive model organism 
B. subtilis to compounds that interfere with or inhibit biosynthesis of a functional cell 
envelope. First, the response to two clinically relevant antibiotics, daptomycin and 
friulimicin B, should be investigated by global in-depth expression profiling at both the 
transcriptome and proteome level. These two antibiotics are structurally similar and 
interfere with cell envelope integrity, but it has been suggested that they have a completely 
different molecular MOA. Similarities and differences in the expression profiles as well as 
comparison with responses provoked by antibiotics with already well-known targets should 
provide data to gain a deeper understanding of the specific MOA of daptomycin and 
friulimicin B. Secondly, the transcriptional response of B. subtilis to rhamnolipids, which 
are biosurfactants produced by the soil bacterium Pseudomonas aeruginosa, should be 
investigated by DNA microarray analysis. While rhamnolipids are not used for treatment 
of infections, thereby not being classical antibiotics, they show antimicrobial activity. The 
resulting gene expression profile should be further analyzed and possible resistance 
determinants identified. 
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The second aim of this work was the characterization of a novel group of ECF σ factors 
(ECF41), which was identified by a comprehensive classification of this protein family 
(Staroń et al., 2009). Special features of this group are the lack of an obvious anti-σ factor 
and an unusual C-terminal extension of the ECF proteins. The phylogenetic distribution 
and genomic context conservation of this novel group should be determined. A target 
promoter as well as the corresponding target genes should be identified by both in silico 
and in vivo approaches, possibly assigning a function to the ECF41 σ factors. Moreover, a 
potential role of the C-terminal extension in the signal transducing process should be 
considered and the influence of mutations and truncations on promoter activation and 
interaction with RNAP should be investigated. To gain a representative understanding of 
the whole group of ECF41 σ factors, experiments should be carried out in two organisms 
from different bacterial phyla, namely Bacillus licheniformis and R. sphaeroides. 
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The related lipo(depsi)peptide antibiotics daptomycin and friulimicin B show great potential in the treat-
ment of multiply resistant gram-positive pathogens. Applying genome-wide in-depth expression profiling, we
compared the respective stress responses of Bacillus subtilis. Both antibiotics target envelope integrity, based
on the strong induction of extracytoplasmic function  factor-dependent gene expression. The cell envelope
stress-sensing two-component system LiaRS is exclusively and strongly induced by daptomycin, indicative of
different mechanisms of action in the two compounds.
Staphylococcus aureus is a leading cause of nosocomial in-
fections, especially in mechanically ventilated patients. Its re-
markable potential to acquire and accumulate high-level resis-
tance against most of the classical antibiotics (including
vancomycin) used for the treatment of gram-positive infections
is one of the reasons for the ongoing mortality caused by
hospital-acquired S. aureus infections (7, 17).
Daptomycin is the first of a new class of cyclic lipodepsipep-
tide antibiotics (Fig. 1A) with strong bactericidal activities
against gram-positive pathogens (2). It interferes with cell en-
velope integrity, and cell death occurs presumably by either
membrane depolarization or membrane perforation (19, 20).
Friulimicin B, an acidic, cyclic lipopeptide produced by Acti-
noplanes friuliensis, shows structural similarities to daptomycin
(Fig. 1B) and is also active against multidrug-resistant gram-
positive bacteria (1, 22).
As part of a coordinated effort to study and characterize its
mode of action, we have performed comparative in-depth ex-
pression profiling for both antibiotics. This technique is a pow-
erful approach to elucidate the inhibitory mechanisms of novel
antimicrobial compounds (4, 9) and has been successfully ap-
plied to characterize and differentiate antimicrobial actions,
often using Bacillus subtilis as a model organism (3, 10). B.
subtilis is particularly well suited for studying cell wall antibi-
otics, since the regulatory network orchestrating its cell enve-
lope stress response (CESR) is well characterized. It consists of
four two-component systems and at least four extracytoplasmic
function (ECF)  factors (11).
Here, we present results from an in-depth analysis of the
expression signature provoked by the treatment of B. subtilis
with sublethal amounts of daptomycin and friulimicin B. Our
data show that both antibiotics specifically target cell envelope
integrity. But significant differences in the corresponding
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FIG. 1. Chemical structures of the lipodepsipeptide antibiotic dap-
tomycin (A) and the lipopeptide antibiotic friulimicin B (B).
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CESRs, as clearly documented by transcriptomics, proteomics,
and detailed gene expression profiling, strongly suggest differ-
ent modes of action of the two structurally related antibiotics.
(This study was presented in part at the 47th International
Conference on Antimicrobial Agents and Chemotherapy, Chi-
cago, IL, 17 to 20 September 2007 [25]).
Transcriptomics and proteomics. For microarray experi-
ments, midlogarithmic cultures of B. subtilis were challenged
with 1 g/ml (sublethal amounts) of either daptomycin or
friulimicin B. The cells were harvested 10 min postinduction,
and cell pellets were directly snap-frozen in liquid nitrogen.
RNA preparation and microarray experiments were per-
formed essentially as described previously (13, 23). To validate
the gene expression profiles, we also performed two-dimen-
sional gel electrophoresis of the cytoplasmic proteome of B.
subtilis cells, quantifying de novo protein synthesis after the
addition of daptomycin or friulimicin B by incubating the cul-
tures in the presence of L-[35S]methionine, as described previ-
ously (3). The results are summarized in Table 1 and Fig. 2.
The complete microarray data sets can be found in the sup-
plemental material and, together with additional supporting
information, at http://microbial-stress.iab.kit.edu/87.php.
Both antibiotics induced a limited number of genes, most of
which could be assigned to known CESR regulons. Daptomy-
cin specifically and strongly activated the LiaRS two-compo-
nent system, with more than 200-fold induction of its primary
target genes, liaIH. This induction has also been observed
recently in an independent study (9a) and is in good agreement
with data from the orthologous VraSR system of S. aureus
which was also induced by daptomycin (16). Moreover, a
strong LiaH induction was also observed with proteomics anal-
ysis, where it was identified in three strong neighboring spots
(differing in their isoelectric points), indicative of posttransla-
tional modifications (Fig. 2).
Both compounds induced numerous genes known to be reg-
ulated by ECF  factors. This ECF-dependent response was
much stronger for friulimicin B (Table 1). In addition, only
seven genes/proteins of unknown regulation were differentially
expressed (Table 1 and Fig. 2), including the actin homolog
mreBH, which was induced about three- to fourfold by both
TABLE 1. Marker genes induced by daptomycin and/or friulimicin B
Gene(s)a
Induction by:b
Regulator(s)c Localization(putative)d Homology, function, remarks
e
DAP FRI
ywaC 4.5  4.3 8.7  3.8 V, M, W C Putative GTP-pyrophosphokinase
mreBH 3.9  1.9 3.1  1.2 C Control of cell shape; membrane-associated
ydaH 3.3  0.3 9.1  2.4 M M Conserved membrane protein
yqjL 3.3  0.3 8.9  1.6 V, M C Putative hydrolase
bcrC 3.3  1.0 8.2  2.8 V, M, W, X M Undecaprenyl pyrophosphate phosphatase
yrhH 3.1  1.3 8.5  3.4 V, M, W C Putative methyltransferase
liaIH(GFSR) 429  53  LiaRS M, S Conserved membrane protein; phage-shock protein A
homolog (three-component regulatory system)
gerAAABAC 15  2.9  (LiaRS) M, S Downstream lia operon, known polar effect from PliaI
ybeF 4.6  0.9  M Conserved membrane protein
sigM-yhdLK  7.4  4.0 M C, M ECF  factor
yjbC-spx  7.2  1.7 V, M, W C Glutaredoxin family; transcriptional regulator Spx
sms-yacKL  7.1  0.5 M C, C, M DNA repair/binding proteins; membrane protein
radC  6.9  2.1 M C DNA repair protein
ypuA  6.5  2.3 M S Conserved hypothetical
ypbG  6.4  1.0 M S Putative phosphoesterase
ypuD  6.2  0.7 M S Unknown
ycgRQ  5.9  0.6 V, M M Conserved membrane protein; permease
yrhIJ  5.7  0.8 M C, Cytochrome P450; transcriptional repressor BscR
sigV-yrhM  5.1  2.0 V C, M ECF  factor
yfnI  4.7  2.0 M M (S)f Similar to phosphoglycerol transferases
yebC  4.1  0.6 M M Unknown
yppC  4.1  0.4 C Conserved hypothetical
ywnJ  4.1  0.1 M, X M Unknown
ywtF  3.9  0.6 M C (S)f Putative transcriptional regulator
pbpI  3.8  1.3 M Class B penicillin-binding protein
rodA  3.8  0.9 M M Control of cell shape and elongation
ylxW  3.5  0.3 M M Unknown
yoxD  3.7  0.2 C Putative 3-oxoacyl-acyl-carrier protein
yqiG  3.4  0.4 C Putative NADH-dependent flavin oxidoreductase
yjbQ  3.4  0.2 M Putative Na/H antiporter
a Only genes that were induced threefold in three independent experiments by daptomycin and/or friulimicin B are shown. The proteins corresponding to the
underlined genes were also significantly upregulated in the cytoplasmic proteome (Fig. 2).
b Average induction ratio of the highest value for each locus (usually the first gene in an operon) and the corresponding standard deviation are given. DAP,
daptomycin; FRI, friulimicin B; , no significant induction.
c Assignment of regulators is based on the corresponding regulon papers: LiaRS (12), M (8), V (24), W (6), and X (5).
d Localization of the corresponding proteins is based on the presence of transmembrane regions (membrane proteins) and signal peptides (secreted proteins)
detected with SMART. C, cytoplasmic proteins; M, membrane proteins; S, secreted proteins.
e Putative function is derived from BSORF/Subtilist entries (at http://bacillus.genome.ad.jp/ and http://genolist.pasteur.fr/SubtiList/genome.cgi, respectively), NCBI
blast (http://blast.ncbi.nlm.nih.gov/Blast.cgi), or SMART (http://smart.embl-heidelberg.de/) analysis.
f YfnI and YwtF are assigned to secreted proteins based on experimental evidence (21).
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FIG. 2. Synthesis patterns of marker proteins after induction with
daptomycin (DAP) or friulimicin B (FRI) compared to patterns of
untreated control cells. Details from the two-dimensional gels of the
cytoplasmic proteome (“spot albums” of marker proteins) are shown
for two time points postinduction with each of two compounds.
(A) Proteins induced by both antibiotics. (B) Daptomycin-specific
spots. (C) Friulimicin B-specific spots. See text for details.
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compounds. Five more genes without known regulator, some
of which are potentially involved in cell envelope biogenesis,
specifically responded to friulimicin B (Table 1). All genes
identified in our analysis have been linked to CESR of B.
subtilis previously (data not shown). While no expression sig-
nature available so far resembles that of friulimicin B, both the
transcriptome and the proteome profile for daptomycin closely
resemble those of bacitracin (3, 14).
In-depth gene expression profiling. The results of our mi-
croarray study led to three follow-up analyses on the specificity
of the corresponding CESR. (i) We analyzed the induction of
all seven ECF  factors by quantitative real-time reverse trans-
criptase PCR (RT-PCR), based on the known and highly ECF-
specific autoregulation of their own genes, to determine the
respective inducer spectrum and strength. The primers used
for amplification are listed in Table 2. Both antibiotics activate
M and V, with friulimicin B provoking a significantly stron-
ger response. In addition, friulimicin B also induced the un-
characterized ECF  factor YlaC (Table 3).
(ii) The much stronger activation of ECF target genes by
friulimicin B was not due to the corresponding lack of liaIH
induction, as demonstrated by the induction values of ECF
genes in the liaIH mutant strain TMB0389, which were iden-
tical to those in the wild type (data not shown). The stronger
ECF response to friulimicin B is therefore LiaIH independent
and a true antibiotic-specific difference in the corresponding
gene induction profiles.
(iii) We also quantified the activity of the LiaR target pro-
moter PliaI as a function of the daptomycin/friulimicin B con-
centrations over a range of 4 orders of magnitude by perform-
ing a -galactosidase assay (using strain BFS2470 as described
previously) (15). PliaI induction was indeed only observed in
the presence of daptomycin and in a very narrow window of
antibiotic concentrations (between 0.5 and 2 g/ml) (data not
shown). These results strongly suggest different modes of ac-
tion for daptomycin and friulimicin B.
Conclusions. Our data clearly allowed the identification of
cell envelope integrity as the site of daptomycin and friulimicin
B action, but the results strongly suggest mechanistic differ-
ences between the two compounds. This assumption is primar-
ily based on the dramatic differences in the LiaRS response.
Moreover, friulimicin B activates both M and V more
strongly than daptomycin and, additionally, induces YlaC ex-
pression (summarized in Fig. 3). The strong similarities of
CESR between daptomycin and bacitracin were initially
viewed as an indication that daptomycin might interfere with
the lipid II cycle of cell wall biosynthesis. But a detailed bio-
chemical mechanism of action study revealed that friulimicin
B, like amphomycin but in contrast to the membrane-interfering
daptomycin, inhibits cell wall biosynthesis by binding bactopre-
nol phosphate (18).
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Abstract
Rhamnolipids are biosurfactants produced by the soil bacterium Pseudomonas
aeruginosa. In addition to their high industrial potential as surface-active mole-
cules, rhamnolipids also have antimicrobial properties. In densely populated
habitats, such as the soil, production of antimicrobial compounds is important
to inhibit growth of competitors. For the latter, it is crucial for survival to
sense and respond to the presence of those antibiotics. To gain a first insight
into the biological competition involving biosurfactants, we investigated the
cellular response of the model organism Bacillus subtilis upon exposure to
rhamnolipids by genome-wide transcriptional profiling. Most of the differen-
tially expressed genes can be assigned to two different regulatory networks: the
cell envelope stress response mediated by the two-component system LiaRS
and the extracytoplasmic function r factor rM and the CssRS-dependent secre-
tion stress response. Subsequent phenotypic analysis demonstrated a protective
function of LiaRS and rM against cell lysis caused by rhamnolipids. Taken
together, we present the first evidence that a single antimicrobial compound
can simultaneously induce genes from two independent stress stimulons.
Introduction
The soil is a complex habitat characterized by high popu-
lation density and nutrient limitation. To survive in such
a competitive environment, bacteria developed a number
of different strategies. One such strategy is the production
of antimicrobial compounds to inhibit growth of compet-
itors (Paul & Clark, 1996; Tate, 2000). In addition to
classical antibiotics that target essential structures or pro-
cesses within the bacterial cell, antimicrobial activities,
often based on biophysical effects, can also be assigned to
ionophores, ion-channel forming agents or biosurfactants
(Berdy, 2005).
Biosurfactants are surface-active molecules synthesized
by microorganisms. They consist of a hydrophilic and a
hydrophobic part and are able to reduce surface tension
and enhance the emulsification of hydrocarbons. Biosurf-
actants are commercially used for bioremediation pro-
cesses as well as the pharmaceutical, cosmetics, and food
industries (Banat et al., 2000). Rhamnolipids are biosurf-
actants produced by the soil bacterium Pseudomonas
aeruginosa. These surface-active molecules are glycolipids
composed of one or two L-rhamnose moieties and one or
two b-hydroxydecanoic acid residues (Soberon-Chavez
et al., 2005). The synthesis from rhamnose and fatty acid
precursors is catalyzed by the products of three genes,
rhlABC, and regulated in a cell density-dependent manner
by quorum sensing. The amount and composition of syn-
thesized rhamnolipids depends on growth conditions and
available carbon source (Soberon-Chavez et al., 2005).
Rhamnolipids have been shown to exhibit antimicro-
bial activity against Gram-positive bacteria and, but to a
much lesser extent, also against Gram-negative species
(Itoh et al., 1971; Lang et al., 1989). They modify the cell
surface by increasing its hydrophobicity and membrane
permeability (Vasileva-Tonkova et al., 2011). Although
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the production of rhamnolipids by P. aeruginosa is well
understood (Soberon-Chavez et al., 2005), only little is
known about the physiological reaction to the presence of
this biosurfactant.
The response to antimicrobial compounds that interfere
with the cell envelope integrity has been extensively studied
in the model organism Bacillus subtilis. Here, the regulatory
network of the cell envelope stress response is mediated by
two regulatory principles: two-component systems (TCS)
and extracytoplasmic function (ECF) r factors. Four TCS
(BceRS, LiaRS, PsdRS and YxdJK) and at least three ECF r
factors (rM, rW and rX) have been described to respond
to cell wall antibiotics, such as vancomycin, bacitracin,
or cationic antimicrobial peptides (Jordan et al., 2008).
Bacillus subtilis inhabits the same environment as the
rhamnolipid-producing species P. aeruginosa. Therefore,
we decided to investigate the response of B. subtilis
to rhamnolipids by genome-wide DNA microarray analy-
sis followed by hierarchical clustering of differentially
expressed genes and phenotypic characterization to gain a
first insight into this interspecies competition.
Materials and methods
Bacterial strains and growth conditions
Bacillus subtilis and Escherichia coli were routinely grown
in LB medium at 37 °C with aeration. All strains and
plasmids used in this study are listed in Table 1. Standard
cloning techniques were applied (Sambrook & Russell,
2001) and transformation was carried out as described
(Harwood & Cutting, 1990). Ampicillin (100 lg mL1)
was used for selection of E. coli, kanamycin (10 lg mL1)
and erythromycin (1 lg mL1) plus lincomycin (25 lg
mL1) for macrolide-lincosamide-streptogramin B (MLS)
resistance were used for selection of B. subtilis mutants.
Rhamnolipids were isolated from P. aeruginosa as a mix-
ture of mono- and di-rhamnolipid (Müller et al., 2010),
dissolved in ethanol and used at the indicated concentra-
tions. All experiments were performed with rhamnolipids
from the same purification, as the composition and bio-
logical activity varies between different cultivations of
P. aeruginosa (R. Hausmann, pers. commun.).
Preparation of total RNA
Bacillus subtilis W168 was grown aerobically in LB med-
ium at 37 °C until an OD600 nm of c. 0.5. The culture was
split and one sample was induced with sublethal concen-
trations (50 lg mL1) of rhamnolipids, leaving the other
sample as uninduced control. After 10 min, 30 mL cul-
ture were mixed with 15 mL cold killing buffer (20 mM
Tris–HCl, pH 7.0, 0.5 mM MgCl2, 20 mM NaN3), har-
vested by centrifugation and frozen in liquid nitrogen,
before the pellets were stored at 80 °C. Total RNA was
isolated as described previously (Wolf et al., 2010). Con-
taminating DNA was removed using the RNase-free
DNase kit (Qiagen) and quality control of the RNA was
performed with an RNA 6000 Nano LabChip Kit (Agilent
Technologies) on an Agilent 2100 Bioanalyzer according
to the manufacturer’s instructions.
DNA microarray analysis
RNA samples from three independent cultivations were
used for cDNA synthesis and hybridized with dye-swap
to Agilent custom DNA microarrays. Synthesis of fluores-
cently labeled cDNA, hybridization and scanning of the
microarrays were performed as described previously (Otto
et al., 2010). Data were extracted and processed using
Table 1. Strains, vectors, and plasmids used in this study
Strain
Genotype or
characteristic(s)*
Reference, source
or construction
E. coli strains
DH5a recA1 endA1 gyrA96
thi hsdR17rK- mK
+relA1 supE44 Φ80
DlacZDM15
D(lacZYA-argF)U169
Laboratory stock
B. subtilis
strains
W168 Wild type, trpC2 Laboratory stock
TMB149 W168 sigW::MLS LFH-PCR?W168
TMB329 W168 DliaF Wolf et al. (2010)
TMB589 W168 DliaR pMAD-based clean
deletion
TMB1003 W168 sigM::kan HB0829 chrom.
DNA?W168
TMB1070 W168 cssRS::kan LFH-PCR?W168
TMB1392 W168 DliaR sigM::
kan sigW::MLS
HB0829 chrom.
DNA?TMB589
TMB1393 W168 sigM::kan
sigW::MLS
HB0829 chrom.
DNA?TMB1003
HB0829 NCIB3610 sigM::
kan sigW::MLS
Mascher et al. (2007)
Vectors or
plasmids
pMAD bgaB, ermC, bla, MCS Arnaud et al. (2004)
pDG780 pBluescriptKS+ kan,
source of resistance
cassette for LFH-PCR
Guerout-Fleury et al.
(1995)
pDG647 pSB119, MLS, source
of resistance cassette
for LFH-PCR
Guerout-Fleury et al.
(1995)
pDW104 pMAD DliaR This study
chrom. DNA, chromosomal DNA.
*Resistance cassettes: kan, kanamycin; MLS, macrolide-lincosamide-
streptogramin B; spec, spectinomycin.
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the FEATURE EXTRACTION software (version 10.5; Agilent
Technologies). For each gene on the microarray, the
error-weighted average of the log ratio values of the indi-
vidual probes was calculated using the ROSETTA RESOLVER
software (version 7.2.1; Rosetta Biosoftware). The com-
plete dataset containing induction ratios for all genes
is available at http://www.syntheticmicrobe.bio.lmu.de/
publications/supplemental/index.html.
Measurement of induction by quantitative
real-time RT-PCR
Measurement of transcript abundance was performed in
duplicate by quantitative real-time RT-PCR using the
QuantiFast SYBR Green RT-PCR Kit (Qiagen) according
to the manufacturer’s protocol, with minor modifications.
In brief, 100 ng of DNA-free RNA were used in a total
reaction volume of 20 lL with 0.3 lM of each primer
(Table 2). The reaction was carried out in a MyiQ Cycler
(BioRad). Expression of rpsJ and rpsE was monitored as
constitutive reference. Relative induction levels were cal-
culated as fold changes using the formula: Fold change =
2DDCt ; with DDCt = (Ct,gene x  Ct,constitutive gene)condition
I  (Ct,gene x  Ct,constitutive gene)condition II (Talaat et al.,
2002).
Hierarchical clustering analysis
Clustering was performed using the program CLUSTER 3.0
(de Hoon et al., 2004). Transcriptome data were derived
from this work or published studies (Cao et al., 2002a;
Mascher et al., 2003; Lulko et al., 2007; Wecke et al.,
Table 2. Oligonucleotides used in this study
Nr Name Sequence
Real-time RT-PCR
0125 liaH-RT fwd TGAAACAGCACACGATTGCC
0126 liaH-RT rev GTTTGCCTGTTCATAGGAAGC
1890 cssR-RT fwd TGGATTCTCGATATCATGCTG
1891 cssR-RT rev TAGTCATTGCTGCCAATCTC
1886 htrA-RT fwd AACGAGGATTCGGATGGTTC
1887 htrA-RT rev TGTAACAGATTGCGTTTGCTG
1888 htrB-RT fwd GCCTTATCTGCCGTCAGAC
1889 htrB-RT rev ATTCCGACAATCGTAGGCTC
0826 sigM-RT fwd GTTTACAGGTTCCTGCTCTC
0827 sigM-RT rev ATGAAGGCGTTTCGCGCCA
0156 rpsJ-RT fwd GAAACGGCAAAACGTTCTGG
0157 rpsJ-RT rev GTGTTGGGTTCACAATGTCG
0158 rpsE-RT fwd GCGTCGTATTGACCCAAGC
0159 rpsE-RT rev TACCAGTACCGAATCCTACG
LFH-PCR
0342 sigW up fwd CCGAGAAGTTCAGGGCAAGCC
0343 sigW up rev CCTATCACCTCAAATGGTTCGCTGCGATGTCCGCAAATGCATCC
0344 sigW do fwd CGAGCGCCTACGAGGAATTTGTATCGCGGATTCACAGAGGCAGAGAGC
0345 sigW do rev GCTGAACCGCTTTCGTGCC
1793 cssR up fwd TTTCACTTTCTGAGCTGGAG
1794 cssR up rev CCTATCACCTCAAATGGTTCGCTGTTCATTCAGGTTATCCTCATC
1795 cssS do fwd CGAGCGCCTACGAGGAATTTGTATCGGGTGTATCATACCGCATAGC
1796 cssS do rev ATTGAGACGGCTTCACAGTG
0137 kan fwd CAGCGAACCATTTGAGGTGATAGG
0138 kan rev CGATACAAATTCCTCGTAGGCGCTCGG
0139 mls fwd CAGCGAACCATTTGAGGTGATAGGGATCCTTTAACTCTGGCAACCCTC
0140 mls rev CGATACAAATTCCTCGTAGGCGCTCGGGCCGACTGCGCAAAAGACATAATCG
0147 kan check rev CTGCCTCCTCATCCTCTTCATCC
0056 kan check fwd CATCCGCAACTGTCCATACTCTG
0148 mls check rev GTTTTGGTCGTAGAGCACACGG
0057 mls check fwd CCTTAAAACATGCAGGAATTGACG
DliaR deletion mutant
1060 liaR up fwd (BamHI) AGCCGGATCCGACAACGGGAATCAGCCTGC
1120 liaR up rev CGAGATGATTTCGGTGTGCGCTGACCATTTCATGATCATC
1059 liaR do fwd CGCACACCGAAATCATCTCG
1061 liaR do rev (NcoI) TATACCATGGGCTGACACAGCAAATTCTCG
Restriction sites for cloning are highlighted in bold, linker regions for joining reactions are underlined.
FEMS Microbiol Lett 323 (2011) 113–123 ª 2011 Federation of European Microbiological Societies
Published by Blackwell Publishing Ltd. All rights reserved
Rhamnolipid stress response 115
2009). The datasets represent the following conditions:
50 lg mL1 rhamnolipids (10 min), 1 lg mL1 daptomy-
cin (10 min), 1 lg mL1 friulimicin (10 min), 2 lg mL1
vancomycin (10 min), 100 lg mL1 bacitracin (5 min)
and secretion stress caused by overexpression of the a-amy-
lase AmyQ. For reasons of clarity, cluster analysis was
restricted to genes induced  threefold and repressed
fivefold by rhamnolipids.
Allelic replacement mutagenesis using long-
flanking homology PCR
The long-flanking homology (LFH) PCR is derived from a
published procedure (Wach, 1996) and performed as previ-
ously described (Mascher et al., 2003). In brief, resistance
cassettes were amplified from suitable vectors as template
(Guerout-Fleury et al., 1995). About 1000-bp DNA frag-
ments flanking the region to be deleted were amplified by
PCR using chromosomal DNA of B. subtilis W168 as tem-
plate. These fragments are here called up- and do-frag-
ments. The up-reverse and do-forward primers carry c. 25-
bp nucleotides complementary to the sequence of the resis-
tance cassettes. All obtained fragments were purified and
used as template in a second PCR with the corresponding
up-forward and do-reverse primers. The PCR products
were directly used to transform B. subtilis W168. Transfor-
mants were screened by colony PCR using the up-forward
and do-reverse primers with check primers annealing
within the resistance cassette. Integrity of the regions flank-
ing the resistance cassette was verified by sequencing of
PCR products. The resulting strains are listed in Table 1,
the oligonucleotides in Table 2.
Construction of a markerless DliaR deletion
mutant
A markerless DliaR deletion strain was constructed using
the vector pMAD (Arnaud et al., 2004) and the oligonucle-
otides listed in Table 2. The procedure has been described
previously (Wolf et al., 2010). In brief, about 1000-bp
regions upstream and downstream of liaR were amplified
using PCR, thereby introducing a 20-bp extension to the
3′-end of the up-fragment, which is complementary to the
5′-end of the do-fragment. The fragments were fused by a
second PCR and the resulting product was cloned into
pMAD, generating pDW104. Bacillus subtilis W168 was
transformed with pDW104 and incubated at 30 °C with
MLS selection on LB agar plates containing 100 lg mL1
X-Gal (5-bromo-4-chloro-3-indolyl-b-D-
galactopyranoside). Blue colonies were selected and
incubated for 6–8 h at 42 °C in LB medium with MLS
selection, which results in the integration of the plasmid
into the chromosome. Again, blue colonies were selected
and incubated for 6 h at 30 °C in LB medium without
selection. Subsequently, the culture was shifted to 42 °C for
3 h, before the cells were plated on LB agar plates without
selection. White colonies were picked and checked for MLS
sensitivity, indicating the loss of the plasmid. Those har-
boring a clean deletion of liaR were identified using PCR.
Concentration-dependent lysis curve
experiments
Bacillus subtilis wild-type and mutant strains were inocu-
lated from fresh overnight cultures and grown aerobically
in LB medium until an OD600nm of c. 0.5. The cultures were
split into 1 mL samples and different concentrations of
rhamnolipids were added. The effect of rhamnolipids on cell
density of each sample was monitored over a period of 7 h.
Results and discussion
The transcriptional response to rhamnolipids
Genome-wide expression profiling is a powerful approach
to characterize the response to a certain stimulus, such as
the presence of antimicrobial compounds. It has also
been used to gain insights into inhibitory mechanisms
and to differentiate between different modes of action of
novel antibiotics (Hutter et al., 2004; Fischer & Freiberg,
2007; Wecke et al., 2009). We used genome-wide DNA
microarray analysis to investigate the response of the
model organism B. subtilis to the presence of rhamnoli-
pids, which have been shown to affect cell envelope integ-
rity (Vasileva-Tonkova et al., 2011). B. subtilis was treated
with sublethal concentrations (50 lg mL1) of rhamnoli-
pids, which is sufficient to induce a transcriptional
response, but does not impair growth of the culture, as
can be demonstrated by concentration-dependent lysis
curve experiments (see below and Fig. 3). After 10 min
of induction, total RNA was prepared and DNA micro-
array analysis performed. Expression of 40 loci was
fivefold increased by rhamnolipids compared with the
mRNA levels of an uninduced culture (Table 3 and
Fig. 1a). Almost half of these loci can be assigned to
known regulons of TCS or ECF r factors. The most
strongly induced locus was the liaIHGFSR operon
(c. 640-fold), which is autoregulated by the LiaRS TCS
(Mascher et al., 2004). The first two genes of this locus,
liaIH, represent the main targets of LiaRS-dependent sig-
nal transduction and liaH encodes a phage-shock protein
homolog. The LiaRS TCS is activated by cell wall anti-
biotics, especially lipid II-interacting compounds, but it
does not mediate resistance against most of its inducers
(Mascher et al., 2004; Wolf et al., 2010). Strong expression
of the lia locus also resulted in significant read-through
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Table 3. Genes significantly induced or repressed by rhamnolipids
Gene(s)* Fold changes† Regulators‡ Homology, (putative) function, remarks
Genes induced fivefold
liaIHGFSR 640 ± 501 LiaRS Phage-shock protein homolog, TCS, unknown
htrA 58 ± 15 CssRS Serine protease
htrB 26 ± 6.6 CssRS Serine protease
yuxN 13 ± 4.5 Putative transcriptional regulator, TetR family
yqjL 11 ± 1.2 rM Putative hydrolase
pbpE-racX 11 ± 5.2 rW Penicillin binding protein 4, amino acid racemase
yhaSTU 10 ± 4.4 Potassium efflux K+/H+ antiporter
yxeI 9.4 ± 2.2 Similar to penicillin amidase
yraA 8.6 ± 3.5 Similar to general stress protein
yuaE 8.2 ± 2.8 Hypothetical protein with DUF1569 domain
yrhHIJ 8.0 ± 3.5 rM, rX, rV Putative methyltransferase, transcriptional regulator, and reductase
sigM-yhdLK 7.8 ± 1.3 rM ECF r factor
yebC 7.8 ± 1.4 rM Putative membrane protein
ybfO 7.7 ± 3.3 rW Similar to erythromycin esterase
ylbP 7.4 ± 2.1 Putative acetyltransferase, GNAT family
phoA 7.2 ± 3.8 Alkaline phosphatase A
bcrC 7.2 ± 2.7 rV, rM, rW, rX Undecaprenyl pyrophosphate phosphatase
gabD 7.1 ± 2.7 Succinate-semialdehyde dehydrogenase
ywrO 7.0 ± 2.5 Similar to NAD(P)H oxidoreductase
ydaH 6.9 ± 2.4 rM Putative membrane protein with DUF2837 domain
opuCABCD 6.8 ± 4.8 Osmoprotection
ypbGH 6.7 ± 1.4 rM Putative phosphoesterase and MecA paralog
yceB 6.5 ± 2.8 Putative monooxygenase
yvrD 6.5 ± 1.1 Similar to ketoacyl-carrier protein reductase
ywaC 6.4 ± 2.8 rW, rM, rV Similar to GTP-pyrophosphokinase
yqjG 6.2 ± 1.7 Similar to lipoprotein SpoIIIJ-like
yheCDE 6.0 ± 1.1 Spore coat proteins
yhjN 5.9 ± 0.8 Putative membrane-anchored ammonia monooxygenase
dhaS 5.8 ± 1.4 Aldehyde dehydrogenase
yfjR 5.8 ± 2.8 Similar to 3-hydroxyisobutyrate dehydrogenase
radC 5.5 ± 1.8 rM DNA repair protein
yvgP 5.5 ± 0.9 Monovalent cation/H+ antiporter NhaK
trxA 5.4 ± 1.2 Thioredoxin, putative monooxygenase
nfrA-ywcH 5.2 ± 1.2 NADPH-linked nitro/flavin reductase, similar to monooxygenase
gerAABC 5.2 ± 2.2 Germination, downstream of liaIHGFSR
ypuA 5.2 ± 0.9 rM, rV Protein of unknown function with DUF1002 domain
ywnJ 5.2 ± 1.5 rM, rW, rX Putative VanZ-like membrane protein
yrbC 5.1 ± 2.5 Uncharacterized conserved protein with DUF28 domain
ycgJ 5.0 ± 1.6 Putative methyltransferase
yfiBC 5.0 ± 1.4 Similar to ABC transporter
Genes repressed  fivefold
cydABCD 0.19 ± 0.09 Cytochrome bd ubiquinol oxidase
rbsRKDACB 0.19 ± 0.07 Ribose transport
yuaJ 0.19 ± 0.07 Putative thiamine transporter
yonPO 0.18 ± 0.07 Hypothetical proteins (prophage SPb)
narGHJI 0.18 ± 0.05 Nitrate reductase
mtbP 0.17 ± 0.06 Modification methylase
pur operon 0.17 ± 0.08 Purine biosynthesis
yxaI 0.17 ± 0.08 Putative membrane protein
yolJ 0.15 ± 0.06 Similar to glycosyltransferase
xylAB 0.13 ± 0.02 Xylose metabolism
sboAXablA-G 0.13 ± 0.03 Bacteriocin subtilosin A
bdbA 0.12 ± 0.06 Thiol-disulfide oxidoreductase
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transcription of the downstream located gerAAABAC
operon, which has been observed previously for both
B. subtilis and Bacillus licheniformis (Mascher et al., 2003;
Wecke et al., 2006).
The genes htrA (c. 60-fold) and htrB (c. 25-fold), both
encoding serine proteases, were also strongly induced by
rhamnolipids (Table 3 and Fig. 1a). Expression of both
genes is controlled by the TCS CssRS, which is activated
by heat and secretion stress. Expression of cssRS itself was
not induced by rhamnolipids, similar to the effect of heat
stress, although moderately increased expression of this
operon can be observed under secretion stress conditions
caused by overexpression of the secretory protein a-amy-
lase (Darmon et al., 2002; Hyyryläinen et al., 2005).
Almost one-third of the remaining fivefold induced
loci represent target genes of ECF r factors, predomi-
nantly rM, with its own autoregulated operon sigM-
yhdLK being approximately eightfold induced (Table 3
and Fig. 1a). As a result of a previously described regula-
tory overlap between different ECF r factors of B. subtilis
(Qiu & Helmann, 2001; Mascher et al., 2007), expression
of some genes, such as bcrC and ywaC, can be regulated
by more than one ECF r factor. But the autoregulated
loci of the remaining six ECF r factors of B. subtilis were
not significantly induced ( threefold), indicating that
the ECF response to rhamnolipids is mediated mainly by
rM. This ECF r factor is activated by cell wall antibiotics
like vancomycin, bacitracin, and phosphomycin, but also
under acid, salt, and heat stress conditions (Cao et al.,
2002a, b; Mascher et al., 2003; Thackray & Moir, 2003).
Other genes significantly induced by rhamnolipids can-
not be assigned to known cell envelope stress regulons.
They often encode proteins of unknown function or pro-
teins presumably involved in metabolic and redox pro-
cesses (e.g. gabD encoding a succinate-semialdehyde
dehydrogenase or trxA encoding thioredoxin).
We verified the main findings of our DNA microarray
analysis, in particular the activation of the TCS LiaRS
and CssRS as well as rM, independently by real-time RT-
PCR and basically obtained the same results, albeit with an
overall higher induction ratio (Fig. 1b). Such discrepancy
Table 3. Continued.
Gene(s)* Fold changes† Regulators‡ Homology, (putative) function, remarks
pyr operon 0.07 ± 0.06 PyrR Pyrimidine biosynthesis
pstSCABABB 0.07 ± 0.03 PhoPR Phosphate ABC transporter
des 0.06 ± 0.04 DesKR Fatty acid desaturase
*Only genes that were induced or repressed  fivefold on average are listed.
†Highest induction ratios for each locus (usually the first gene in an operon) and the corresponding standard deviation are given.
‡Assignment of regulators is based on (Turner et al., 1994; Qi et al., 1997; Huang & Helmann, 1998; Huang et al., 1999; Aguilar et al., 2001;
Hyyryläinen et al., 2001; Wiegert et al., 2001; Cao et al., 2002a,b; Darmon et al., 2002; Cao & Helmann, 2004; Zellmeier et al., 2005; Jordan
et al., 2006; Eiamphungporn & Helmann, 2008).
Fig. 1. The transcriptional response to rhamnolipids. (a) Scatter plot
of DNA microarray analysis. The average signal intensities for each
gene are shown from cells induced with 50 lg mL1 rhamnolipids for
10 min (y-axis) and uninduced control (x-axis). The pyr operon (▲),
pstSCABABB (D), des (●) and genes regulated by LiaRS (□), CssRS (♦)
and rM (■) are highlighted; all other genes are represented as gray
squares. (b) Verification of the transcriptome data by real-time RT-
PCR. Real-time RT-PCR was performed as described in Materials and
methods with the same RNA as used for DNA microarray analysis.
Induction ratios for each gene were calculated based on the
uninduced control, as described previously (Talaat et al., 2002). Each
value is the average of two microarray hybridizations or real-time RT-
PCR experiments, the error bar indicating the standard deviation.
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was observed in numerous studies before and is attributed
to the overall lower dynamic range of DNA microarrays
compared with other methods such as real-time RT-PCR
(Conway & Schoolnik, 2003; Pappas et al., 2004).
Treatment with rhamnolipids also led to decreased
expression of a certain set of genes (Fig. 1a and Table 3).
Among the fivefold repressed loci are genes encoding
proteins involved in purine and pyrimidine biosynthesis
(pyr and pur operon), phosphate transport (pstSCABABB)
and sugar metabolism (rbsRKDACB, xylAB) (Table 2).
Differential expression of the pyr operon in response
to cell envelope stress has been observed previously for
B. licheniformis (Wecke et al., 2006).
With almost 20-fold repression, the most strongly
downregulated gene is des, which encodes a fatty acid
desaturase (Aguilar et al., 1998). Expression of des is con-
trolled by the TCS DesRK and induced by cold shock.
The desaturase is important for maintaining membrane
fluidity at low temperature by introducing double bonds
in phospholipids (Aguilar et al., 2001), indicating that
rhamnolipid treatment at sublethal concentrations could
interfere with membrane fluidity.
Hierarchical clustering analysis of genes
differentially expressed in response to
rhamnolipids
Our DNA microarray analysis clearly indicates that
rhamnolipids induce both the cell envelope and the secre-
tion stress response. To further validate this novel induc-
tion pattern, we performed hierarchical clustering analysis
using transcriptome data of B. subtilis induced with differ-
ent cell wall antibiotics (vancomycin, bacitracin, daptomy-
cin and friulimicin) and exposed to secretion stress. For
reason of clarity, we limited our analysis to genes induced
 threefold and repressed fivefold by rhamnolipids.
Genes controlled by the same regulator form discrete
clusters based on their expression pattern under different
stress conditions (Fig. 2a). Genes belonging to the cell
envelope stress response of B. subtilis are grouped in three
clusters and can be assigned to two regulators, rM and
the LiaRS TCS (Fig. 2b). They are induced by cell wall
antibiotics and rhamnolipids, but not by secretion stress
(with the exception of liaH). One of these three clusters
contains the target operon of the LiaRS TCS as well as
the downstream genes gerAAAB. The other two clusters
include mostly target genes of rM. Noteworthy, within
the rM regulon, there is a subset of genes, including the
mreBCDminCD operon involved in cell division, that is
not induced by vancomycin (upper part of rM1 cluster in
Fig. 2b). Differences in the induction profiles of subsets
of rM-dependent genes have been observed previously
(Eiamphungporn & Helmann, 2008).
Genes mediating the secretion stress response also clus-
ter together (Fig. 2b). The CssRS-dependent target genes
htrA and htrB are not only induced by secretion stress
and rhamnolipids, but also weakly by vancomycin and
bacitracin.
Genes repressed by rhamnolipids show almost unchanged
expression under the other conditions tested (Fig. 2c).
One exception is the pyr operon, which is strongly repressed
by rhamnolipids, but weakly induced by friulimicin and
vancomycin.
Taken together, the hierarchical clustering analysis indi-
cates that rhamnolipids induce a combination of two dif-
ferent stress responses: the cell envelope stress response
represented by the LiaRS TCS and the ECF r factor rM,
and the heat and secretion stress response mediated by
CssRS. Simultaneous induction of the LiaRS TCS and rM
is common for cell wall antibiotics such as daptomycin,
vancomycin, or bacitracin (Mascher et al., 2003; Hach-
mann et al., 2009; Wecke et al., 2009). But none of the
rM-dependent target genes is induced by secretion stress,
while both the CssRS and LiaRS TCS are induced by cell
wall antibiotics, rhamnolipids, and secretion stress, but
with different intensities (Fig. 2d).
The LiaRS TCS and rM protect cells from
rhamnolipid-dependent lysis
Bacteria use signal transducing systems to detect harmful
compounds and alter gene expression to protect the cell.
We hypothesize that the signal transducing systems acti-
vated by rhamnolipids confer resistance and counteract
cell damage caused by this antimicrobial compound.
Therefore, we compared the growth behavior of B. subtilis
wild-type cultures exposed to different rhamnolipid con-
centrations with strains carrying gene deletions leading to
‘ON’ or ‘OFF’ states of the induced signal transducing
systems, which results either in no or constitutively high
expression of the corresponding target genes. The strains
were grown in LB medium to mid-logarithmic growth
phase, the cultures were split and different concentrations
of rhamnolipids were added. Subsequent lysis of each
sample was monitored by measuring OD600 nm.
For the B. subtilis wild-type strain W168, a concentra-
tion of 50 lg mL1 rhamnolipids did not affect growth
(Fig. 3), but was sufficient to induce a transcriptional
response as investigated using DNA microarray analysis
(Fig. 1a and Table 3). Higher concentrations of rhamnoli-
pids lead to rapid lysis of the culture within 1 h after
addition (Fig. 3). Remarkably, even after severe lysis the
cultures resumed growth.
To reveal a possible protective function of the LiaRS
TCS, we compared the lysis in response to rhamnolipids of
two strains carrying deletions in the lia locus: deletion of
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the response regulator LiaR results in a ‘Lia OFF’ mutant,
while deletion of the inhibitory protein LiaF represents a
‘Lia ON’ strain with constitutive expression of the target
genes liaIH (Jordan et al., 2006; Wolf et al., 2010). Behav-
ior of the DliaR mutant was comparable to the wild-type
strain, while the DliaF mutant clearly displayed recovery
advantages and regained growth more quickly even after
addition of high rhamnolipid concentrations (Fig. 3). We
also investigated the effect of rhamnolipids on a mutant
strain lacking the CssRS TCS that orchestrates the secretion
stress response, but did not observe any differences com-
pared with the wild type (Fig. 3).
As a large part of the induced genes are regulated by
rM, we investigated how this ECF r factor contributes to
resistance against rhamnolipids. Compared with the wild
type, a sigM::kan mutant strain showed an impaired
growth phenotype (Fig. 3). While growth of the wild type
was not affected at concentrations of 50 lg mL1, growth
of the sigM::kan mutant was clearly arrested. rM controls
expression of at least 30 operons involved in cell division,
DNA repair and cell envelope synthesis (Eiamphungporn
& Helmann, 2008). Another ECF r factor which controls
a similar large regulon is rW (Helmann, 2006). Since
expression of the sigW–rsiW operon was induced 2.8-fold
by rhamnolipids (Table S1), we also included a sigW::
MLS mutant strain in our lysis curve experiments. But
this strain shows the same behavior as the wild type, indi-
cating that rW is not responsible for resistance against
rhamnolipids (Fig. 3). Therefore, the ECF response to
rhamnolipids is mainly mediated by rM, which is in
Fig. 2. Hierarchical clustering analysis of genes differentially expressed in response to rhamnolipids. The clustering analysis was performed using
the software CLUSTER 3.0 (de Hoon et al., 2004). Transcriptome data for Bacillus subtilis treated with friulimicin (fri), vancomycin (van),
rhamnolipids (rha), bacitracin (bac), daptomycin (dap) and exposed to secretion stress (sec) caused by overexpression of a-amylase were analyzed
(see Materials and methods for details). Green indicates induction of the corresponding gene, red repression under the designated condition.
Cluster analysis was limited to genes induced  threefold and repressed  fivefold by rhamnolipids (a). Cluster containing target genes of rM,
LiaRS and CssRS (b) and genes repressed by rhamnolipids (c) are shown in detail. A schematic representation of the network orchestrating the
response to rhamnolipids summarizes the results of the cluster analysis (d). The thickness of the arrows corresponds to the induction of the given
regulators. Sec, secretion stress; Rha, rhamnolipids; Ces, cell envelope stress.
ª 2011 Federation of European Microbiological Societies FEMS Microbiol Lett 323 (2011) 113–123
Published by Blackwell Publishing Ltd. All rights reserved
120 T. Wecke et al.
agreement with induction ratios of the sigM and sigW
operons (eight- vs. threefold, respectively).
We also tested if a combined deletion of both rM and
rW has an additive affect and leads to a more pro-
nounced phenotype, as a functional overlap of ECF r fac-
tors in response to different antimicrobial compounds
has already been demonstrated (Mascher et al., 2007).
Indeed, the double mutant shows an increased sensitivity
compared with the sigM::kan strain, as it did not resume
growth in the presence of 100 lg mL1 rhamnolipid
(Fig. 3). Additional deletion of liaR, resulting in inactiva-
tion of a third cell wall stress responsive system, did not
lead to a stronger susceptibility phenotype (Fig. 3). Taken
together, rM seems to play a central role in rhamnolipid
resistance, while rW and the LiaRS TCS have only minor
functions.
Summary and conclusions
Here, we present the first investigation of the transcrip-
tional response to rhamnolipids, industrially important
surface-active molecules with antimicrobial properties. In
B. subtilis, exposure to rhamnolipids provokes a complex
reaction that combines the cell envelope and secretion
stress response (Fig. 2d). The main regulators orchestrating
this response are the TCS LiaRS and CssRS, as well as the
ECF r factor rM. In addition to the target genes of these
regulators, a number of genes encoding either metabolic
enzymes or hypothetical proteins of unknown functions
are also induced. Our data show a protective role of LiaRS
and rM against rhamnolipid damage, while the CssRS TCS
has no effect on rhamnolipid sensitivity (Fig. 3).
As rhamnolipids alter the properties of membranes,
induction of the cell envelope stress response could help
to maintain cell envelope integrity. While the physiologi-
cal role of most of the strongly induced genes has not
been elucidated yet, some of them have known or
assumed functions in counteracting membrane damage.
The LiaR-controlled liaIH operon encodes a small mem-
brane protein and a member of the phage-shock protein
family, respectively. Their gene products have recently
been linked to resistance against daptomycin, another
membrane-perturbating agent (Hachmann et al., 2009;
Wolf et al., 2010). Other genes, like the ECF-regulated
bcrC gene and the pbpE-racX operon encode functions
involved in cell envelope biogenesis, which might also
help to stabilize the envelope against membrane damage.
Moreover, and given the prominent role of rM in pro-
tecting cells from rhamnolipid damage (Fig. 3), it is note-
worthy that some of the most strongly induced rM-target
genes of unknown function, such as yebC, ywnJ or ydaH,
encode putative membrane proteins (Table 3). A possible
role of these proteins in counteracting membrane damage
needs to be addressed in future studies.
In contrast, the physiological role of CssRS activation by
rhamnolipids is not clear. Its induction could indicate
severe changes of membrane protein composition and
accumulation of misfolded secreted proteins in the cell
envelope caused by rhamnolipid treatment. Alternatively,
rhamnolipid-dependent interference with membrane integ-
Fig. 3. Growth of Bacillus subtilis wild-type and mutant strains exposed to different concentrations of rhamnolipids. Bacillus subtilis wild type
(W168), TMB1070 (cssRS::kan), TMB589 (DliaR), TMB329 (DliaF ), TMB1003 (sigM::kan), TMB149 (sigW::MLS), TMB1393 (sigM::kan sigW::MLS)
and TMB1392 (DliaR sigM::kan sigW::MLS) were grown in LB medium to mid-logarithmic growth phase. The cultures were split into 1 mL
samples and induced with increasing concentrations of rhamnolipids: 0 lg mL1 (■), 50 lg mL1 (□), 100 lg mL1 (▲), 200 lg mL1 (D) and
300 lg mL1 (♦). Cell density was monitored by measuring OD600nm over a time period of 7 h.
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rity could affect functionality of the secretion machinery.
The CssRS TCS has also been shown to be not only
induced by mammalian peptidoglycan recognition pro-
teins, but also seems to be required for the killing mecha-
nism of these proteins (Kashyap et al., 2011).
Although the data presented here clearly indicates that
rhamnolipids interfere with cell envelope integrity, future
studies will be required to gain an understanding of the
mode of action of rhamnolipids and its use as antimicrobial
active compound. Taken together, this is the first analysis
of a bacterial stress stimulon in response to rhamnolipids
showing that a single antimicrobial compound induces a
combination of two normally independent stress responses.
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Abstract 
Bacteria need signal transducing systems to respond to environmental changes. Next to 
one- and two-component systems, alternative σ factors of the extracytoplasmic function 
(ECF) protein family represent the third fundamental mechanisms of bacterial signal 
transduction. A comprehensive classification of these proteins identified more than 40 
phylogenetically distinct groups, most of which are not experimentally investigated. Here, 
we present the characterization of such a group with unique features, termed ECF41. 
Among analyzed bacterial genomes, ECF41 σ factors are widely distributed with about 
400 proteins from ten different phyla. They lack obvious anti-σ factors that typically 
control activity of other ECF σ factors, but their structural genes are often predicted to be 
co-transcribed with carboxymuconolactone decarboxylases, oxidoreductases or epimerases 
based on genomic context conservation. We demonstrate for Bacillus licheniformis and 
Rhodobacter sphaeroides that the corresponding genes are preceded by a highly conserved 
promoter motif and are the only detectable targets of ECF41-dependent gene expression. In 
contrast to other ECF σ factors, proteins of group ECF41 contain a large C-terminal 
extension, which is crucial for σ factor activity. Our data strongly suggest that ECF41 σ 
factors are regulated by a novel mechanism possibly based on the presence of a fused anti-
σ factor-like domain. 
Introduction 
Bacteria populate complex habitats in which extracellular conditions can change very 
rapidly. In order to survive in such an environment, bacterial cells have to be able to sense 
and respond to these variations before cell damage actually occurs. Therefore, bacteria 
need signal transducing systems, which enable them to sense these extracellular changes 
and respond by differential gene expression.  
A common mechanism to control gene expression at the level of transcription initiation is 
the use of σ factors, which constitute an essential subunit of the RNA polymerase (RNAP) 
holoenzyme and determine the promoter specificity. In addition to the primary σ factor, 
which is responsible for general expression of most genes in exponentially growing cells, 
most bacteria contain one or more alternative σ factors. These proteins are activated only 
under certain conditions and control expression of a specific set of target genes by 
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recognizing alternative promoter sequences (Helmann, 2010, Helmann & Chamberlin, 
1988). 
Most σ factors belong to the σ70 family based on their relation to the primary σ factor of 
Escherichia coli, σ70 (Gruber & Gross, 2003, Paget & Helmann, 2003). Based on sequence 
similarity, domain architecture and function, the proteins of the σ70 family can be divided 
into four groups. Group 1 comprises the essential primary σ factors, which contain four 
highly conserved domains (designated σ1 through σ4) (Gruber & Gross, 2003). Group 2 σ 
factors are closely related to group 1 proteins, but are not essential for growth. The group 3 
σ factors lack the σ1 domain and have functions in cellular processes such as sporulation, 
flagella biosynthesis, or heat shock response. The largest and most diverse group 4 
contains the proteins of the ECF family, named after their function in response to 
extracellular stimuli (Butcher et al., 2008, Helmann, 2002, Lonetto et al., 1994). 
In contrast to other σ70 proteins, the ECF σ factors only contain two of the four conserved 
domains, σ2 and σ4, which are sufficient for promoter recognition and interaction with 
RNAP. The bipartite promoter recognized by ECF σ factors typically contains a highly 
conserved ‘AAC’ signature in the -35 region and a ‘CGT’ motif in the -10 region 
(Helmann, 2002). In general, ECF σ factors autoregulate their own expression and are co-
transcribed with a gene encoding an anti-σ factor, which regulates the activity of the σ 
factor. In the absence of a stimulus, the anti-σ factor binds the ECF σ factor and keeps it 
inactive. Upon receiving the appropriate signal, the anti-σ factor gets inactivated, thereby 
releasing and activating the σ factor (Butcher et al., 2008, Helmann, 2002). The major 
principles of σ factor activation are based on either the regulated proteolysis of a 
membrane-anchored anti-σ factor as exemplified by RseA-σE of E. coli and RsiW-σW of 
Bacillus subtilis (Ades, 2004, Heinrich & Wiegert, 2009) or conformational changes of a 
soluble anti-σ factor, as has been described for RsrA-σR of Streptomyces coelicolor 
(Campbell et al., 2008, Kang et al., 1999). For yet other examples, such as S. coelicolor σE 
or EcfG-homologs in α-proteobacteria, two-component systems play a crucial role in 
regulating the activity of the ECF σ factors (Francez-Charlot et al., 2009, Hong et al., 
2002).  
A recent classification of the ECF σ factor protein family based on sequence similarity and 
genomic context conservation revealed a wide distribution and combinatorial complexity 
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of ECF-dependent signal transduction. This study identified more than 40 phylogenetically 
distinct groups of ECF σ factors including major groups containing the E. coli σE- and 
FecI-like proteins as well as cytoplasmic-sensing ECF σ factors. But in addition to these 
well-understood examples, a number of ECF groups were identified that have not yet been 
investigated experimentally (Staroń et al., 2009).  
Here, we describe the characterization of one such uncharacterized group, ECF41. This 
group is widely distributed with about 400 proteins from 10 different phyla. Based on their 
genomic organization, the genes encoding these ECF41 σ factors are not transcriptionally 
linked to genes encoding proteins related to known anti-σ factors. Instead, they are located 
next to genes encoding carboxymuconolactone decarboxylases (CMD proteins), 
oxidoreductases or epimerases. To extract general features of ECF41-dependent gene 
regulation, we experimentally investigated ECF41 σ factors from two different organisms, 
Bacillus licheniformis (Firmicutes) and Rhodobacter sphaeroides (α-proteobacteria). In 
both organisms, the ECF41 σ factor appears to control expression of a single transcript that 
is preceded by a highly conserved ECF41-specific promoter motif. A unique feature of 
ECF41 proteins is the presence of a large C-terminal extension, containing a number of 
conserved signature motifs. We provide evidence that this C-terminal extension is involved 
in regulation of σ factor activity and we propose that it functions as a fused anti-σ factor 
domain.  
Experimental procedures 
Bioinformatics analysis. 510 ECF41 proteins were extracted in October 2010 from the 
MiST2 database (Ulrich & Zhulin, 2010) available at http://mistdb.com. False positives 
(unclassified ECF σ factors) and redundant proteins (proteins from more than one 
sequenced strain per species) were removed leaving 373 sequences for further analysis. 
Multiple sequence alignments were performed using ClustalW (Thompson et al., 1994) 
and phylogenetic trees were generated from gapless multiple sequence alignments using 
the Neighbor-Joining method of the Phylip (Felsenstein, 1989) program Protdist, both 
implemented in the BioEdit program package (Hall, 1999). Genomic context analysis was 
performed using the databases MicrobesOnline (Alm et al., 2005) at 
http://www.microbesonline.org and MiST2 (Ulrich & Zhulin, 2010) available at 
Chapter 4 
52 
http://mistdb.com/. Protein domain architecture was analyzed using the SMART database 
(Letunic et al., 2006, Schultz et al., 1998) available at http://smart.embl-heidelberg.de/. 
250 bp region upstream of the genes encoding the ECF41 σ factors and the corresponding 
COE were analysed for putative promoter motifs either manually or with the help of 
MEME (Bailey & Elkan, 1994), available at http://meme.nbcr.net/. Conservation of 
putative target promoters was illustrated using the WebLogo tool (Crooks et al., 2004) at 
http://weblogo.berkeley.edu. The promoter sequence of group ECF41 σ factors was used to 
screen the genomes of R. sphaeroides 2.4.1 and B. licheniformis DSM13 for putative target 
genes with the help of the virtual footprint algorithm (Münch et al., 2005), implemented 
into the Prodoric database (Münch et al., 2003) at http://www.prodoric.de/vfp/. As input 
pattern, the generated position weight matrix or the promoter consensus as IUPAC code 
was used.  
Bacterial strains and growth conditions. B. subtilis, B. licheniformis and E. coli were 
grown in LB medium at 37°C with aeration. R. sphaeroides was grown aerobically in 
Sistrom’s minimal medium (Sistrom, 1960) at 30°C. All strains used in this study are listed 
in Table 4.1. The antibiotics spectinomycin (100 µg/ml), chloramphenicol (5 µg/ml) and 
erythromycin (1 µg/ml) plus lincomycin (25 µg/ml) for macrolide-lincosamide-
streptogram (MLS) resistance were used for selection of B. subtilis and B. licheniformis 
mutants. Plasmid containing E. coli strains were grown with ampicillin (100 µg/ml) or 
kanamycin (50 µg/ml). R. sphaeroides mutants were selected using tetracycline (1 µg/ml), 
spectinomycin (25 µg/ml) or kanamycin (25 µg/ml).  
DNA manipulations. Standard cloning techniques were applied (Sambrook & Russell, 
2001). All plasmids used in this study are listed in Table 4.2, oligonucleotides in Table 4.3. 
E. coli strain S17-1 (Simon et al., 1983) was used for conjugational DNA transfer in R. 
sphaeroides. In brief, a 1:1 cell mixture of exponentially growing donor and recipient 
strains were harvested, washed, and resuspended in LB medium. The cell mixture was 
applied to a filter disc and incubated overnight on a LB plate at 30°C. The filter disc was 
transferred to Sistrom’s minimal medium (Sistrom, 1960) and incubated for 3 h at 30°C on 
a shaker, before the cells were plated on agar plates with selection. Conjugants were 
obtained after 3-4 days incubation at 30°C.  
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Table 4.1. Bacterial strains used in this study 
Strain Genotype or characteristic(s) Source or reference 
E. coli strains   
S17-1 C600::RP-4 2-(Tc::Mu)(Km::Tn7) thi pro hsdR 
hsdM
+
recA 
(Simon et al., 1983) 
DH5α recA1 endA1 gyrA96 thi hsdR17(rK- mK+) relA1 
supE44 Φ80∆lacZ∆M15 ∆(lacZYA-argF)U169 
(Sambrook & Russell, 
2001) 
   
B. subtilis strains   
W168 Wild type strain, trpC2 Laboratory stock 
1A774 JH642 rpoC::(His6-tag) Sp
R BGSC (C. Moran) 
TMB1099 1A774 pPH0401 This study 
TMB1100 1A774 pPH0403 This study 
TMB1101 1A774 pTW0412 This study 
TMB695 W168 pPH0401 This study 
TMB746 W168 pPH0403 This study 
TMB666 W168 pTW0412 This study 
TMB428 W168 thrC::pTW6302 This study 
TMB455 TMB428 amyE::pTW901 This study 
TMB451 W168 amyE::pTW901 This study 
TMB456 TMB428 amyE::pTW902 This study 
TMB574 TMB451 thrC::pTW6304 This study 
TMB575 TMB451 thrC::pTW6305 This study 
TMB577 TMB451 thrC::pTW6307 This study 
TMB623 TMB428 pHCMC04 This study 
TMB696 TMB428 pPH0401 This study 
TMB744 TMB428 pPH0405 This study 
TMB743 TMB428 pPH0404 This study 
TMB742 TMB428 pPH0403 This study 
TMB741 TMB428 pPH0402 This study 
TMB667 TMB428 pTW0412 This study 
TMB795 TMB428 pPH0406 This study 
TMB797 TMB428 pPH0407 This study 
TMB1016 TMB428 pTW0414 This study 
TMB793 TMB428 pPH0408 This study 
   
B. licheniformis strains   
DSM13 Wild type strain Laboratory stock 
MW3 DSM13∆hsdR1 ∆hsdR2 (Waschkau et al., 2008) 
TMBli003 MW3 ∆ydfG This study 
TMBli006  MW3 ∆ecf41Bli This study 
   
R. sphaeroides strains   
2.4.1 Wild type strain Laboratory stock 
TMR003 2.4.1 pTW0503 This study 
TMR004 YSD418 pTW0501 This study 
TMR005 YSD418 pTW0502 This study 
TMR006 YSD418 pTW0503 This study 
YSD418 2.4.1 PRSP_0606::pSUP202-lacZ This study 
YSD354 2.4.1 pIND4 This study 
YSD239 2.4.1 ∆RSP_0606-ecf41Rsp Ω::Spec
R This study 
YSD333 2.4.1 pYSD161 This study 
YSD434 YSD418 pIND4 This study 
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Table 4.2. Vectors and plasmids used in this study 
Name Genotype or characteristic featuresa Primers for cloning Source or reference 
Vectors    
pDG1663 lacZ fusion vector, integrates in thrC, MLSR   (Guerout-Fleury et 
al., 1996) 
pHCMC04 Xylose-inducible expression vector, CmR  (Nguyen et al., 
2005) 
pIND4 IPTG-inducible expression vector, KnR   (Ind et al., 2009) 
pSUP202 Mobilizable vector, ApR, CmR, TcR  (Simon et al., 1983) 
pSWEET Xylose-inducible expression vector, 
integrates in amyE, CmR 
 (Bhavsar et al., 
2001) 
pMAD Shuttle vector for construction of makerless 
deletion mutans, MLSR 
 (Arnaud et al., 
2004) 
pHP45Ω Source of Ω::SpecR cassette  (Prentki & Krisch, 
1984) 
pGEM-T Cloning vector  Promega Corp. 
    
Plasmids    
pTW101 pMAD ecf41Bli up/do 779/780, 781/782 This study 
pTW102 pMAD ydfG up/do 783/784, 785/786 This study 
pTW6302 pDG1663 PydfG(-146-54)-lacZ 712/713 This study 
pTW6304 pDG1663 PnhaX(-355-40)-lacZ 1130/1131 This study 
pTW6305 pDG1663 PybpE(-111-63)-lacZ 1136/1137 This study 
pTW6307 pDG1663 PuvrX(-173-54)-lacZ 1132/1133 This study 
pTW901 pSWEET ecfI41Bli 699/669 This study 
pTW902 pSWEET ecf41Bli-ydfG 699/705 This study 
pPH0401 pHCMC04 ecf41Bli-FLAG 1416/1294 This study 
pPH0405 pHCMC04 ecf41Bli aa1-270-FLAG 1416/1471 This study 
pPH0404 pHCMC04 ecf41Bli aa1-234-FLAG 1416/1470 This study 
pPH0403 pHCMC04 ecf41Bli aa1-204-FLAG 1416/1469 This study 
pPH0402 pHCMC04 ecf41Bli aa1-192-FLAG 1416/1468 This study 
pTW0412 pHCMC04 ecf41Bli aa1-167-FLAG 1416/1411 This study 
pPH0406 pHCMC04 ecf41Bli WLPEP→A-FLAG 1416/1474, 
1475/1294 
This study 
pPH0407 pHCMC04 ecf41Bli DGGGK→A-FLAG 1416/1476, 
1478/1294 
This study 
pPH0408 pHCMC04 ecf41Bli NPDKL→A-FLAG 1416/1479 This study 
pTW0414 pHCMC04 ecf41Bli INDQKGVL→A-FLAG 1416/1579, 
1580/1294 
This study 
pSUP202-
lacZ 
pSUP202 with promoter-less lacZ gene 199/200 This study 
pSUP202-
PRSP_0606-lacZ 
PRSP_0606 fused to lacZ gene 109/219 This study 
pYSD122 pSUP202 with the Ω::SpecR cassette and 
genomic regions flanking RSP_0606-
ecf41Rsp 
109/110/125/126 This study 
pYSD161 pIND4 ecf41Rsp 185/186 This study 
pTW0501 pIND4 ecf41Rsp 1881/1603 This study 
pTW0502 pIND4 ecf41Rsp aa1-169 1881/1604 This study 
pTW0503 pIND4 ecf41Rsp aa1-206 1881/1605 This study 
aResistance cassettes: MLSR, macrolide-lincosamide-streptogram; CmR, chloramphenicol; KnR, kanamycin; ApR, ampicillin; TcR, 
tetracycline; SpecR, spectinomycin  
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Table 4.3. Oligonucleotides used in this study 
Number and name Sequence 
Construction of promoter lacZ fusiona  
712 (PydfG fwd (EcoRI)) AGTCGAATTCCTTGGAATCCGGAAGGCGAT 
713 (PydfG rev (BamHI)) AGCTGGATCCCATTCCTCTGTATCCCTCAG 
1130 (PnhaX fwd (EcoRI)) AGTCGAATTCGCACACTGTGTACCAGCATG 
1131 (PnhaX rev (BamHI)) AGTCGGATCCTTCCGTCAAACGCGACTATG 
1132 (PuvrX fwd (EcoRI)) AGTCGAATTCAAATTCCGAACTGGAATGGTC 
1133 (PuvrX rev (EcoRI)) AGTCGGATCCAGCTCCGCATATCAACGCAC 
1136 (PypbE fwd (EcoRI)) AGTCGAATTCGATTGAGCTTTGAACGGACAG 
1137 (PypbE rev (BamHI)) AGTCGGATCCTCATTTCAGCGCTGGCCTTC 
109 (RSP_0606-ecf41Rsp operon fwd) AGGCAAAGTAGAGACCGCGTCC 
219 (RSP_0606 promoter rev (XbaI)) ATGTTCTAGACGCTCTCTCCTTTTGCAACTGA 
210 (lacZ start codon  (ScaI, XbaI)) CTAGTACTGTATCTAGATGACCATGATTACGGATTC
A 
200 (lacZ terminator rev) CATTACGGATCTTTTCTTTCG 
  
Mutagenesis/expression experimentsa b c d  
1416 (3xFLAG-ecf41Bli fwd (BamHI)) AGTCGGATCCAAGGAGGTGAGGATCTATGGATTATAAG
GATCATGATGGTGATTATAAGGATCATGATATCGACTACA
AAGACGATGACGACAAGGAATATTATCGACAATATCA
TTC 
1294 (ecf41Bli  rev (AatII)) AGTCGACGTCTTATATTTTAATGTGCTTCAGTTTATC 
1471 (ecf41Bli 270 rev (AatII)) AGTCGACGTCTCAATTTTTGACGGAATCGCCTTC 
1470 (ecf41Bli 234 rev (AatII)) AGTCGACGTCTCAAAAGCGGCCGGAAAAGCTTC 
1469 (ecf41Bli 204 rev (AatII)) AGTCGACGTCTCACACTTTTCCGCCGCCATCT 
1468 (ecf41Bli 192 rev (AatII)) AGTCGACGTCTCATTCAATCAATTTCTTGGAAAACTC 
1411 (ecf41Bli 167 rev (AatII)) AGTCGACGTCTCATTCTTCAACCGGCTGTGAA 
1474 (WLPEP up rev) AGCCGCTGCGGCAGCTTCCCCGATATATACCTCC 
1475 (WLPEP do fwd) GCTGCCGCAGCGGCTCAGGTGGCGCTTTCAGCTC 
1476 (DGGGK up rev) AGCCGCTGCGGCAGCTGTATACAATACGGCATCTTC 
1478 (DGGGK do fwd) GCTGCCGCAGCGGCTGTGCGCAGCGCTTTGAGA 
1479 (NPDKL rev (AatII)) AGTCGACGTCTTATATTTTAATGTGCTTAGCCGCTGC
AGCAGCTGACACGATAAACACATTTTTGACG 
1579 (INDQKGVL up rev) TGCGGCAGCAGCCGCTGCGGCAGCATCGACTGGCAT
AAAGCGGC 
1580 (INDQKGVL do fwd) GCTGCCGCAGCGGCTGCTGCCGCAATCATGAAAAAC
AACCGCCCGGCT 
699 (ecf41Bli fwd (PacI)) TACGTTAATTAATTTTAGGCAAAATATCTATGGG 
669 (ecf41Bli rev (BamHI)) GACTGGATCCTTATATTTTAATGTGCTTCAGTTTATC 
705 (ecf41Bli-ydfG rev (BamHI)) AGCTGGATCCCGCTCAAATAAAGTGAAAGATAG 
1881 (ecf41Rsp fwd (NcoI)) GTCACCATGGCGCCTGACGTCTACCTGCA 
1603 (ecf41Rsp  rev (HindIII)) GTCAAAGCTTTCAGTTGAGCCTGATACGGGTC 
1604 (ecf41Rsp 169 rev (HindIII)) GTCAAAGCTTTCACGCTGCCTCGCGCTCCACCT 
1605 (ecf41Rsp 206 rev (HindIII)) GTCAAAGCTTTCAGACCTTGCCGCCACCGTCCGA 
185 (ecf41Rsp fwd (BsrDI)) GTAGCAATGCATGTCGCCTGACGTCTACCTGCAG 
186 (ecf41Rsp rev (HindIII)) GTAAAGCTTTCAGTTGAGCCTGATACGGGTCAGC 
  
Deletion mutantsa d   
779 (ecf41Bli clean up fwd (BamHI)) AGTCGGATCCTATCCAGCCGATTGTCGTCA 
780 (ecf41Bli clean up rev) GGAGTTTGTGACAAAAAACGAGACGCTCCCCCATAG
ATATTTTGC 
781 (ecf41Bli clean do fwd) CGTTTTTTGTCACAAACTCC 
782 (ecf41Bli clean do rev (EcoRI)) AGTCGAATTCACCTACTTTCACATTGAACAAG 
783 (ydfG clean up fwd (BamHI)) AGTCGGATCCTGGCGCTTTCAGCTCAAATC 
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Number and name Sequence 
784 (ydfG clean up rev) GTCTATTCCTCCTTTAAGTGTT 
785 (ydfG clean do fwd) AACACTTAAAGGAGGAATAGACTTGAAATCCCCCCA
ACACAG 
786 (ydfG clean do rev (EcoRI)) AGTCGAATTCCCGTCGATCATCAGATCCGT 
109 (RSP_0606- ecf41Rsp operon fwd) AGGCAAAGTAGAGACCGCGTCC 
110 (RSP_0606- ecf41Rsp operon rev) ACGGGTTGGCACGCTGGATGAG 
125 (RSP_0606 rev-inverted) GCGTTTGAAATGGTCGGTCATGC 
126 (RSP_ ecf41Rsp fwd-inverted) TGACCCGTATCAGGCTCAACTG 
  
Northern Hybridization  
688 (ydfG-fwd) CTGAGGGATACAGAGGAATG 
761 (ydfG-probe-T7-rev) CTAATACGACTCACTATAGGGAGACGATGGCAATC
CTGTTCCAG 
  
5’RACE  
679 (RACE PCR) GATATGCGCGAATTCCTG 
689 (GSP1-ydfG) CTTGCATCCTTCGTATGCATA 
690 (GSP2-ydfG) CACATCCGTTCAGCTGTGA 
1414 (GSP1-RSP_0606) AGCGTGCATCTGCAGACAGA 
1415 (GSP2-RSP_0606) AGCTGGATCCCATCTTCACCAGATGCAGCA 
aRestriction sites are highlighted in bold. 
bSequence of FLAG-tag is shown in underlined italics. 
cInserted sequences (stop codons or Shine-Dalgarno sequences) are highlighted in italics. 
dLinker sequences for amino acid exchanges and joining reactions are underlined. 
eSequence representing the T7 promoter for in vitro transcription is shown in bold and underlined. 
Construction of markerless ecf41Bli and ydfG deletion mutants in B. licheniformis. 
Markerless B. licheniformis ∆ecf41Bli and ∆ydfG mutants were constructed using the vector 
pMAD (Arnaud et al., 2004). 700 bp fragments up- and downstream of ecf41Bli and ydfG 
were amplified by PCR using the oligonucleotides listed in Table 4.3, introducing 
extensions at the 3’ end of the up fragments which are complementary to the 5’ end of the 
down fragments. These regions were used to fuse the fragments in a second joining PCR. 
The resulting products were then cloned into pMAD using BamHI and EcoRI generating 
pTW101 and pTW102. The plasmids were introduced into B. licheniformis MW3 as 
described (Waschkau et al., 2008). Generation of markerless deletion mutants basically 
followed the established procedure (Arnaud et al., 2004). In brief, transformants were 
incubated at 30°C with MLS selection on LB agar plates supplemented with X-Gal. Blue 
colonies were picked and incubated for 6-8 h at 42°C in LB medium with MLS selection, 
resulting in the integration of the plasmid into the chromosome. Again, blue colonies were 
picked from LB X-Gal plates and incubated for 6 h at 30°C in LB medium without 
selection. Subsequently, the liquid culture was shifted to 42 °C for 3 h, and the cells were 
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then plated on LB X-Gal plates, this time without selective pressure. White colonies that 
had lost the plasmid were picked and deletion of ecf41Bli or ydfG was checked by PCR. 
Construction of a RSP_0606-ecf41Rsp deletion mutant in R. sphaeroides. RSP_0606-
ecf41Rsp with 1.3 kb flanking regions on both sides was amplified from chromosomal DNA 
of R. sphaeroides using oligonucleotides 109 and 110 and ligated into the vector pGEM-T 
(Promega). To replace RSP_0606-ecf41Rsp with a resistance cassette, the regions flanking 
the genes and the plasmid were amplified using internal oligonucleotides (125, 126) and 
ligated to the Ω fragment derived from pHP45Ω (Prentki & Krisch, 1984), conferring 
spectinomycin resistance. The resulting construct was amplified using oligonucleotides 
109 and 110, cloned into the suicide vector pSUP202 (which contains a tetracycline 
resistance marker) digested with ScaI to make pYSD122. The plasmid pYSD122 was than 
conjugated into R. sphaeroides 2.4.1. Double recombinants corresponding to the deletion 
mutants were selected for spectinomycin resistance and sensitivity to tetracycline. Plasmid 
constructs were verified by sequencing, and the deletion in the R. sphaeroides genome was 
verified by PCR. 
Measurement of promoter activity by β-galactosidase assays. Because of the lack of 
genetic tools for B. licheniformis, we developed a heterologous expression system in B. 
subtilis, an organism lacking an ECF41 σ factor. A DNA fragment from B. licheniformis 
containing the intergenic region between ydfG and ecf41Bli was fused to a promoter-less 
lacZ gene using the vector pDG1663 and integrated into the thrC locus of B. subtilis. In 
addition, we fused a FLAG-tag to the N-terminus of Ecf41Bli and its mutated or truncated 
versions and expressed the protein from the xylose-inducible promoter of the shuttle vector 
pHCMC04, allowing determination of PydfG activity by β-galactosidase assays in response 
to Ecf41Bli expression. The resulting B. subtilis strains were inoculated from fresh 
overnight cultures and grown in LB medium at 37°C with aeration until they reached an 
OD600 of ~0.4. The cultures were split and 0.5% xylose was added to one sample to induce 
expression of Ecf41Bli from the inducible promoter. After incubation for 1 h at 37°C, 2 ml 
of each sample were harvested and the cell pellets frozen at -20°C. The pellets were 
resuspended in 1 ml working buffer and assayed for β-galactosidase activity with 
normalization to cell density (Miller, 1972). 
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A DNA fragment containing the upstream region of RSP_0606 was amplified and cloned 
into the suicide vector pSUP202 carrying a promoter-less lacZ gene. The resulting plasmid 
was conjugated into R. sphaeroides and integrated into the chromosome by single crossing 
over, thereby bringing the expression of β-galactosidase under control of PRSP_0606. Full-
length and truncated ecf41Rsp was amplified and cloned into the overexpression vector 
pIND4, thereby bringing its expression under control of an IPTG-inducible promoter. The 
resulting R. sphaeroides strains were grown aerobically in Sistrom’s minimal medium 
(Sistrom, 1960) to an OD600 of ~0.4. The cultures were split and expression of Ecf41Rsp 
was induced in one sample by adding 100 µM IPTG. After 3 h the cells were harvested and 
β-galactosidase activity was measured as described (Miller, 1972). 
Preparation of total RNA. B. licheniformis MW3 (wt) and TMBli003 (∆ecf41Bli) were 
grown aerobically in LB medium at 37°C. Every 2 hours 30 ml samples were taken and 
mixed with cold killing buffer (20 mM Tris-HCl, pH 7.0, 0.5 mM MgCl2, 20 mM NaN3), 
harvested by centrifugation and frozen in liquid nitrogen, before the pellets were stored at -
80°C. The cells were resuspended in 200 µl killing buffer, immediately transferred to a 
pre-cooled Teflon vessel and disrupted with a Micro-Dismembrator U (Sartorius) for 3 min 
at 2000 rpm. The resulting cell powder was resuspended in 3 ml prewarmed lysis solution 
(4 M guanidine-thiocyanate, 25 mM sodium acetate, pH 5.2, 0.5% N-lauroyl sarcosinate) 
and total RNA was extracted twice with acid phenol (phenol/chloroform/isoamylalcohol 
25/24/1, pH 4.5-5) and once with chloroform (chloroform/isoamylalcohol 24/1) followed 
by isopropanol precipitation. Contaminating DNA was removed using the Baseline-ZERO 
DNAse (Epicentre Biotechnologies) according to the manufacturer’s protocol. RNA was 
quantified with a NanoDrop 1000 Spectrophotometer (Thermo Scientific) and used for 
5’RACE and Northern Blot analysis. 
R. sphaeroides YSD354 (pIND4) and YSD333 (pYSD161) were grown aerobically in 
Sistrom’s minimal medium (Sistrom, 1960) containing 25 µg/ml kanamycin at 30°C. At 
OD600 of ~0.3 expression of Ecf41Rsp was induced by adding 100 µM IPTG. After 3 hours 
44 ml of culture were mixed with 6 ml stop solution (5% acid phenol in ethanol) and 
harvested by centrifugation. The pellets were frozen in an ethanol/dry ice bath and stored 
at -80°C. Cells were resuspended in 2 ml lysis solution (2% SDS, 16 mM EDTA) and 
incubated at 65°C for 5 min. RNA was extracted three times with acid phenol prewarmed 
to 65°C followed by chloroform extraction and isopropanol precipitation. To remove 
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contaminating DNA the RNA was incubated with 2 units RQ1 DNase (Promega) in the 
presence of 80 units RNasin Plus RNase Inhibitor (Promega) for 30 min at 37°C. The RNA 
was finally purified with the RNeasy Mini Kit (Qiagen) and used for DNA Microarray 
analysis and 5’RACE. 
Probe preparation and Northern Blot analysis. A ~500 bp internal fragment of ydfG 
was amplified by PCR with oligonucleotides listed in Table 4.3. A digoxigenin (DIG)-
UTP-labeled RNA probe was synthesized by in vitro transcription using the DIG RNA 
Labeling Mix (Roche) and T7 RNA polymerase (Roche) according to the manufacturer’s 
protocol.  
For Northern Blot analysis 10 µg of total RNA were separated under denaturing conditions 
on a 1% formaldehyde agarose gel and transferred to a positively charged nylone 
membrane (Roche) in a downward transfer using 20x SSC (3 M NaCl, 0.3 M sodium 
citrate, pH 7.0) as transfer buffer. The RNA was crosslinked by exposing the membrane to 
UV light. The blot was prehybridized at 68°C for 1 h with hybridization solution (5x SSC, 
50% formamide, 2% Blocking Reagent (Roche), 0.1% N-lauroyl sarcosinate and 0.02% 
SDS). Hybridization was carried out overnight at 68°C in the same solution with 1 µg 
DIG-labeled RNA probe. The membrane was washed twice for 5 min at room temperature 
(2x SSC, 0.1 % SDS) and three times for 15 min at 68°C (0.1x SSC, 0.1 % SDS). The 
signal was detected with an anti-digoxigenin antibody conjugated to alkaline phosphatase 
(Roche) and CDP-Star (Roche) according to the manufacturer’s instructions. The signals 
were visualized using a LumiImager (Peqlab). 
DNA microarray analysis. RNA samples from three independent cultivations were used 
for cDNA synthesis and DNA microarray hybridization. 10 µg of total RNA were mixed 
with 3 µg random hexamers and denatured at 70°C for 10 min before the temperature was 
decreased in 6 cycles (1 min each) by 10C°/cycle to 10°C to optimize annealing of the 
hexamers. cDNA was synthesized using SuperScript II Reverse Transcriptase (Invitrogen) 
according to the manufacturer’s instruction. Temperature was increased from 20°C to 42°C 
in 22 cycles of 3 min with 1°C increment followed by incubation at 42°C for 1 hour and 
inactivation at 70°C for 10 min. Remaining RNA was removed by alkaline hydrolysis and 
cDNA was purified using the PCR Purification Kit (Qiagen). 3.2 µg cDNA were 
fragmented with 0.25 units RQ1 DNase (Promega) for 10 min at 37°C followed by 
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inactivation for 10 min at 98°C. cDNA was labelled using the BioArray Terminal Labeling 
Kit with Biotin-ddUTP for DNA Probe Array Assays (Enzo) according to the 
manufacturer’s protocol. Labeled cDNA samples (3µg/array) were hybridized to 
Affymetrix (Santa Clara, CA) custom arrays (Pappas et al., 2004) according to the 
manufacturer’s directions. Processing, normalization, and statistical analysis of the array 
data were performed in the R statistical software environment (http://www.r-project.org/). 
Data were normalized using the affyPLM package with default settings (Bolstad, 2004). 
Differentially expressed genes were detected using the limma package with a false 
discovery rate set at 0.05 (Smyth, 2005).  
Determination of transcriptional start sites by 5’-RACE. The 5’ ends of ydfG and 
RSP_0606 mRNAs were identified by rapid amplification of cDNA ends (RACE). 15 µg 
of total RNA were incubated with 25 units tobacco acid pyrophosphatase (TAP, Epicentre 
Biotechnologies) in the delivered buffer at 37°C for 60 min in the presence of 40 units 
Super RNaseIn RNAse inhibitor (Ambion). As a control, 15 µg RNA were incubated under 
the same conditions, but without TAP. The reactions were phenol/chloroform extracted 
and ethanol precipitated. After dissolving the pellets in water, the RNA was mixed with 
500 pmol RACE adapter (5’-GAUAUGCGCGAAUUCCUGUAGAACGAACACUAGA-
AGAAA-3’) and denatured at 95°C for 5 min. Ligation of the adapter was carried out at 
17°C overnight with 100 units T4 RNA ligase (Epicentre Biotechnologies) in the presence 
of 80 units Super RNaseIn RNAse inhibitor (Ambion). Again, the reactions were 
phenol/chloroform extracted, ethanol precipitated and the pellets were resuspended in 
water. 1 µg RNA was used for reverse transcription with gene specific primers (GSP1, 
Table 4.3) and the iScript Select cDNA Synthesis Kit (Bio-Rad) according to the 
manufacturer’s protocol. The cDNA was then amplified with nested primers and a primer 
complementary to the RACE adapter sequence (GSP2 and 679, Table 4.3) and the 
transcription start sites were identified by sequencing. 
Western Blot analysis. B. subtilis strains containing overexpression plasmids were grown 
in LB medium at 37° to an OD600 ~0.4. Expression of Ecf41Bli-FLAG and its variants was 
induced by adding 0.5 % xylose. After 1 h 15 ml of each culture were harvested. The 
pellets were resuspended in ZAP buffer (10 mM Tris, pH 7.4, 200 mM NaCl), cells were 
lysed by sonication and cell debris was removed by centrifugation. 20 µg of the cleared 
lysate were separated by SDS-PAGE and transferred to a Polyvinylidene difluoride 
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(PVDF) membrane using a Mini Trans-Blot Electrophoretic Transfer Cell (Bio-Rad) 
according to the manufacturer’s instructions. The membrane was then incubated overnight 
at 4°C with blotto (2.5% skim milk in TBS (50 mM Tris, pH 7.6, 150 mM NaCl)) to 
prevent non-specific binding. Then, the membrane was incubated with the primary 
antibody (anti-FLAG (Sigma) diluted 1:2000 in blotto) at room temperature for 1 h 
followed by four 10 min washing steps with blotto. Then the blot was incubated for 1 h 
with the secondary antibody (anti-rabbit IgG HRP conjugate (Promega) diluted 1:2000 in 
blotto). After four washing steps with blotto, the membrane was washed with TBS before 
the signals were detected with a LumiImager (Peqlab) using AceGlow (Peqlab) as 
chemiluminescence substrate. 
RNAP pull-down assays. Different versions of Ecf41Bli-FLAG under control of a xylose-
inducible promoter were introduced into B. subtilis 1A774, which contains a His6-tag fused 
to the β’ subunit of the RNAP, to form strains TMB1099 (wt Ecf41Bli), TMB1100 (Ecf41Bli 
204) and TMB1101 (Ecf41Bli 167). As controls, the same constructs were transformed into 
B. subtilis W168 resulting in TMB695, TMB746 and TMB666. The RNA pull-down 
assays were performed as described previously (MacLellan et al., 2008). In brief, 100 ml 
LB medium supplemented with 5 µg/ml chloramphenicol were inoculated from fresh 
overnight cultures and grown till OD600 ~0.4. Cultures were induced with 0.5% xylose for 
1 hour and cells were harvested by centrifugation. The pellets were resuspended in 
phosphate buffer (50 mM phosphate buffer, pH 7.6, 100 mM NaCl, 0.1 mM PMSF, 5 mM 
imidazole) and cells were lysed by sonication. The cleared lysate was loaded on a column 
containing 0.5 ml Ni2+-NTA metal affinity beads. The beads were washed with each 10 
column volumes of the above mentioned phosphate buffer containing 5, 10 and 20 mM 
imidazole. Elution was carried out using 0.5 ml phosphate buffer with increasing imidazole 
concentration (50, 100, 250 and 500 mM). Samples of the cleared lysate, washing steps 
and elution fractions were run in duplicates on 10 and 12% SDS-PAGE gels and checked 
for presence of RNAP (coomassie staining) and Ecf41Bli-FLAG (Western Blot using anti-
FLAG antibodies). For quantitative analysis 5 µg of lysate as well as 5 and 10 µg of the 
100 mM imidazole elution fractions were used and analysed as mentioned above.  
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Results 
In silico analysis of group ECF41 σ factors 
Phylogenetic distribution. The initial analysis of group ECF41 (Staroń et al., 2009) was 
based on a dataset generated in 2008 containing 115 ECF41 protein sequences from five 
different phyla. To account for the huge increase in bacterial genomes sequenced within 
the last three years, we re-analysed group ECF41 based on 373 ECF41 σ factors extracted 
in October 2010 from the Microbial Signal Transduction Database (MiST2) (Ulrich & 
Zhulin, 2010) (Table S1). The proteins of group ECF41 are widely distributed and can be 
found in ten different phyla (Table 4.4): Actinobacteria (68%, 252 proteins), Proteobacteria 
(23%, 84 proteins), Firmicutes (4%, 15 proteins) and Chloroflexi (3%, 11 proteins), 
Acidobacteria (4 proteins), Bacteriodetes, Cyanobacteria (2 proteins each) and 
Spirochaetes, Verrucomicrobia and Gemmatimonadetes (1 protein each). It should be 
noted that some phyla are heavily underrepresented among the available genome 
sequences, as has been discussed recently (Staroń et al., 2009).  
Table 4.4. Phylogenetic distribution of ECF41 σ factors 
Phyla 
ECF41 
proteins per 
phylum 
% of ECF41 
proteins 
Species with 
ECF41 
protein 
% of 
sequenced 
species 
Sequenced 
genomes/speciesa 
Actinobacteria 252 68 60 51 181/118 
Proteobacteria 84 23 66 15 705/414 
Firmicutes 15 4.0 10 2.5 404/182 
Chloroflexi 11 2.9 3 60 15/5 
Acidobacteria 4 1.1 4 67 6/6 
Bacteriodetes 2 0.5 2 4.4 53/45 
Cyanobacteria 2 0.5 2 6.3 44/32 
Spirochaetes 1 0.3 1 5.6 23/18 
Verrucomicrobia 1 0.3 1 25 4/4 
Gemmatimonadetes 1 0.3 1 100 1/1 
a Numbers of sequenced genomes and species of each phylum were extracted from the MiST2 database (Ulrich & Zhulin, 2010) in 
October 2010. 
The 373 proteins of group ECF41 derive from 150 different species. Therefore, these 
organisms often encode more than one copy of the ECF41 gene in the genome (Table 4.4 
and S1). Especially within the Actinobacteria multiple copies are very common. Only 14 
out of the 60 ECF41-containing actinobacterial species harbor just one copy of this σ 
factor, while the genomes of the remaining 46 contain several copies. Especially the genus 
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Streptomyces contains large numbers of ECF41 σ factors with at least 4 copies per genome, 
which may reflect the complex lifestyle of these bacteria (Flärdh & Buttner, 2009). The 
ECF41 copy number correlates well with the genome size and the overall abundance of 
signal transducing systems. For example, the genome of S. coelicolor encodes as many as 
45 ECF σ factors (Bentley et al., 2002), 13 of which belong to group ECF41. A high 
abundance of ECF41 genes can also be found in the phylum Chloroflexi (11 ECF41 σ 
factors/3 genomes), whereas most of the Proteobacteria (84 ECF41 σ factors/66 genomes) 
and Firmicutes (15 ECF41 σ factors/10 genomes) harbour only one to two ECF41 σ factors 
per genome.  
We constructed an unrooted phylogenetic tree based on a gapless multiple sequence 
alignment of all 373 ECF41 σ factors using the Neighbor-Joining method implemented in 
the Phylip program Protdist (Felsenstein, 1989) provided by the BioEdit Sequence 
Alignment Editor (Hall, 1999) (Fig. 4.1).  
 
Figure 4.1. Phylogenetic tree of ECF41 σ factors. The phylogenetic tree is based on a gapless multiple 
sequence alignment of 373 ECF41 protein sequences constructed using ClustalW (Thompson et al., 1994). 
The resulting phylogenetic tree was calculated using the neighbor-joining method of the Phylip (Felsenstein, 
1989) program Protdist implemented in the BioEdit Sequence Alignment Editor (Hall, 1999). Assignment to 
bacterial phyla is indicated by a color code. Ecf41Rsp of R. sphaeroides, Ecf41Bli of B. licheniformis and σ
J of 
M. tuberculosis are highlighted. 
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In general, the terminal nodes representing sequences of ECF41 σ factors cluster according 
to the phylum (Fig. 4.1). The two phyla containing the highest number of sequences 
(Actinobacteria and Proteobacteria) are divided into five and three different branches, 
respectively. One cluster within one actinobacterial branch is rather diverse and includes 
ECF σ factors from Proteobacteria, Chloroflexi, Firmicutes and Acidobacteria. The 
remaining ECF41 σ factors from Firmicutes as well as Chloroflexi form single branches. 
The ECF41 proteins from Bacteriodetes and Cyanobacteria also cluster together, whereas 
the proteins from Acidobacteria, Spirochaetes, Verrucomicrobia and Gemmatimonadetes 
cluster within or between actinobacterial and proteobacterial branches (Fig. 4.1). 
Genomic context conservation. In contrast to most ECF σ factors studied to date (Butcher 
et al., 2008), no gene encoding an obvious anti-σ factor can be found in direct vicinity of 
the genes encoding the ECF41 σ factors. Instead, they are genomically associated with 
genes encoding CMD proteins, oxidoreductases or epimerases (COE) (Table S1 and Fig. 
4.2). While this genomic context is highly conserved, the order and orientation of the 
associated genes is diverse. In almost 50% of the cases, both genes are orientated in the 
same direction and could potentially be transcribed as an operon. In less than 20% the 
genes are orientated divergently. The remaining ~30% of ECF41 σ factors do not cluster 
with genes encoding COE. Such “orphans” are especially abundant in actinobacterial 
species (Fig. 4.2), which contain multiple copies of ECF41 genes in the genome. But in 
general, at least one copy of the ECF41 genes shows the conserved genomic context. 
Carboxymuconolactone decarboxylases. Commonly, proteins of the CMD family 
(PF02627) can be divided into two main groups: the γ-CMD proteins and the AhpD-like 
alkylhydroperoxidases (Ito et al., 2006). The γ-CMD proteins are involved in the 
degradation of aromatic compounds. They catalyze the decarboxylation of γ-
carboxymuconolactone to β-ketoadipate enol-lactone in the protocatechuate branch of the 
β-ketoadipate pathway (Eulberg et al., 1998). The best investigated example of the second 
group is the alkylhydroperoxidase AhpD of Mycobacterium tuberculosis. This protein 
contains a CxxC motif critical for catalytic activity and is part of the antioxidant defense 
system of this organism (Hillas et al., 2000, Koshkin et al., 2003). In the archaeon 
Methanosarcina acetivorans it was shown that the product of gene MA3736 encodes an 
uncharacterized CMD protein homolog with disulfide reductase activity dependent on a 
CxxC motif (Lessner & Ferry, 2007). It was suggested to play a role in the oxidative stress 
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response of this organism. All CMD proteins genomically linked to ECF41 σ factors 
contain a conserved CxxC motif, suggesting a role of this group in the defense against 
oxidative stress. 
 
Figure 4.2. Genomic context conservation of ECF41 σ factors. ECF σ factors are shown by black, CMD 
proteins by grey, oxidoreductases by striped and epimerases by dotted arrows. Genes encoding hypothetical 
proteins, that either contain the conserved promoter motif or are located between the ECF41 σ factor and the 
COE, are displayed in white. The genomic context is represented according to the phylum with the number of 
species in parentheses. The number in front of each context indicates how often this combination of genes 
occurs within the designated phylum. 
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Oxidoreductases. The reactions catalyzed by oxidoreductases can be very diverse, but are 
always characterized by the transfer of electrons from one molecule to another, often using 
NAD(P)H or FAD as cofactors. Since oxidoreductases can use a variety of different 
molecules as electron donor or acceptor, it is difficult to assign a specific function to these 
enzymes. In case of genes next to ECF41 σ factors, they were classified as oxidoreductase 
if their product carried at least one of the following Pfam domains: Oxidored_FMN, 
Flavodoxin_2, Pyr_redox/_2, FAD_binding_2/3/4, Amino_oxidase, Pyridox_oxidase or 
FMN_red.  
Epimerases. The third group contained either a NmrA (PF05368) or an Epimerase 
(PF01370) domain. NmrA is a negative transcriptional regulator of AreA and involved in 
nitrogen metabolite repression in different fungi. The crystal structure of NmrA revealed a 
Rossmann fold and similarity to members of the short-chain dehydrogenase/reductase 
family (Stammers et al., 2001), which generally deploy nucleotide-sugar substrates for 
chemical conversions. The Rossmann-fold is typical for two domain redox enzymes that 
use NAD+ as cofactor. The UDP-galactose 4-epimerase is the best understood example of 
this family and catalyzes the conversion of UDP-galactose to UDP-glucose (Allard et al., 
2001). 
Miscellaneous. In some cases, genes encoding other than the above mentioned proteins can 
also be linked to ECF41 σ factors. These neighboring genes were included in Fig. 4.2 if 
they (i) carry the typical promoter sequence (see below), or (ii) are located between the 
ECF41- and the COE-encoding genes. Most of these other genes encode hypothetical 
proteins of unknown function. Four of these hypothetical proteins (Table S1) contain the 
conserved β-barrel domain of the cupin superfamily, which members often function as 
dioxygenases in bacteria (Dunwell et al., 2004). The C-terminal domain of the cytoplasmic 
anti-σ factor ChrR from R. sphaeroides σE also adopts such a cupin fold (Campbell et al., 
2007). In all four cases, the genes encoding these cupin fold proteins are in the same 
orientation than the ECF σ factor and presumably form an operon. 
ECF41 proteins contain a large C-terminal extension. Group 4 alternative σ factors 
contain the smallest proteins of the σ70 family, in which only regions σ2 and σ4 are 
sufficient for promoter recognition and RNAP interaction. An alignment of classical ECF 
σ factors from different organisms and proteins of group ECF41 revealed a large C-
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terminal extension of about 100 amino acids only present in ECF41 σ factors (Fig. 4.3). 
Based on an alignment of all ECF41 proteins (Fig. S1), we identified three conserved 
motifs within this extension. Another characteristic feature of the ECF41 proteins is a 
highly conserved WLPEP motif in the linker region between σ2 and σ4, which usually does 
not show much sequence conservation in other ECF σ factors (Fig. 4.3).  
 
Figure 4.3. Characteristic features of group ECF41 proteins and comparison with classical ECF σ 
factors. The multiple sequence alignment of selected ECF σ factors was constructed using ClustalW 
(Thompson et al., 1994). Identical amino acids at the same position are shaded in black, similar amino acids 
in grey. The σ2 and σ4 domains and the C-terminal extension are marked. Conserved motives of ECF41 
proteins are defined by the complete multiple sequence alignment of group ECF41 (Fig. S1) and underlined. 
Abbreviations: Bce, Bacillus cereus; Bli, Bacillus licheniformis; Bsu, Bacillus subtilis; Eco, Escherichia coli; 
Nfa, Nocardia farcinica; Rsp, Rhodobacter sphaeroides; Reu, Ralstonia eutropha. 
By analogy to other group 4 σ factors, we expect activity of the ECF41 proteins to be 
regulated. Based on the observations regarding the genomic context and domain 
architecture of ECF41 σ factors, we propose three hypotheses to explain their regulation: 
(i) the COE genes could be targets of ECF41-dependent regulation, (ii) the COE could be 
part of the signal transducing mechanism and function as an anti-σ factor, or (iii) the C-
terminal extension could be involved in controlling σ factor activity.  
To address these hypotheses directly and generalize our findings, we experimentally 
investigated ECF41 σ factors from two different organisms: BLi04371 of B. licheniformis 
Chapter 4 
68 
and RSP_0607 of R. sphaeroides. We named the genes encoding the ECF41 σ factors to 
ecf41Bli and ecf41Rsp and used these terms for the following analysis. The genomic 
neighborhood including the genes encoding the CMD proteins YdfG and RSP_0606 is 
shown in Fig. 4.4 A.  
 
Figure 4.4. Targets of ECF41-dependent signal transduction. (A) Genomic context organization and 
target promoter sequence of the ECF41 σ factors from B. licheniformis and R. sphaeroides. Genes encoding 
the ECF41 σ factor (black) and the CMD protein (grey) as well as the promoter sequences are shown. 
Flanking genes not belonging to the ECF41 loci are shown in white. The -35 and -10 region, the 
transcriptional start site +1 and the ATG start codon are highlighted in bold. The RACE adapter sequence is 
indicated by lower case letters. (B) Northern Blot analysis of Ecf41Bli-dependent ydfG expression in B. 
licheniformis. B. licheniformis MW3 (wt) and TMBli003 (∆ecf41Bli) were grown aerobically in LB medium. 
At the time points indicated by arrows, samples of both strains were harvested and total RNA was prepared. 
10 µg total RNA were separated on a 1% formaldehyde gel and transferred to a nylon membrane followed by 
hybridization and detection with a DIG-labeled ydfG-specific probe. Ribosomal RNA is shown to ensure 
equal amounts of RNA in each lane. (C) Weblogo of ECF41-dependent target promoters. The weblogo was 
generated using the WebLogo tool (Crooks et al., 2004) available at http://weblogo.berkeley.edu. The 
weblogo graphically represents a position weight matrix and illustrates the degree of sequence conservation 
for each nucleotide. The matrix is based on 285 putative promoter sequences identified upstream of genes 
encoding ECF41 σ factors and COE. (D) ECF41-dependent target promoter activation. B. subtilis strains 
TMB696 (Ecf41Bli) and TMB623 (pHCMC04) were grown in LB medium to OD600 ~0.4 and split into two 
samples. In one sample, expression of Ecf41Bli was induced by addition of 0.5 % xylose and cells were 
harvested after 1 h. R. sphaeroides strains TMR005 (Ecf41Rsp) and YSD434 (pIND4) were grown in 
Sistrom’s minimal medium to OD600 ~0.3 and split into two samples. In one sample, expression of Ecf41Rsp 
was induced by 100 µM IPTG. After 3 hours, the cells were harvested. PydfG and PRSP_0606 activities were 
measured by β-galactosidase assays with normalization to cell density.  
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Targets of ECF41 σ factors 
COE-encoding genes represent targets of ECF41-dependent signal transduction. We 
first investigated if the COE-encoding genes next to the ECF41 σ factors are targets of the 
ECF41-dependent signal transduction. Therefore, we monitored expression of ydfG at 
different growth phases in a B. licheniformis wild type and an isogenic ∆ecfI41Bli deletion 
strain. Both strains show no difference in growth behavior (Fig. 4.4 B) indicating that 
Ecf41Bli is not required under standard laboratory conditions. At designated time points 
samples of both strains were taken, total RNA was prepared and Northern Blot analysis 
was performed using a ydfG-specific probe. At the transition from the exponential to the 
stationary growth phase, a ~0.5 kb transcript appears in the wild type strain in agreement 
with a monocistronic expression of ydfG (Fig. 4.4 B). No ydfG transcript is visible in the 
∆ecfI41Bli deletion mutant, demonstrating that detectable expression of ydfG is completely 
Ecf41Bli-dependent under the condition tested.  
We also examined the transcriptome upon overexpression of Ecf41Rsp in R. sphaeroides by 
DNA microarrays to test if a similar result can be obtained in another organism and to 
possibly identify additional target genes of ECF41 σ factors. The mRNA level for ecf41Rsp 
was ~80-fold increased in cells overexpressing this protein. The only other more than 2-
fold induced gene was RSP_0606 (~3-fold), which encodes the associated CMD protein 
(data not shown). These results indicate that Ecf41Rsp seems to control expression of only a 
single transcript that contains the ecf41Rsp and RSP_0606 genes.  
Analysis of ECF41-dependent target promoters in B. licheniformis and R. 
sphaeroides. Since ECF σ factors recognize alternative promoter sequences, we 
investigated if the identified ECF41 target genes ydfG and RSP_0606 are preceded by such 
a unique sequence motif. We therefore mapped the transcriptional start site by 5’RACE in 
RNA samples from cells overexpressing the ECF41 σ factor (R. sphaeroides) or samples 
taken throughout the growth cycle (B. licheniformis) (Fig. 4.4 B). In both organisms, we 
identified a “G” residue as the transcriptional start site followed by a 22/23 bp untranslated 
region containing a suitable ribosome binding site (Fig. 4.4 A). Upstream of this start point 
we identified a bipartite sequence motif with similarity to ECF-dependent promoter 
elements: a -35 region identical in both organisms (“TGTCACA”) and a -10 region 
(“TGTT” or “CGTC”). 
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Next we tested if this predicted target promoter responds to the corresponding ECF41 σ 
factor. Because of the lack of genetic tools for B. licheniformis, we heterologously 
expressed Ecf41Bli-FLAG from a xylose-inducible promoter in B. subtilis, an organism 
lacking an ECF41 σ factor, and measured the activity of the target promoter PydfG 
transcriptionally fused to lacZ by β-galactosidase assays (Fig. 4.4 D). Without xylose, the 
resulting reporter strain TMB696 shows only low PydfG activity, presumably due to weak 
basal expression of Ecf41Bli from PxylA in complex LB medium. Addition of 0.5 % xylose 
increased promoter activity ~70-fold, indicating that Ecf41Bli activates PydfG upon its 
overexpression. Almost no β-galactosidase activity was detectable in the control strain 
TMB623, harboring only the empty expression vector, demonstrating that PydfG from B. 
licheniformis is not recognized and activated by any σ factor of B. subtilis under the 
laboratory conditions used in these experiments. 
To test for promoter recognition in R. sphaeroides, we expressed Ecf41Rsp from an IPTG-
inducible promoter and measured the activity of the target promoter PRSP_0606 by β-
galactosidase assays. Without inducer present, strain TMR005 shows PRSP_0606 activity of 
about 25 Miller Units, which can be increased 2-fold by addition of IPTG (Fig. 4.4 D). The 
high PRSP_0606 activity of TMR005 in the absence of IPTG is presumably due to background 
transcription from the leaky promoter of the expression plasmid. In comparison, the control 
strain YSD434, which carries the empty vector, shows only marginal promoter activity. 
These results from two independent organisms demonstrate that the promoter identified by 
5’RACE (Fig. 4.4 A) specifically responds to the overexpression of ECF41 σ factors. 
Prediction of a general ECF41-dependent target promoter motif. After we identified 
an ECF41-dependent promoter in two organisms, we expected that this motif should also 
be present in the ECF41 loci other organisms. To verify this, we extracted 250 bp regions 
upstream of the COE- as well as the ECF41-encoding genes and searched for  
overrepresented sequence motifs with similarity to the identified promoter, either manually 
or by using the MEME algorithm (Bailey & Elkan, 1994). We identified these two motifs 
separated by a 16+/-1 bp spacer within most of these regions and constructed a weblogo 
based on 285 sequences (Fig. 4.4 C). The -10 region with the consensus ‘CGTC’ is 
comparable to many typical ECF promoters, whereas the -35 consensus ‘TGTCACA’ is 
specific for group ECF41. This bipartite promoter motif can be found upstream of both the 
COE- and ECF41-encoding genes, often preceding a potential operon consisting of these 
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two genes (Table 4.5 and Table S1). In about one-third of all ECF41 σ factors, the COE-
encoding gene is located upstream of and in the same orientation than the ECF gene. Here, 
the COE gene usually carries the promoter motif while the ECF σ factor lacks it. In case of 
this predominant locus organization, both genes could form an operon transcribed from the 
COE promoter. If the ECF σ factor is located upstream of the COE gene, less than 30% of 
the ECF- and almost 50% of the COE-encoding genes harbour the promoter, in case of 
20% both genes are preceded by the motif. About 17% of the ECF41 σ factors show 
opposite orientation relative to the COE gene, either >ECF><COE< or <ECF< >COE>. In 
the latter case often both genes are preceded by the motif, whereas for the first combination 
usually only either the ECF- or COE-encoding gene shows the promoter. More than 30% 
of all ECF41 σ factors do not show the genomic context conservation. Of these “orphan” 
genes, only 30% are preceded by the ECF41-specific promoter.  
Table 4.5. Genomic context and promoter occurrence  
Genomic contexta Number PECF
b PCOE
b 
>ECF> 126 (34%) 38 n.a. 
>COE> >ECF> 107 (29%) - 97 
>ECF> >COE> 53 (14%) 14 24 
>ECF> <COE< 9 (2%) 3 4 
<ECF< >COE> 55 (15%) 36 41 
ungrouped 23 (6%) n.a. n.a. 
aThe arrows indicate the organization of the genes. ECF, gene encoding an 
ECF41 σ factor; COE, gene encoding a CMD protein, oxidoreductase or 
epimerase; ungrouped, genomic context differs from the above mentioned 
groups and contains genes encoding hypothetical proteins of unknown 
function. 
 b “-“, no promoter occurs upstream of the gene; n.a., the corresponding 
gene is not present or was omitted from analysis in case of ungrouped 
genomic context. 
Next we used the derived position weight matrix graphically represented in Fig. 4.4 C to 
perform genome-wide searches for additional ECF41 target promoters in R. sphaeroides 
and B. licheniformis, using the algorithm virtual footprint (Münch et al., 2005) 
implemented in the Prodoric database (Münch et al., 2003). In both organisms, only a few 
potential ECF41 target promoters could be identified (Table 4.6), but none exactly matched 
the ECF41 consensus. Construction of transcriptional lacZ-fusions to three of these 
promoters from B. licheniformis (PnhaX, PuvrX and PypbE) and subsequent determination of β-
galactosidase activity did not reveal any Ecf41Bli-dependent activation. Even expression of 
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a highly active truncated version of Ecf41Bli (see below) did not result in any promoter 
activation (data not shown).  
Table 4.6. Putative ECF41 target promoters in B. licheniformis and R. sphaeroides 
Genea Promoter sequenceb 
5’ 
UTRc 
Putative function, homology 
B. licheniformis   
BLi01248 TGTCACAAAAACATAAATAATAGATGTC 142 Hypothetical, putative membrane protein 
Bli03073 TGTCACCCCTTCCTT-TTTCGAGCCGTC 109 Hypothetical, putative membrane protein 
hprP TGTCACGCTTGCTTTTATTTTTCTCGTC 163 Putative phosphatase 
mtrB TGTCACTTCAGCTGT-AAGGGGAACGTT 76 Transcription attenuation protein 
nhaX TGTCACGTTTAGGTG--CTTTTGTTGTT 199 Stress response protein 
pucR TGTCACAAATCCGCT--CATTTTTTGTT 39 Purine catabolism regulatory protein 
sat TGTCACAAGCGTTCTGCTGGCATCTGTC 97 Sulfate adenylyltransferase, dissimilatory-type 
spoIISB TGTCACAGAATTTGA-TTATCTCCTGTT 60 Stage II sporulation protein SB 
uvrX TGTCACCTTCTTTCC-AAAGAAGGTGTT 120 DNA-damage repair protein 
ybxF TGTCACTAAAAATTG-TCATCATATGTT 68 Firmicutes ribosomal L7Ae family protein 
ydfG TGTCACAAACTCCGT-TTCTCTCTTGTT 31 Putative CMD protein 
yfmE TGTCACGGCAATGAT-TGGGACGCCGTT 42 Heme ABC type transporter HtsABC, permease  
ykpA TGTCACAAAGAAAGTGGAAATAAGCGTT 108 ABC transporter, ATP-binding protein 
ypbE TGTCACGGCACATTTTTTGATCGATGTT 48 Unknown, LysM domain, cell wall degradation 
yvdI TGTCACACTGCTCATTTCTTTCATTGTC 63 Maltose/maltodextrin ABC transporter  
    
R. sphaeroides   
gcvH TGTCACGTCCGGCG-GCTTCGGCCCCTC 151 Glycine cleavage system H protein,  
repA  TGTCACCGTTTCG--CCCCAAGAACGTG 152 RepA partitioning protein/ATPase, ParA type 
rplL  TGTCACCCACC--ATGTTGGACCCCATC 20 Ribosomal protein 
RSP_0606 TGTCACAACCGC-CTTCCCTCGCCCGTC 32 Putative CMD protein 
aGenes highlighted in bold were tested for activation by the corresponding ECF41 σ factor. 
bUnderlining indicates -35 (left) and -10 (right) regions, the spacing was adjusted indicated by dashes. 
c5’UTR, length of 5’-untranslated region (in nucleotides) between the postulated transcriptional start site and the AUG start codon. 
In addition, we performed genome-wide analysis on the presence and conservation of the 
ECF41 promoter motif upstream of orthologous genes in a wide range of ECF41-harboring 
organisms. While this in silico analysis has been successfully used to identify candidate 
promoters and core regulons for other regulators including ECF σ factors (Dufour et al., 
2010, Dufour et al., 2008), it failed to reveal any potential conserved regulon members, 
with the exception of genes encoding the COE or ECF41 σ factor (Fig. 4.5). Taken 
together, our collective data strongly suggest that the proteins of group ECF41 generally 
control only a single target gene or operon, which includes the COE and the ECF41 σ 
factor, if co-transcribed. The COE-encoding genes therefore represent the only known and 
detectable targets of ECF41-dependent gene expression. 
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Figure 4.5. Potential ECF41 target genes across selected bacteria. The analysis was performed as 
described (Dufour et al., 2008). Shown are groups of orthologous genes (columns) that contain the putative 
ECF41 binding motif in their promoter regions across indicated species (rows). A gray box means that the 
organism does not possess a homolog for the corresponding group; black means that it possesses a homolog 
for the group but no conserved ECF41 binding motif was found in its upstream region; red and yellow means 
that an ECF41 binding motif was found in the promoter region for the gene. Shades from red to yellow 
represent the similarity to the ECF41 consensus promoter motif with yellow being most similar. 
Phenotypes linked to ECF41-dependent gene expression. In B. licheniformis and R. 
sphaeroides, the only detectable target gene of the ECF41 σ factor encodes a CMD protein. 
These proteins are not necessarily involved in degradation of aromatic compounds, but 
could also exhibit a role in the oxidative stress response (Hillas et al., 2000, Lessner & 
Ferry, 2007). Additionally, a strain of M. tuberculosis lacking the ECF41 σ factor σJ is 
slightly more sensitive to H2O2 (Hu et al., 2004). Based on these observations, we 
investigated a potential link between ECF41 σ factors and oxidative stress response. We 
determined minimal inhibitory concentrations and performed serial dilution spot tests to 
compare the viability of a R. sphaeroides wild type and RSP_0606-ecf41Rsp deletion 
mutant (YSD239) or Ecf41Rsp overexpression strain (TMR003) strain  as well as B. 
licheniformis wild type and ∆ecf41Bli or ∆ydfG (TMBli006 or TMBli003) deletion strains, 
respectively. No significant differences were observed in the presence of H2O2, cumene 
hydroperoxide, t-butyl hydroperoxide or paraquat (data not shown). 
We subsequently performed phenotype microarray (PM) analysis. This high-throughput 
approach allows testing hundreds of different conditions in parallel in order to identify 
phenotypes associated with genetic alterations (Bochner, 2003). Our PM analysis included 
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960 assays for carbon, nitrogen, phosphorus and sulfur utilization, nutrient stimulation, pH 
and osmotic stress as well as chemical sensitivity tests covering 240 different substances 
(see http://www.biolog.com/PM_Maps.html for details). We compared phenotypic 
differences between the R. sphaeroides wild type strain and RSP_0606-ecf41Rsp deletion 
(YSD239) as well as an Ecf41Rsp overexpression strain (TMR006). Overall, only a very 
few phenotypes can be linked to the expression or deletion of the ECF41 σ factor 
(supplementary material). Besides resistance to spectinomycin due to the resistance 
cassette, strain YSD239 showed only a positive phenotype against the sulfonamide 
antibiotic sulfadiazine. As expected, strain TMR006 displayed relative resistance to 
aminoglycoside antibiotics (kanamycin, neomycin, geneticin, paromomycin) due to the 
resistance cassette of the overexpression plasmid. Surprisingly, gained phenotypes can be 
observed for the carbon sources adonitol, D-mannitol, D-sorbitol and glucose, suggesting a 
metabolic function of ECF41 in utilization of additional carbon sources. But none of these 
additional phenotypes not due to the presence of a resistance cassette could be verified by 
serial dilution spot tests (data not shown). 
Hence, we were not able to identify any ECF41-related phenotype. Therefore, we can so 
far only speculate on the physiological role of ECF41 σ factors. One likely possibility is 
that the COE proteins are involved in a very specific, presumably degradative metabolic 
pathway, instead of mediating a stress response. In the presence of a suitable substrate, the 
synthesis of the COE proteins could then be induced to facilitate the conversion of the 
metabolite. 
The wide distribution and conservation of ECF41 σ factors indicates an important cellular 
role of these proteins. Since ECF41 proteins are particularly abundant in Actinobacteria 
with sometimes more than 10 copies per genome (Table 4.4 and S1), it might be 
worthwhile to study the function of ECF41 σ factors in members of this bacterial phylum. 
Alternatively, one could establish a high-throughput approach to study induction of the 
COE genes in response to a wide array of chemical compounds. Moreover, a biochemical 
analysis of representative COE proteins might also help to shed some light on the 
physiological role ECF41-dependent gene regulation. 
Chapter 4 
75 
Signal Transduction of ECF41 σ factors 
The activity of ECF σ factors is normally regulated by a cognate anti-σ factor. The genes 
encoding these two proteins are usually located next to each other on the chromosome and 
co-transcribed (Butcher et al., 2008, Helmann, 2002). As mentioned above, no obvious 
anti-σ factor is encoded in direct vicinity to the genes encoding the ECF41 σ factors. The 
results of our in silico analysis (Fig. 4.2 and 4.3) suggest that either the corresponding COE 
or the C-terminal extension of the ECF41 proteins could be involved in the regulation of σ 
factor activity. We first tested if expression of YdfG has any influence on the target 
promoter activation by Ecf41Bli, but did not observe any effects (data not shown). 
Therefore, we focused our attention on the C-terminal extension. A multiple sequence 
alignment of all ECF41 proteins (Fig. S1) revealed four highly conserved motifs, three 
within the C-terminal extension and one in the linker region between σ2 and σ4 (Fig. 4.3). 
To study a possible function of these unique features, we investigated the effect of (i) 
exchanging the conserved motifs against alanine residues and (ii) C-terminal truncations of 
Ecf41Bli.  
Mutational study of conserved motifs. First, we constructed overexpression plasmids 
with variants of Ecf41Bli, in which either of the conserved motives is exchanged against 
alanine residues (Fig. 4.6 A). The resulting modified versions of Ecf41Bli, which also 
carried N-terminal FLAG-tags, were expressed heterologously in B. subtilis and the effect 
on PydfG activation was measured by β-galactosidase assays (Fig. 4.6 B). Exchange of 
INDQKGVL showed the strongest effect and resulted in about 3-fold higher activity 
compared to expression of the wild type protein. The other amino acid exchanges also led 
to alterations in promoter activity. The proteins with exchanges in WLPEP showed 
reduced and in DGGGK increased activity, NPDKL is comparable to the wild type version 
of Ecf41Bli. Expression of all these Ecf41Bli-FLAG variants was verified by Western Blot 
analysis using a FLAG-tag specific antibody (data not shown).  
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Figure 4.6. Influence of highly conserved residues of Ecf41Bli on target promoter activation. (A) 
Schematic representation of cloned Ecf41Bli alleles with amino acid exchanges. The name of each variant is 
given at the beginning of each line. The domains σ2 and σ4 as well as the C-terminal extension are displayed 
as grey boxes. The highly conserved motives and the exchange of amino acids against alanine residues are 
shown. (B) β-galactosidase activities of B. subtilis strains overexpressing the Ecf41Bli-FLAG variants. Strains 
TMB696 (wt), TMB795 (WLPEP), TMB797 (DGGGK), TMB1016 (INDQKGVL) and TMB793 (NPDKL) 
were grown in LB medium to OD600 ~0.4 and split into two samples. In one sample, protein expression was 
induced by addition of 0.5 % xylose. The cells were harvested after 1 h and β-galactosidase activity was 
measured as described. Expression of each allele was verified by Western Blot analysis using a FLAG-tag 
specific antibody. 
Sequential deletion analysis of the C-terminal extension. Next, we investigated variants 
of Ecf41Bli lacking increasing parts of the C-terminal extension. We constructed five C-
terminally truncated alleles of ecf41Bli-FLAG and tested their ability to activate the target 
promoter PydfG. The different mutant proteins were named according to their length (Fig. 
4.7 A). Truncation of only 15 C-terminal amino acids of Ecf41Bli (270) resulted in a 4-fold 
higher activity compared to the wild type protein (Fig. 4.7 B). Further truncations (234 and 
204) led to even higher activity up to a ~20-fold increase relative to the full-length protein. 
In contrast, expression of variant 167, which lacks the whole extension, completely lost the 
ability to activate the target promoter. This was unexpected, since regions σ2 and σ4 are 
usually sufficient for promoter recognition and activation by other ECF σ factors. This 
indicates that at least N-terminal parts of the extension are required for ECF41-dependent 
promoter activation, although partly truncations lead to a highly active protein. Expression 
of all of these Ecf41Bli-FLAG variants was verified by Western Blot (Fig. 4.8 B and data 
not shown). 
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Figure 4.7. Effect of C-terminal truncations of ECF41 σ factors on target promoter activation. (A) 
Schematic representation of C-terminally truncated Ecf41Bli proteins of B. licheniformis. Details are shown as 
described for Fig. 4.6. The proteins are named according to their length (B) β-galactosidase activities of B. 
subtilis strains overexpressing truncated Ecf41Bli-FLAG proteins. Strains TMB696 (wt), TMB744 (270), 
TMB743 (234), TMB742 (204), TMB741 (192) and TMB667 (167) were grown in LB medium to OD600 
~0.4 and split into two samples. In one sample, protein expression was induced by addition of 0.5 % xylose. 
The cells were harvested after 1 h and β-galactosidase activity was measured. (C) Schematic representation 
of C-terminally truncated Ecf41Rsp proteins of R. sphaeroides. Details are shown as described for Fig. 4.6. 
(D) β-galactosidase activities of R. sphaeroides strains overexpressing truncated Ecf41Rsp proteins. Strains 
TMR004 (wt), TMR005 (169) and TMR006 (206) were grown in Sistrom’s minimal medium to OD600 ~0.4 
and split into two samples. In one sample, expression of Ecf41Rsp variants was induced by 100 µM IPTG. 
After 3 hours, the cells were harvested and β-galactosidase assays were performed. 
To test if similar results can be observed for Ecf41Rsp, we tested the effects of C-terminal 
truncations on σ factor function in R. sphaeroides (Fig. 4.7 C and D). Expression of the C-
terminal truncated Ecf41Rsp (206) led to ~120-fold higher PRSP_0606 activity than the full-
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length protein, whereas deletion of the whole extension (169) resulted in a total loss of 
promoter activation. Our collective data therefore strongly suggest that the C-terminal 
extension of group ECF41 proteins might represent a fused anti-σ domain, which is 
involved in controlling σ factor activity.  
Interaction of Ecf41Bli with RNA polymerase. Bacterial σ factors form a complex with 
the RNAP core enzyme and recruit the resulting holoenzyme to the corresponding target 
promoters (Burgess & Anthony, 2001). To demonstrate that Ecf41Bli interacts with RNAP, 
we performed in vivo RNAP pull-down assays. Ecf41Bli-FLAG was expressed from a 
xylose-inducible promoter in a B. subtilis strain carrying a His6-tagged β’-subunit of 
RNAP. The His6-tag was used for rapid purification of RNAP holoenzyme (Anthony et al., 
2000). The success of the purification was verified by the presence of bands on a 
Coomassie stained SDS-PAGE gel corresponding to the ββ’ and α subunits (Fig. 4.8 A). 
Western Blot analysis with a FLAG-tag specific antibody shows that Ecf41Bli-FLAG co-
purifies with RNAP (Fig. 4.8 B). The same protein is not detectable in the elution samples 
of cells lacking the His6-tag (data not shown) indicating that enrichment of Ecf41Bli-FLAG 
from B. licheniformis is due to interaction with RNAP. 
 
Figure 4.8. Interaction of Ecf41Bli with RNA polymerase. (A) SDS-PAGE of Ni affinity-purified proteins 
from strains TMB1099 (wt), TMB1100 (204) and TMB1101 (167) carrying a His6-tag fused to the β’ subunit 
of the RNAP. The different truncated versions of Ecf41Bli-FLAG were overexpressed and the RNAP complex 
was purified (see Experimental procedures for details). 5 µg of the cleared lysate and 5 and 10 µg of the 100 
mM imidazole elution fractions were loaded. (B) Detection of co-purified Ecf41Bli-FLAG and its variants by 
Western Blot analysis of a gel identical to the one in (A) using a FLAG-tag specific antibody. 
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Next, we analyzed if the observed effect of Ecf41Bli truncations (Fig. 4.7 A and B) on 
target promoter activation can be explained by their ability to interact with RNAP core 
enzyme. We repeated the RNAP pull-down assay quantitatively with the highly active 
(204), the inactive (167) and the wild type version of Ecf41Bli-FLAG. All three proteins are 
expressed at comparable levels in soluble form as demonstrated by Western Blot analysis 
of the cleared lysate before purification, but show considerable different binding behavior 
to RNAP (Fig. 4.8 B). Hardly any binding can be observed for the shortest Ecf41Bli protein 
(167), which is consistent with its inability to activate the target promoter (Fig. 4.7 B). In 
contrast, the protein with only partly truncated extension (204) co-purifies with RNAP to a 
much lesser extent than the full-length protein although promoter activation is significantly 
higher.  
Altogether, C-terminal truncations of Ecf41Bli significantly alter the binding behavior to 
RNAP, but this affinity does not completely reflect the observed σ factor activity of the 
corresponding allele. While loss of promoter activation for the complete deletion of the C-
terminal extension can be – at least partially – explained by the significantly reduced 
ability of the shortest version of Ecf41Bli (167) to interact with RNAP, additional factors 
must account for the strongly increased promoter activation of the partly truncated version 
(204), despite its weaker interaction with RNAP compared to the wild type protein.  
Taken together, our data demonstrates that the ECF41 σ factors seem to have a completely 
new way of signal transduction presumably not involving a second protein functioning as 
an anti-σ factor. Instead, the C-terminal extension, which is not present in other ECF σ 
factors, affects both the target promoter activation and binding to RNAP (Fig. 4.7 and 4.8). 
Discussion 
A recent classification identified a large number of novel groups of ECF σ factors with 
unique features compared to “classical” ECF σ factors (Staroń et al., 2009), including 
group ECF41. This group shows a wide phylogenetic distribution with about 400 proteins 
from ten different phyla (Table 4.4, Table S1 and Fig. 4.1). The genomic context of group 
ECF41 is highly conserved and distinct from other ECF groups. An obvious anti-σ factor is 
missing. Instead, a gene encoding a CMD protein, an oxidoreductase or an epimerase 
(COE) is located directly up- or downstream of the ECF41 σ factor (Fig. 4.2). We did not 
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observe any function of the COE proteins in signal transduction, but identified the 
neighbouring genes encoding these proteins as the sole targets of ECF41 σ factors, both by 
in silico and comprehensive gene expression analyses. We identified a unique promoter 
signature (TGTCACA-n16-CGTC) upstream of these COE genes that is recognized by the 
corresponding ECF41 σ factor (Fig. 4.4).  
The most important finding of our study concerns the regulatory role of the C-terminal 
extension of group ECF41, which is not present in any other group of ECF σ factors 
(Staroń et al., 2009). Based on our data, ECF41-dependent signal transduction does not 
seem to involve a second protein that functions as an anti-σ factor. Instead, our data clearly 
demonstrate the importance of the C-terminal extension for both target promoter activation 
and affinity to RNAP (Fig. 4.7 and 4.8). Moreover, our sequential deletion analysis 
indicates that the extension plays both a positive and negative role in ECF41-dependent 
gene regulation. A short N-terminal part of the extension directly following the region σ4 is 
absolutely required for σ factor activity, in contrast to other ECF σ factors described so far. 
But most of the C-terminal part of the extension clearly plays a negative regulatory role: 
even partial deletions result in a strongly increased activity of the target promoters in both 
organisms studied (Fig. 4.7), suggesting that this part of the extension functions as a fused 
anti-σ domain. To our knowledge, this is the first report of an anti-σ factor-like domain 
being fused to its σ factor. Based on our results, we propose that the group of ECF41 σ 
factors represent a novel mechanism of ECF-dependent signal transduction. 
While our data clearly establishe a regulatory role of the C-terminal extension for the 
activity of the ECF41 σ factors, the exact molecular mechanism will be the subject of 
further investigations. One possibility would be that the C-terminal extension functions as 
a sensory domain. In the absence of a suitable trigger, it could keep the σ factor domains 
inactive through intra- or intermolecular interactions. Presence of the input signal could 
then result in a conformational change that releases the σ factor domains from the 
inhibitory grip of the extension, thereby initiating transcription of the COE genes. Such a 
mechanism involving intramolecular interactions has for example been described for the 
primary σ factor of E. coli, σ70. While this σ factor does not need to be activated, binding 
of free σ70 to DNA and efficient transcription initiation is inhibited by region 1.1, 
presumably by interaction with the σ4 DNA-binding domain (Dombroski et al., 1993a, 
Johnson & Dombroski, 1997). An inhibitory role of an N-terminal region has also been 
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shown for alternative σ factors such as E. coli σ32 (Dombroski et al., 1993a). If a similar 
mechanism also applies to the C-terminal region of ECF41 σ factors needs to be 
investigated.  
Alternatively, though maybe less likely, a stimulation sensed by the C-terminal anti-σ 
domain could also result in a conformational change that exposes a protease recognition 
site. After regulated cleavage, the truncated and thereby activated σ factor would then 
mediate transcription initiation. Alternative σ factors like σK and σE, that are involved in 
the sporulation process in B. subtilis, are known to be expressed as inactive precursors. 
Activation is achieved by regulated proteolytic processing of the N-terminus of these 
proteins (LaBell et al., 1987, Lu et al., 1990, Zhang et al., 1998). But in addition to its 
inhibitory function, the role of the extension of ECF41 proteins seems to be more complex. 
Partial deletion of the C-terminal extension results in high activity, but at least the N-
terminal part of the extension is also required for transcription. Since a complete deletion 
of the C-terminal extension seems to decrease the affinity of the ECF41 σ factor to RNAP 
(Fig. 4.8), the N-terminal part of the extension could be involved in stabilizing the complex 
of RNAP and σ factor. So far, we do not know any inducing conditions for ECF41-
dependent gene expression. Hence, we could not investigate the influence of the C-
terminal extension in signal transduction under natural conditions. 
Moreover, a comprehensive phenotypic profiling of R. sphaeroides RSP_0606-ecf41Rsp 
deletion and Ecf41Rsp overexpression strains using phenotype microarrays (Bochner, 2003) 
did not reveal any function related to ECF41 σ factors. Therefore, biochemical 
characterization of the COE proteins could help to shed some light on the physiological 
role of ECF41-dependent gene regulation. 
Future studies will be necessary to unravel both the physiological role and the mechanistic 
details underlying ECF41-dependent signaling. But the data presented in this initial study 
clearly demonstrates the value of our ECF classification and can serve as blueprint for 
studying additional conserved and novel groups of ECF σ factors, with yet to be explored 
mechanisms of signal transduction and gene regulation. 
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Chapter 5 
Discussion 
In their natural habitat, bacteria encounter a number of environmental threats including the 
presence of antibiotics. Because of its crucial function, a preferred target of antibiotics is 
the bacterial cell wall. Inhibition of its biosynthesis and severe loss of its integrity rapidly 
cause cell death. In order to survive in such menacing habitats, bacteria developed a 
number of signal transducing systems, which enable the sensing of and response to harmful 
compounds and conditions. In the Gram-positive model organism B. subtilis the response 
to cell wall active antibiotics is well-known and orchestrated by two signal transducing 
principles: TCSs and ECF σ factors.  
This thesis aimed to investigate the response to antimicrobial compounds with a focus on 
the role of ECF σ factors. In chapter 2 we investigated and compared the response of B. 
subtilis to daptomycin and friulimicin B, two structurally similar and clinically relevant 
antibiotics, by in-depth expression profiling on both the transcriptome and proteome level. 
Chapter 3 presented the transcriptional response of B. subtilis to rhamnolipids, which are 
industrially important biosurfactants showing also antimicrobial activity. Finally, in 
chapter 4 we characterized a novel group of ECF σ factors (ECF41) including a 
comprehensive bioinformatics analysis and experimental investigations in both B. 
licheniformis and R. sphaeroides. 
The following discussion is divided into two parts: In the first part (section 5.1), the impact 
of genome-wide expression profiling on antibiotic research will be reviewed. In the second 
part (section 5.2 to 5.5), the results presented in chapters 2 to 4 of this thesis will be 
discussed in detail and put into the context of recent findings and the available literature. 
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5.1 
Antibiotic research in the age of omics – from expression 
profiles to interspecies communication 
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The ‘age of omics’ has revolutionized our way of studying microbial physiology by introducing global analysis
tools such as comparative genomics and global expression techniques including DNA microarrays (transcrip-
tomics) and two-dimensional protein gel electrophoresis (proteomics). From the very beginning, such
approaches have also been incorporated into the portfolio of antibiotic research. Genome mining has been
used to explore the hidden biosynthetic potential in sequenced bacterial chromosomes, but also to search
for novel antibiotic targets. Moreover, numerous studies investigating changes in expression patterns in
response to antibiotic presence at the level of both the transcriptome and proteome have been performed
over the years, which have helped us gain a deeper understanding of antimicrobial action. This review will
focus on the impact that applying global expression studies has had on antibiotic research in the last
decade. Signatures of differential gene expression in response to antibiotics have led to a deeper understanding
of bacterial resistance mechanisms as well as stress response networks. They have also helped to predict the
mechanism of action of novel antimicrobial compounds or to identify potential antibiotic-specific biosensors.
Moreover, such studies have revealed novel inhibitory mechanisms of seemingly well-known drugs that
might be useful for the development of co-drugs for antibiotic therapy and have identified the potential role
of antibiotics as mediators of intercellular communication.
Keywords: antibacterials, transcriptomics, proteomics, expression profiling, DNA microarray
Introduction
The dawning of the genomic era has fostered high hopes in the
field of antibiotic discovery. After the disillusionment of the
failure of high-throughput screenings of compound libraries
had settled, scientists eagerly leaped at this new potential
‘magic bullet’ of antibiotic discovery. Academic researchers,
small biotech start-ups and the major pharmaceutical compa-
nies in unison praised the potential of genomic information
and genome-wide expression tools, such as DNA microarrays
and proteomics, as an almost fail-proof bet in identifying and
characterizing novel antimicrobial targets and compounds. In
the years 1998–2002 alone, more than 30 review articles were
devoted to this subject, with only just about as many finished
microbial genomes and hardly any global expression studies
available to back up the hopes and wishes. It was a time of
general euphoria of what the ‘age of omics’ might bring.
Now, almost 10 years later, with close to 2000 microbial
genomes sequenced, and a similar number of published transcrip-
tome studies, the use of genomic information and techniques for
the development and study of new antimicrobial compounds is
still going strong. But many of the recent overview articles are
much more cautious in what they promise1 – 3 or even announce
the renaissance of classical approaches for drug discovery.4 With
the first decade closing in, this seems to be a good time to look
back on what we have learned from applying omics tools to the
discovery and analysis of antimicrobial compounds. Have any
novel antimicrobial activities been discovered by these new
tools? Did the powerful global expression techniques help to
unravel or predict the mechanism of action (MOA)? Could this
knowledge, if gained, be used to develop reliable high-throughput
screens to narrow down the site of action for the next generation
of compounds? Which of the old hopes were justified and what
promises were fulfilled in these 10 years? And where do we go
from here?
Three core aspects of genomics were always linked to sup-
porting the development of new antibiotics: (i) identification of
new drug targets by comparative genomics; (ii) exploitation of
the biosynthetic potential hidden in microbial genomes by
genome mining; and (iii) study of drug action based on genome-
wide expression profiling.
Identification of novel drug targets by
comparative genomics
High hopes were initially raised that the powerful new tools of
genome mining and comparative genomics would pave the
# The Author 2011. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved.
For Permissions, please e-mail: journals.permissions@oup.com
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way to identifying new targets for drug development.5 – 7 Signifi-
cant progress has been made in developing methods and data-
bases for the prediction and identification of potential drug
targets in silico,8 – 11 but little has yet emerged from these
efforts. One obstacle to this process might be the restrictive defi-
nition of good antibiotic targets as products of conserved essen-
tial genes,2 which are at the core of most current bioinformatical
target identification pipelines. Moreover, many essential func-
tions are not encoded by a single essential gene,12 thereby ham-
pering their identification, since it is not easy to recognize
genomic redundancy by sequence-based approaches alone.
Nevertheless, promising results have recently been reported
describing the identification of potential new targets that could
be used in drug screening programmes. One example is the
ATP binding protein YjeE from Haemophilus influenzae, where
its use in an affinity-based screen identified a novel group of anti-
bacterial agents.13 A comparable screen of a wide variety of bio-
active compounds with known modes of action showed that
expression of the orthologous protein in Escherichia coli was
increased in the presence of fluoroquinolone antibiotics such as
norfloxacin.14
Similar approaches raised hopes to identify new drugs for
better treatment of Mycobacterium tuberculosis infections. A
medium-throughput whole-cell assay with live mycobacteria
revealed diarylquinolines as a new class of anti-tuberculosis
drugs, with R207910 being the most active of these com-
pounds.15 Subsequent whole-genome sequencing identified
mutations in the atpE gene, encoding the ATPase synthase
subunit c, as being responsible for inter-strain differences in
susceptibility. The low degree of sequence similarity between
AtpE of mycobacteria and other bacteria as well as humans
makes this protein a very promising target, and preliminary
pharmacokinetic studies in humans appear encouraging.
Another study used a whole-cell screen to identify pyrimi-
dine–imidazole compounds that inhibit the growth of Myco-
bacterium bovis and M. tuberculosis.16 Full-genome
sequencing of spontaneous resistant mutants in combination
with other MOA studies linked the biological activity of pyrimi-
dine–imidazoles to glycerol metabolism. Unfortunately, these
compounds did not display any antibacterial activity in an in
vivo mouse model, since this metabolic pathway is not rel-
evant for M. tuberculosis during infection of mice. Nevertheless,
these data clearly demonstrate the impact of central meta-
bolic pathways on drug efficacy. It is important to consider
such connections in order to successfully develop screens for
antibiotic discovery.
The power of such whole-cell screens can be further increased
by combination with specific reporter gene assays, as has been
demonstrated in a study on DNA gyrase inhibitors and other
DNA damaging agents using Pseudomonas aeruginosa as a
model bacterium.17 A strain containing the luciferase operon
fused to a promoter that responds to ciprofloxacin was used to
screen a library of 2000 bioactive compounds and identified 13
compounds that inhibit DNA synthesis, although by different
mechanisms.
The above cited studies clearly demonstrate the feasibility of
screening compound libraries using either isolated targets or
whole cells, although, to our knowledge, none of these
approaches led to novel antibiotics in clinical development.
Genome mining to exploit the hidden
antibiotic biosynthetic potential
In contrast to harnessing (comparative) genomics for the predic-
tion of new drug targets, the discovery of novel antibiotic biosyn-
thesis loci by genome mining is a promising and straightforward
road to the identification of new compounds.18 – 20 In recent
years, appropriate software tools have been developed to ident-
ify biosynthetic gene clusters and predict the structure of the
corresponding products.21 – 23 To date, a number of antibiotic bio-
synthesis loci have been characterized by a combination of
genome mining and subsequent functional characterization,
including those for cyclic lipopeptide antibiotics from P. aerugi-
nosa and Bacillus amyloliquefaciens,24,25 polyketides from
B. amyloliquefaciens26 and polymyxin from Paenibacillus poly-
myxa.27 Moreover, genome mining together with comparative
metabolic profiling and comparative genomics also helped to
identify an important class of chemical compounds that function
as antibiotic biosynthesis inducers in actinobacteria.28 This
discovery might pave the way for the controlled induction of bio-
synthetic pathways, which is currently one of the major limit-
ations for the biotechnological production of secondary
metabolites, as most antibiotic biosynthetic pathways are not
expressed under standard laboratory conditions.19 Additional
strategies to activate the expression of silent biosynthetic gene
clusters include the optimization of growth conditions29 or
alterations of the transcription or translation machinery, such as
spontaneous mutations in RNA polymerase or ribosomal protein
S12 that activated production of antibacterial compounds in
different Streptomyces species.30 An altogether different and
novel strategy applies synthetic biology tools to optimize drug pro-
duction. Biosynthetic gene clusters identified by genome mining
can be divided into modules that are often responsible for biosyn-
thesis of a distinct moiety of the final compound. These modules
can be modified and subsequently combined in a plug-and-play
fashion using a host strain already pre-engineered for maximal
expression of certain compounds as the biochemical production
chassis.31 In fact, it was possible to generate unnatural but func-
tional trimodular polyketide synthetases by such a rearrangement
process, which synthesized the expected products.32
Global expression studies of antibiotic action
This mini-review will primarily focus on this third impact of geno-
mics on antibiotic research in recent years. Studying the global
response of bacterial populations to the presence of antibiotics
was among the very first applications of the DNA microarray
technology in the early years of microbial transcriptomics.33 An
ever-increasing number of such studies have been published in
the last 10 years, covering all classical antibiotic targets and a
plethora of different compounds that were tested on a broad
range of microorganisms (Table 1). At about the same time,
in-depth proteome profiling of antibiotic action was also devel-
oped, albeit only for a few model organisms, especially Bacillus
subtilis.34 – 36
While antibiotic induction experiments based on DNA micro-
arrays are technically simple and easy to perform with high
reproducibility between biological replicates, the comparability
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Table 1. Global expression studies on genome-wide responses to antibiotic actiona
Cellular target or antibioticb Organismc Typed Purpose of study, remarksb Ref.
CELL WALL SYNTHESIS
BAC, PEN, VAN B. licheniformis T identification of the cell wall stress response network 41
VAN B. subtilis T identification of the cell wall stress response network 38
BAC B. subtilis T identification of the cell wall stress response network 39
b-lactams B. subtilis T transcriptional signatures (AMX, LEX, CTX, FOX, OXA, PEN) for
MOA predictions
55
CYC, FOF, RIS, VAN B. subtilis T transcriptional signatures for MOA predictions 55
BAC, CYC, MET, VAN B. subtilis P proteome signatures for MOA predictions 56
MET, OXA, VAN B. subtilis T MOA prediction based on transcriptional profiles and
conditional mutants
106
DAP B. subtilis T identification of resistance determinants 49
DAP, FRI B. subtilis P/T mRNA/protein signatures for MOA prediction of closely
related compounds
62
END, BAC B. subtilis T comparative transcriptional signature using a high-density
tiling chip
107
NIS B. subtilis P/T identification of resistance determinants 108
PLE B. subtilis T transcriptional and signature and target identification 65
RAM, MOE B. subtilis T characterization of regulatory systems orchestrating cell wall
stress response
109
AMX C. difficile T transcriptional signature 110
AMP E. coli T transcriptional signature 111
AMP E. coli T transcriptional signature 112
AMD, CSD E. coli T characterization of the cell wall stress response network 113
VAN E. faecalis P comparison of the proteome signature of a VAN-resistant
strain and a clinical isolate
47
Lcn972 L. lactis T characterization of a cell wall stress response system 114
EMB C. glutamicum T MOA study on this anti-tuberculosis drug 115
EMB M. smegmatis P proteome profile for compound comparison with ISO and
5-CPA
61
b-lactams, EMB M. tuberculosis T transcriptional signatures for MOA predictions 54
EMB M. tuberculosis T study on multidrug tolerance 51
VAN M. tuberculosis T transcriptional signature 116
AMX P. multocida T comparative transcriptional signature (together with ENR
and TET)
60
IPM P. aeruginosa T transcriptional signature in biofilms 117
CAZ P. aeruginosa T effect of antibiotics on quorum sensing 118
BAC, CYC, OXA S. aureus T characterization of cell wall stress response 46
VAN S. aureus T characterization of cell wall stress response; comparison
methicillin-susceptible S. aureus/vancomycin-intermediate
S. aureus
42 – 45
FOX S. aureus T impact on haemolytic activity and study of a cell wall stress
response system
119
NIS, OXA, VAN S. aureus T global signatures to compare cell wall stress and membrane
depolarization
120
FOF S. aureus T MOA studies on early-stage cell wall biosynthesis inhibitors 121
MER S. aureus T transcriptional signature 122
FOF S. aureus T transcriptional signature dependent on concentration and
exposure time
123
VAN S. pneumoniae T characterization of cell wall stress response 124
PEN S. pneumoniae T characterization of cell wall stress response 125
CAS S. cerevisiae T transcriptional signature 126
CAS C. albicans T transcriptional signature 127
PEN P. chrysogenum T effects of antibiotic biosynthesis 128
BAC, NIS S. pneumoniae T comparison of the transcriptional signatures of three
different AMPs
129
Continued
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Table 1. Continued
Cellular target or antibioticb Organismc Typed Purpose of study, remarksb Ref.
DNA TOPOLOGY
diverse compounds B. subtilis T transcriptional signatures (CIP, COU, MXF, NAL, NOR, NOV) for
MOA predictions
55
NOV, CIP, NQO, MIT B. subtilis P proteome signatures for MOA predictions 56
AZA, CIP, NAL B. subtilis T MOA prediction based on transcriptional profiles and
conditional mutants
106
DAU, ADM B. subtilis P comparison of the proteome signatures of two functionally
related drugs
130
NOR E. coli T transcriptional signature 111
NOR E. coli T transcriptional signature, induction of prophage genes 131
NOR E. coli T gene expression response to and oxidative damage by DNA
gyrase inhibition
67
OFX E. coli T transcriptional signature 112
SIM E. coli T transcriptional signature 132
NOV, LVX, OFX M. tuberculosis T transcriptional signatures for MOA predictions 54
CIP M. tuberculosis T transcriptional signature, induction of SOS response 68
ENR P. multocida T comparative transcriptional signature (together with AMX
and TET)
60
CIP P. aeruginosa T transcriptional signatures, identification of fluoroquinolone
resistance genes
52
CIP P. aeruginosa T effect of antibiotics on quorum sensing 118
CIP S. pneumoniae T transcriptional signature comparison between wild-type and
CIP-resistant mutant
53
CIP, ENR S. enterica P elucidate the cellular response and mechanism of resistance 133
ELB S. aureus P/T proteomic and transcriptional signature 134
FATTY ACID SYNTHESIS
CER, TCS B. subtilis T transcriptional signatures for MOA predictions 55
CER B. subtilis P proteome signatures for MOA predictions 56
PLC, PLS, CER, TCS B. subtilis P proteomic signature for fatty acid biosynthesis inhibition 135
ISO M. smegmatis P proteome profile for compound comparison with EMB and
5-CPA
61
ISO M. tuberculosis P quantitative proteome signature to establish new technique 136
ISO, TLM, TCS M. tuberculosis T transcriptional signatures to discriminate antibiotic
responses
137
CER, ETH, ISO, TLM M. tuberculosis T transcriptional signatures for MOA predictions 54
ISO, TIO, THL M. tuberculosis T transcriptional signature 138
ISO M. tuberculosis T transcriptional signature 33
ETH, ISO M. tuberculosis T transcriptional signature 139
TCS S. aureus T transcriptional signature 140
TCS S. enterica P proteomic signature comparison of different strains,
identification of TCS resistance determinants
141
FOLATE SYNTHESIS
DAS, SAA, SMZ, TMP B. subtilis T transcriptional signatures for MOA predictions 55
MEMBRANE BIOSYNTHESIS, INTEGRITY AND RESPIRATION
diverse compounds B. subtilis T transcriptional signatures (GRA, MON, NIG, NIT, POL, TRI) for
MOA predictions
55
NIT, GRA, TRI, MON B. subtilis P proteome signatures for MOA predictions 56
LL-37, PG-1, PLL B. subtilis T signature of CAMP stress response and underlying regulatory
network
40
DAP B. subtilis T transcriptional signatures, identification of DAP resistance
determinants
49
RHL B. subtilis T transcriptional signature 142
Continued
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Table 1. Continued
Cellular target or antibioticb Organismc Typed Purpose of study, remarksb Ref.
MNZ C. difficile T transcriptional signature 110
CEC E. coli T transcriptional signatures for MOA prediction 143
ESC E. coli P proteome signature and MOA studies 144
CCCP, NIG, VAL M. tuberculosis T transcriptional signatures for MOA predictions 54
DAP, CCCP S. aureus T global signatures to compare cell wall stress and membrane
depolarization
120
TEM, OVI, DRS S. aureus T transcriptional response to CAMPs 145
CHI S. simulans T transcriptional profile as part of an MOA study 63
POL S. typhimurium P/T proteomic and transcriptome study of virulence genes
induction by CAMPs
146
AMB A. fumigatus P/T proteomic and transcriptional signature 147
AMB, NYT S. cerevisiae T transcriptional signature 148
AMB, KTC S. cerevisiae T transcriptional signature 126
AMB, KTC C. albicans T transcriptional signature 127
AMB, KTC T. rubrum T transcriptional signature 149
LL-37 S. pneumoniae T comparison of the transcriptional signatures of three
different AMPs
129
ENT B. cereus T transcriptional signature 150
PROTEIN SYNTHESIS
TET A. baumannii P proteome signature of a multidrug-resistant strain 151
TET, IPM A. baumannii P proteome signature of a multidrug-resistant strain 152
diverse compounds B. subtilis T signatures (CLR, CLI, CHL, ERY, FUS, NEO, PUR, SPT, TET) for
MOA predictions
55
diverse compounds B. subtilis P signatures (ACT, CHL, ERY, FUS, GEN, KAN, MUP, PUR, STR,
TET) for MOA predict.
56
ACT, AZM, CHL, GEN B. subtilis T MOA prediction based on transcriptional profiles and
conditional mutants
106
CHL, ERY, GEN B. subtilis T transcriptional signature 153
CLI C. difficile T transcriptional signature 110
ERY E. faecalis T transcriptional signature 154
KAN E. coli T transcriptional signature 111
diverse compounds E. coli P proteome signatures (CHL, ERY, FUS, KAN, PUR, STR, TET) for
MOA prediction
155
CTC E. coli P proteome signature 156
CAP, ROX, STR, TET M. tuberculosis T transcriptional signatures for MOA predictions 54
CAP M. tuberculosis T transcriptional signatures for MOA determination 157
STR M. tuberculosis P proteome signature and elucidation of resistance
mechanism
158
STR M. tuberculosis P proteome signature and comparison of susceptible and
resistant isolates
48
TET P. multocida T comparative transcriptional signature (together with AMX
and ENR)
60
AZM P. aeruginosa T effect of antibiotics on quorum sensing 118
AZM P. aeruginosa T transcriptional signature and MOA prediction 159
CST P. aeruginosa T transcriptional signature 160
FUS S. aureus T characterization of FUS stimulon 161
TGC S. aureus T transcriptional signature of biofilm-associated cells of
methicillin-resistant S. aureus
162
ERY S. typhimurium global induction pattern, using a 6500-clone promoter-lux
library
83
CHL, ERY, PUR, TET S. pneumoniae T transcriptional signatures for MOA prediction 163
CHL T. maritima T transcriptional signature 164
STR Y. pestis T transcriptional signature 165
CHL Y. pestis T transcriptional signature 166
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Table 1. Continued
Cellular target or antibioticb Organismc Typed Purpose of study, remarksb Ref.
TET P. falciparum T study of antimalarial activity 167
DOX T. whipplei T transcriptional signature 168
RNA SYNTHESIS
RIF, 5FU B. subtilis P proteome signatures for MOA predictions 56
RIF E. coli P/T transcriptional/proteome signature 111,155
RIF, RFP M. tuberculosis T transcriptional signatures for MOA predictions 54
RIF S. typhimurium global induction pattern, using a 6500-clone promoter-lux
library
83
OTHERS
FUR B. subtilis T global induction pattern 169
MOI B. subtilis T MOA prediction based on transcriptional profiles and
conditional mutants
106
PAMP E. coli T global induction pattern 170
TPP E. coli P proteomics as part of an overall characterization of the
cellular response
171
5-CPA M. smegmatis P proteome profile for compound comparison with ISO and
EMB
61
DER S. aureus T analysis of bacterial resistance to anionic peptides 50
BBR S. aureus T global induction pattern to initiate MOA studies 172
hBD3 S. aureus T global induction pattern as part of MOA studies 173
CRY S. aureus T MOA prediction based on transcriptional profiling 174
RHO S. aureus P proteome signature 175
FUR S. enterica T transcriptional signature and inhibition of biofilm formation 176
SAF, QAD S. cerevisiae T transcriptional signatures of two closely related compounds 177
5FC S. cerevisiae T transcriptional signature 126
BBR S. flexneri T transcriptional signature 178
5FC C. albicans T global gene induction pattern of these antifungal drugs 127
GOM X. fastidiosa T transcriptional signature and effect of biofilm formation 86
aThe studies listed here are compiled from three independent PubMed searches performed in June 2011 using the search strings ‘antibiotic AND DNA
microarray’, ‘antibiotic AND transcriptome’ and ‘antibiotic AND proteomic’.
bAbbreviations: 5-CPA, 5-chloropyrazinamide; 5FC, flucytosine; 5FU, 5-fluoro-uracil; ACT, actinonin; ADM, adriamycin; AMB, amphotericin B; AMD, amdi-
nocillin; AMX, amoxicillin; AMP, ampicillin; AMPs, antimicrobial peptides; AZA, azaserine; AZM, azithromycin; BAC, bacitracin; BBR, berberin chloride;
CAMP, cationic antimicrobial peptide; CAP, capreomycin; CCCP, carbonyl cyanide m-chlorophenylhydrazone; CEC, cecropin A; CAZ, ceftazidime; CER, cer-
ulenin; LEX, cefalexin; CTC, chlortetracycline; CTX, cefotaxime; FOX, cefoxitin; CAS, caspofungin; CHI, chitosan; CIP, ciprofloxacin; CLR, clarithromycin;
CLI, clindamycin; CHL, chloramphenicol; CST, colistin; COU, coumermycin A1; CRY, cryptotanshinone; CSD, cefsulodin; CYC, D-cycloserine; DAP, dapto-
mycin; DAS, dapsone; DAU, daunomycin; DER, dermcidin; DRS, dermaseptin; DOX, doxycycline; ELB, ELB-21; EMB, ethambutol; END, enduracidin; ENR,
enrofloxacin; ENT, enterocin AS-48; ERY, erythromycin; ESC, esculentin-1b(1-18); ETH, ethionamide; FOF, fosfomycin; FRI, friulimicin B; FUR, furanones;
FUS, fusidic acid; GEN, gentamicin; GOM, gomesin; GRA, gramicidin; IPM, imipenem; ISO, isoniazid; KAN, kanamycin; KTC, ketoconazole; LVX, levoflox-
acin; MER, mersacidin; MET, methicillin; MIT, mitomycin C; MNZ, metronidazole; MOE, moenomycin; MOI, moiramide B; MON, monensin; MXF, moxiflox-
acin; MUP, mupirocin; NAL, nalidixic acid; NEO, neomycin; NIG, nigericin; NIS, nisin; NIT, nitrofurantoin; NOR, norfloxacin; NOV, novobiocin; NQO, 4-
nitroquinolone-1-oxide; NYT, nystatin; OFX, ofloxacin; OVI, ovispirin-1; OXA, oxacillin; PAMP, proline-rich antimicrobial peptide; PEN, penicillin G; PLC, pla-
tencin; PLE, plectasin; PLS, platensimycin; POL, polymyxin B; PUR, puromycin; RAM, ramoplanin; RHL, rhamnolipids; RHO, rhodomyrtone; RIF, rifampicin;
RFP, rifapentine; RIS, ristocetin; ROX, roxithromycin; SAA, sulfacetamide; SAF, saframycin; SIM, simocyclinone; SMZ, sulfamethizole; SPT, spectinomycin;
STR, streptomycin; TCS, triclosan; TEM, temporin L; TET, tetracycline; THL, tetrahydrolipstatin; TGC, tigecycline; TIO, tiocarlide; TLM, thiolactomycine;
TMP, trimethoprim; TPP, tea polyphenols; TRI, Triton X-114; VAL, valinomycin; VAN, vancomycin.
cAbbreviations: A. baumannii, Acinetobacter baumannii; A. fumigatus, Aspergillus fumigatus; B. cereus, Bacillus cereus; B. licheniformis, Bacillus licheni-
formis; B. subtilis, Bacillus subtilis; C. albicans, Candida albicans; C. difficile, Clostridium difficile; C. glutamicum; Corynebacterium glutamicum; E. faecalis,
Enterococcus faecalis; E. coli, Escherichia coli; L. lactis, Lactococcus lactis; M. smegmatis, Mycobacterium smegmatis; M. tuberculosis, Mycobacterium
tuberculosis; P. multocida, Pasteurella multocida; P. chrysogenum, Penicillium chrysogenum; P. falciparum, Plasmodium falciparum; P. aeruginosa, Pseu-
domonas aeruginosa; S. cerevisiae, Saccharomyces cerevisiae; S. enterica, Salmonella enterica; S. typhimurium, Salmonella typhimurium; S. flexneri, Shi-
gella flexneri; S. aureus, Staphylococcus aureus; S. simulans, Staphylococcus simulans; S. pneumoniae, Streptococcus pneumoniae; T. maritima,
Thermatoga maritima; T. rubrum, Trichophyton rubrum; T. whipplei, Tropheryma whipplei; X. fastidiosa, Xylella fastidiosa; Y. pestis, Yersinia pestis.
dT, transcriptome study; P, proteomic study.
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between individual studies—even within the same organism—is
unfortunately greatly hampered by the lack of a defined gold
standard. Hence, a wide range of different experimental con-
ditions was used by the individual research groups. Cultures
were induced at different cell densities, using both complex
and minimal media. The antibiotic concentrations varied
greatly between individual studies, ranging from subinhibitory
up to 10 times the MIC. The same is true for the induction
time (i.e. the time between antibiotic addition and harvesting
of the cells), which could be anywhere between 5 min and
.1 h. The last aspect is additionally affected by the downstream
protocol from cell harvest to lysis of the culture. While some
groups took painstaking care that transcription was immediately
stopped after a defined induction time, the protocol of other
groups potentially allowed for an extra induction time during
the downstream processing of cells. All of these parameters, of
course, dramatically affect the overall expression signature.
However, as a first estimate, subinhibitory concentrations and
short induction times provoke very narrow, compound-specific
responses, whereas higher antibiotic concentrations and longer
induction times result in the detection of both non-specific and
secondary effects of antibiotic action.
The motivation for these studies was as varied as the com-
pounds tested. In many cases, the papers primarily describe
the expression signature of an individual compound. These
papers are somewhat characteristic for the early period of micro-
array studies, often offering the infamous long lists of gene
names and induction values. While still being published regularly,
restrictive editorial policies have either required substantial
additional data or forced publication of such studies in note
formats or low-impact journals. While these studies—as with
any global expression profile—can always be a treasure chest
for extracting information on genes of interest, they will not be
further addressed in the context of this review article (but are
comprehensively listed in Table 1). Instead, we will focus our
attention on those studies that have resulted in a deeper under-
standing of some aspects of antimicrobial action.
Resistance mechanisms and stress response
networks
Some genome-wide antibiotic induction experiments were per-
formed with the goal of unravelling resistance mechanisms
and/or the underlying regulatory network that orchestrates anti-
biotic stress responses. This approach was especially successful
in identifying and characterizing cell envelope stress responses
and the corresponding signal transduction systems in many
Gram-positive bacteria.37 A number of independent studies in
the Gram-positive model organism B. subtilis have revealed a
complex regulatory network consisting of more than 10 partly
overlapping signalling systems.38 – 40 Based on these studies, a
regulatory network of similar complexity was deconvoluted in
the related organism Bacillus licheniformis by applying a combi-
nation of comparative transcriptomics and in silico regulon
mining.41 A set of studies in Staphylococcus aureus first
allowed the identification of the cell envelope stress response
in this human pathogen, and subsequently the in-depth profiling
of antibiotic resistance traits in multiresistant strains as well as
different vancomycin-resistant clinical isolates.42 – 46 Similar
studies, in which the proteome/transcriptome of susceptible
and resistant strains or different clinical isolates were compared,
have been performed for vancomycin-induced Enterococcus fae-
calis47 and streptomycin-induced M. tuberculosis.48 A correlation
between the overall antibiotic induction profiles and the
expression of resistance determinants was also investigated for
a number of other compounds, such as daptomycin in B. subti-
lis,49 dermcidin in S. aureus,50 ethambutol in M. tuberculosis51
or the fluoroquinolone antibiotic ciprofloxacin in P. aeruginosa
and Streptococcus pneumoniae.52,53
Large-scale expression panels for MOA
predictions and identification of suitable
antibiotic biosensors
The motivation of many antibiotic induction experiments was
the assumption that the MOA of a given compound is reflected
by the function of the genes/proteins it induces. This hypothesis
led to a number of comprehensive expression studies under
standardized conditions in which large panels of antimicrobial
compounds from different functional classes were compared in
order to produce a gene/protein induction database for MOA
prediction of novel compounds. The three landmark publications
included two transcriptome panels in B. subtilis and M. tuberculo-
sis54,55 as well as a comprehensive proteome study, again in
B. subtilis.56 All three studies demonstrated that it was indeed
possible to identify specific induction patterns for both individual
and functional classes of antibiotics. These expression signatures
could then be applied to narrow down the site of action of novel
antimicrobial compounds that were also included in the
panel.54 – 56 The quantity and quality of the collected expression
data are crucial for MOA prediction. For example, Hutter et al.55
generated a comprehensive database containing genome-wide
expression profiles of B. subtilis treated with 37 antibacterial
compounds with known MOAs from six different classes. This
dataset was tested with regard to its use as a reference for
MOA prediction studies. The success of this strategy correlated
with the number of expression profiles available for each class
and worked exceptionally well for cell wall and protein biosyn-
thesis inhibitors. A hierarchical clustering analysis of expression
data from cells treated with antibiotics from these two MOA
classes reveals completely different expression patterns
(Figure 1). Antibiotics targeting protein biosynthesis all cluster
together and, accordingly, induce a homogeneous set of genes
that is not induced by any of the cell wall active compounds.
In contrast, cell wall antibiotics fall into two distinct clusters
that correlate well with the respective MOA. All b-lactams,
which inhibit the last extracellular step of cell wall biosynthesis,
form one distinct cluster, while the second cluster contains anti-
biotics interfering with earlier membrane-anchored steps of the
biosynthetic pathway.
Comprehensive datasets of expression profiles also enabled
the identification of marker genes for specific antibiotic classes.
Several B. subtilis reporter strains, in which the promoter of the
marker gene is fused to the luciferase reporter gene, have been
generated and shown to respond to antibiotics that interfere
with major biosynthetic pathways of bacterial cells (inhibition
of fatty acid, protein, RNA, DNA or cell wall biosynthesis).57,58
Expression of these marker genes can also be indicative for a
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specific MOA. For example, the ytrABCDEF operon is strongly
induced by glycopeptide antibiotics like vancomycin or ristocetin,
but not (or only weakly) by other cell wall antibiotics (Figure 1).
These so-called biosensors have been successfully used to
predict or confirm the mode of action of poorly characterized
agents.59 Although this approach seems very promising, there
are also clear limitations. Only compounds provoking a response
similar to known induction profiles can be classified correctly,
making identification of completely new targets impossible.
Moreover, antibiotics induce gene expression only within a
certain window of concentration, often impeding the use of bio-
sensors in standardized high-throughput screenings. A low con-
centration of a compound might not be sufficient for induction
of the biosensor, whereas a high concentration might be lethal
for the cell. This could also be an explanation of why compounds
with well-known MOAs do not always induce the corresponding
biosensor.58,59
MOA studies on individual compounds
A side aspect of the studies described above is the direct com-
parison of individual compounds in order to define similarities
and differences in the MOA based on the expression signature.
Small panels often include a number of functionally diverse com-
pounds, such as a transcriptome study in Pasteurella multocida
using amoxicillin (cell wall biosynthesis), enrofloxacin (DNA
gyrase) and tetracycline (translation elongation) stress
responses.60 A similar study at the proteome level was per-
formed in Mycobacterium smegmatis and included the three
anti-tuberculosis drugs ethambutol (cell envelope), isoniazid
(fatty acid biosynthesis) and 5-chloropyrazinamide (unknown
cellular target).61 These studies mostly revealed a combination
of characteristic compound-specific induction profiles (including
target genes/proteins involved in the cellular process inhibited
by the respective antibiotic) and antibiotic-independent (often
overlapping) general stress responses.
Direct comparative expression studies have also been per-
formed to discriminate the MOA of chemically closely related
compounds, such as the lipo(depsi)peptide antibiotics daptomy-
cin and friulimicin B.62 Transcriptional profiling was also used in
combination with physiological and biochemical studies for
detailed MOA studies of novel compounds. Such analyses have
been performed for chitosan,63 the lipopeptide antibiotic friulimi-
cin B62,64 and the defensin plectasin.65 Knowledge of the tran-
scriptional response to novel compounds usually provides
indirect but convincing evidence of the affected cellular
pathway. This allows the performance of specific biochemical
follow-up experiments to identify the exact target molecule
and MOA, as demonstrated for the aforementioned compound
friulimicin B.62,64
In addition to unravelling specific responses and elucidation
of the MOA, transcriptional profiling sometimes also revealed
important secondary effects of antimicrobial drug action. The
sB-dependent general stress response is induced by the cell
wall antibiotic vancomycin in both Listeria monocytogenes66
and B. subtilis.38 In the latter organism, sB is also activated by
treatment with bacitracin.39 Although both antibiotics target
cell wall biosynthesis, they do not share a common MOA,
suggesting that induction of sB occurs as a secondary response
to a general loss in cell envelope integrity. DNA damage caused
by quinolone antibiotics induces the SOS response, resulting in
increased expression of enzymes involved in DNA repair, recom-
bination and mutagenesis.67 – 69 These observations might point
towards a new direction of antimicrobial therapy, e.g. the devel-
opment of co-drugs that target (and thereby suppress) protec-
tive functions embedded in such secondary responses, as will
be discussed further below.
New inhibitory mechanisms of old drugs
The increasing and on-going emergence of resistant bacterial
strains necessitates the development of new classes of anti-
biotics with completely novel MOAs. An overview of antibiotic dis-
covery within the last 70 years together with an up-to-date
survey of new antibiotics already in clinical trials and an
outlook on future progress is nicely summarized in a recent
review by Coates et al.70 Development and marketing of ana-
logues of already well-investigated antibiotics is less risky and
financially more feasible than the identification of completely
novel antibiotic classes. But in addition to putting effort into
developing new antibiotics, it might also be a worthwhile endea-
vour to more closely investigate the effects of already existing
and clinically used drugs, since global expression studies on anti-
microbial action also helped to discover novel inhibitory mechan-
isms for seemingly well-known compounds.
Several studies have presented evidence that the interaction
of an antibiotic with its specific target is not the only path
leading to cell death.67,71 Most importantly, it was demonstrated
that several compounds induce the production of reactive
oxygen species, which significantly contribute to the killing
potential of bactericidal antibiotics. A microarray analysis of
E. coli cells treated with the DNA gyrase inhibitor norfloxacin
revealed not only induction of the SOS response, but also
up-regulation of genes involved in the response to oxidative
stress and iron-sulphur cluster biosynthesis.67 Moreover, this
study presented convincing evidence that norfloxacin treatment
induces Fenton reaction-mediated formation of hydroxyl rad-
icals, ultimately causing cell death. Even antibiotics of different
classes (such as quinolones, b-lactams or aminoglycosides)
that interact with different primary targets within the cell
mediate killing by this common mechanism in both Gram-
negative and Gram-positive bacteria.71 These landmark studies
indicate that reactive oxygen species represent a central aspect
of the killing mechanism of many bactericidal antibiotics.
Figure 1. Hierarchical clustering analysis of genes differentially expressed in response to cell wall and protein biosynthesis inhibitors. The clustering
analysis was performed using the software Cluster 3.0.179 Transcriptome data for B. subtilis treated with fosfomycin (FOF), cefotaxime (CTX), penicillin
G (PEN), cefalexin (LEX), amoxicillin (AMX), bacitracin (BAC), daptomycin (DAP), ristocetin (RIS), vancomycin (VAN), friulimicin (FRI), erythromycin (ERY),
neomycin (NEO), chloramphenicol (CHL), spectinomycin (SPT), tetracycline (TET), clindamycin (CLI) and fusidic acid (FUS) were derived from published
studies.39,55,62 Green indicates induction of the corresponding gene and red indicates repression under the designated condition. Cluster analysis was
limited to genes induced ≥5-fold by at least one antibiotic. Distinct clusters are highlighted and the corresponding gene names are given.
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In contrast, bacteriostatic drugs did not provoke the generation
of reactive oxygen species.
Development of co-drugs
The efficacy of a single antibiotic can often be enhanced by the
administration of a second antimicrobial compound with comp-
lementary properties, i.e. a co-drug. A classic example of this
concept is the combination of the sulphonamide antibiotic sulfa-
methoxazole and its potentiator trimethoprim. These two com-
pounds inhibit different steps of the folate pathway and have a
greater effect when applied together than given separately.72,73
Another more recent example is the combination of the semi-
synthetic streptogramins quinupristin and dalfopristin.74 These
two antibiotics together are bactericidal because of synergistic
effects; binding of one compound to the ribosome enhances
the binding and efficacy of the second drug.75,76
During the last decade, the use of genome-wide expression
profiling on antibiotic action has opened new doors to the identi-
fication and development of co-drugs. Non-essential proteins
from secondary responses (e.g. those involved in counteracting
oxidative stress and its resulting damage), which have thus far
been ignored in the process of antibacterial drug discovery and
development, could serve as possible new targets for co-drugs
to potentiate the effect of already established antibiotics. The
killing effect of antibiotics can also be increased by inhibition or
deletion of systems counteracting cellular damage, such as the
SOS response induced by quinolone and aminoglycoside anti-
biotics.71,77 Synergism can also be achieved by a combination
of antibiotics, in which cell envelope damage caused by one
compound increases the uptake of a second drug.78 A different
approach using a combination of two different compounds has
already been successfully applied to overcome b-lactam resist-
ance.79 Here, the most important resistance mechanism is the
production of b-lactamases. This defence strategy can be over-
come by the co-administration of inhibitors with high binding
affinity and low hydrolysing rate, often being b-lactams them-
selves, which bind to the catalytic site, resulting in the inacti-
vation of b-lactamases.80,81
Beyond antimicrobial action: antibiotics as
signalling molecules and vice versa
As already mentioned previously, antibiotic induction exper-
iments, especially when performed at subinhibitory concen-
trations, also revealed a whole new layer of antibiotic action
that goes beyond mere growth inhibition. Antibiotics affect bac-
terial cells differentially depending on the concentration, a
phenomenon also known as hormesis.82 While growth inhibition
occurs at high doses, low antibiotic concentrations have a stimu-
lating effect and specifically modulate global gene expression.
This phenomenon provokes questions about the role of
antibiotics in nature, where the actual concentration rarely
reaches inhibitory levels outside the direct vicinity of the produ-
cing strain. Is there a second function besides interspecies com-
petition? The seminal collaborative study from the Davies’s and
Surette’s labs already indicated the potential of antibiotics as a
means of interspecies chemical communication, e.g. in the soil
environment.83 Expression of up to 5% of the Salmonella
typhimurium genes can be positively or negatively affected by
different antibiotics at concentrations well below the MIC,
leading to no or only minor effects on growth. Many of the cor-
responding gene products are involved in transport processes,
virulence or DNA repair. Moreover, similar studies also unravelled
novel links between antibiotic stress responses and bacterial
differentiation and intracellular communication. Even very
complex phenotypes can be induced by antibiotic treatment at
subinhibitory concentrations. Ciprofloxacin, tetracycline and
tobramycin not only increased the expression of genes involved
in differentiation in P. aeruginosa, but also actually induced
biofilm formation.84,85 The antimicrobial peptide gomesin also
increased biofilm formation of the plant pathogen Xylella fasti-
diosa.86 This is a crucial finding, since cells within a biofilm are
generally more resistant to antibiotic treatment due to high
cell density, slow growth and production of an extracellular
matrix, resulting in antibiotic exclusion.87 Therefore, it is a neat
survival strategy for a bacterial population to already respond
to very low antibiotic concentrations by inducing differentiation
into a biofilm, thereby increasing antibiotic resistance before
the compound concentration reaches a critical level.
The result of bacterial signalling mediated by antibiotics does
not have to be related to resistance advantages. For example,
antibiotics can fulfil important regulatory functions regarding
their own biosynthesis or other cellular processes. This is
especially true for antimicrobial peptides, such as lantibiotics,88
bacteriocins89 and microcins,90 which have recently gained a
lot of attention.91 The production of lantibiotics from Gram-
positive bacteria, such as nisin from Lactococcus lactis and sub-
tilisin from B. subtilis, is regulated in a concentration-dependent
manner92 by a process called quorum sensing.93 The biosyn-
thesis of another antimicrobial molecule, the lipopeptide
antibiotic surfactin, is connected to the quorum-sensing
process responsible for competence development.94 In this
way, B. subtilis uses a single pathway to regulate two adaptive
processes, antibiotic biosynthesis and DNA uptake. However,
antibiotics can also negatively affect quorum sensing and sub-
sequent differentiation. For example, subinhibitory concen-
trations of tobramycin significantly lower the accumulation of
an autoinducer in P. aeruginosa, which subsequently impairs
swarming motility, biofilm formation and pyocyanin pro-
duction.95 The previously mentioned studies clearly demonstrate
that antibiotics are not only (or not even primarily) used for bio-
logical warfare, but also play an important role in bacterial
signalling.
However, this link between cellular signalling and antimicro-
bial activities also works the other way around. Classical quorum-
sensing autoinducers, such as N-acylhomoserine lactones used
by Gram-negative bacteria, can also have antibacterial proper-
ties. One such molecule (3-oxo-N-acylhomoserine lactone) syn-
thesized by P. aeruginosa exhibits activity against Gram-positive
bacteria, but not against Gram-negative species.96 Such studies
suggest that bacteria not only use typical antibiotics to gain
competitive advantages, but also molecules embedded in their
natural life style. Moreover, they emphasize the concept that
many, if not most, antibiotics seem to have more than one func-
tion. And growth inhibition might sometimes (maybe often?) be
only a beneficial side effect in addition to the primary function in
its natural habitat. From an ecological point of view, it is rather
attractive to think of antibiotics as dual-use goods that
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combine signalling and differentiation of the producer species
with growth suppression of potential competitors for the same
ecological niche.
Summary and outlook
This article highlights the most significant achievements of
applying omics tools to antibiotic research. Clearly, some of the
initial hopes were premature and could not be fulfilled, despite
some promising advances, as has also been discussed in a
recent article by Livermore.97 Up to now, no new lead compound
has emerged from these global approaches, and antibiotic
research in recent years has been primarily characterized by
the development of analogues of known compounds rather
than the discovery of novel antibiotic classes.98 But often the dis-
covery of compounds with promising antimicrobial activities is
not the major issue. It takes a lot of time and (financial) effort
to develop and finally introduce a new compound into the
market.97 Considering the costs and challenges for the clinical
development of a new antibiotic, as well as the short-term thera-
peutic use once it is on the market, it is often more profitable for
pharmaceutical companies to invest in therapeutic areas other
than anti-infectives.99,100 Hence, a number of major pharma-
ceutical companies that initially embraced the promises
and potential of omics approaches for antimicrobial research
and development have given up on this strategy and left the
field to smaller start-up companies. Nevertheless, global
expression profiling studies have significantly deepened our
understanding of antibiotic inhibition and uncovered unexpected
new layers of antimicrobial action with regard to additional
inhibitory effects of bactericidal drugs and the role of antibacter-
ial compounds as signalling molecules for intra- and interspecies
communication.
The development of new co-drugs seems to be a particularly
promising approach for combating the ever-increasing threat of
multiresistant human pathogens. Given the paucity of new anti-
biotic classes in the late stages of clinical development, regaining
or even enhancing the inhibitory potential of well-established
drugs might be an alternative route for improving clinical antimi-
crobial therapy.
While the initial hopes of what the ‘age of omics’ might bring
for antibiotic discovery may not have been fulfilled (at least so
far), global expression profiling approaches have definitely
opened new doors for future antibacterial research. An especially
powerful approach to combating the ever-increasing threat of
microbial resistance, which has only become feasible in recent
years with the advent of high-throughput sequencing strategies,
is comparative whole-genome sequencing of antibiotic-
susceptible versus -resistant strains, especially when combined
with antibiotic-induced expression profiling panels of the same
strains. Such information may be crucial to not only identifying
resistance mechanisms, but to gaining insight into potential
targets for new (co-)drugs. Likewise, comparative genomics of
large numbers of pathogenic and closely related non-pathogenic
strains might also be a promising strategy for the discovery of
novel antibiotic targets.
Once a potential novel drug target with suitable features (e.g.
essential functionality, conservation amongst bacteria and lack
of a counterpart in mammalian cells) has been identified, the
next challenge is the development of sensitive high-throughput
screens of large compound libraries. Since the binding of a com-
pound to a target does not always correlate with antibacterial
activity, the use of whole cells instead of isolated targets for
screening could directly select for compounds with beneficial
pharmaceutical properties, such as the ability to penetrate bac-
terial cells or resist efflux. However, although a number of new
targets have been identified and used in screening programmes,
the resulting number of potential new antibacterial agents has
been disappointingly small.99 To increase the success of these
high-throughput screens, the compound libraries should be
expanded to include unconventional classes, chemically modi-
fied molecules, as well as natural products from new sources,
such as secondary metabolites from marine microorganisms.101
So far, all antibiotics are derived from culturable organisms.
However, as most microbes cannot currently be cultured under
laboratory conditions,102 it might be worthwhile to start explor-
ing the biosynthetic potential of non-culturable bacteria by
metagenomic approaches, a technique that has thus far been
applied primarily to study the antibiotic resistance profile (the
resistome) in a given habitat, such as the soil.103 Large
genomic DNA fragments isolated from complex habitats can
be cloned into suitable vectors and the corresponding genes
can be expressed and screened for antibacterial activity.1,104,105
It will be interesting to see how these new directions might
influence the field of antibiotic research a decade from now.
Most likely there will be new twists and turns, new hopes and
ideas that we are currently not even aware of. Global expression
profiling, even after having become an established tool (or
because of this) will surely prove to be a valuable approach to
fostering our knowledge of antibiotic action for many years to
come.
Note added in proof
While this article was in proof, a comprehensive review was pub-
lished by Romero et al. that beautifully summarizes our current
state of knowledge on the role of antibiotics as signalling mol-
ecules (Romero D, Traxler MF, López D et al. Antibiotics as
signal molecules. Chem Rev 2011; doi:10.1021/cr2000509).
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5.2 Mechanism of action of  daptomycin and friulimicin B 
Analysis of differential gene expression upon antibiotic treatment is a powerful tool to gain 
information about the MOA of novel antimicrobial compounds, as has been discussed in 
the previous section. Therefore, we investigated changes in gene expression in response to 
two clinically relevant lipopeptide antibiotics, daptomycin and friulimicin B, on both the 
transcriptome and proteome level in B. subtilis (chapter 2, Table 1 and Fig. 2). Although 
these antibiotics are structurally similar, they provoke different expression profiles, as can 
be best demonstrated by a graphical representation of the microarray analysis presented in 
chapter 2 (Fig. 5.1). 
 
Figure 5.1. Graphical comparison of the daptomycin (y axis) and friulimicin B stimulon (x axis). Genes 
regulated by LiaRS (□) and ECF-dependent target genes (■) that were induced ≥ 3-fold by at least one of the 
antibiotics are highlighted. Additional marker genes are highlighted (∆, ▲, ) and their names are given. 
Note that the induction of gerAAABAC is due to a known polar effect of the liaI promoter. All other genes are 
represented as small grey dots.  
Both antibiotics induce numerous ECF-dependent target genes. Induction of this ECF 
response is much stronger for friulimicin B than for daptomycin. The only ECF-
independent gene significantly induced by both antibiotics is mreBH encoding a cell shape-
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determining protein. Daptomycin specifically and strongly activates the LiaRS TCS, 
resulting in increased expression of liaIHGFSR as well as read-through transcription of the 
downstream located gerAAABAC operon, which has also been observed previously after 
induction with other antibiotics (Mascher et al., 2003). Another gene exclusively induced 
by daptomycin is ybeF encoding a small putative membrane protein. The striking 
differences in the transcriptional responses induced by daptomycin and friulimicin B, 
which were also confined by the corresponding proteome profiles, strongly suggest that 
these structurally similar antibiotics act via different MOAs. In the following sections, 
conclusions drawn from these expression profiles as well as recent studies regarding the 
MOA of daptomycin and friulimicin B will be discussed. 
5.2.1 Daptomycin 
The response to daptomycin has also been investigated by other research groups. In S. 
aureus, daptomycin induced a typical cell wall stress stimulon including genes related to 
the cell envelope or involved in different cellular processes, DNA metabolism or protein 
fate (Muthaiyan et al., 2008). Such an expression profile is characteristic for cell wall-
active antibiotics like oxacillin, bacitracin or D-cycloserine (Utaida et al., 2003). A 
significant number of genes belonging to this cell wall stress stimulon are controlled by the 
TCS VraSR, which is homologous to the B. subtilis LiaRS TCS (Muthaiyan et al., 2008).  
An analysis of the transcriptional and physiological response to daptomycin in B. subtilis, 
the same organism we used, was also performed by Hachmann and colleagues (Hachmann 
et al., 2009). In agreement with our results, the most strongly induced locus was the target 
operon of the LiaRS TCS followed by a number of ECF σ factor-dependent genes, 
primarily targets of σM. In addition, expression of yvrI and yvrL was also strongly induced. 
YvrI is part of an unusual two-subunit bacterial σ factor controlling expression of the 
oxdC-yvrL operon, encoding an oxalate decarboxylase and a regulatory protein, 
respectively (MacLellan et al., 2009b, MacLellan et al., 2008).  
Moreover, genetic alterations within the lia locus as well as deletions of different ECF σ 
factors influence daptomycin resistance. Deletion mutants carrying resistance cassettes in 
genes like liaIH or liaR, in which the physiologically relevant genes of the lia locus are not 
present or inducible, respectively, show increased daptomycin susceptibility. In contrast, 
deletion of liaF, leading to constitutive expression of the lia locus, does not influence 
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resistance. A slight increase in susceptibility has also been observed for mutant strains of 
σ
M and σW. This phenotype can be further enhanced by combination of deletion mutants, 
either of both ECF σ factors or with liaIH/liaR (Hachmann et al., 2009).  
Although daptomycin has been clinically used for several years now, its exact MOA is still 
unknown. It is generally established that daptomycin affects membrane integrity by 
insertion and probably pore formation, but the steps leading to this final cause of cell death 
are still subject of discussion. It has been suggested that Ca2+-bound daptomycin first 
inserts into the cytoplasmic membrane and then oligomerizes to form pores. Subsequently, 
this disrupts membrane integrity resulting in depolarization and leakage of ions, ultimately 
causing cell death (Silverman et al., 2003). Another model proposed that daptomycin binds 
Ca2+ and forms loose micelles in solution. In close proximity to the membrane, these 
micelles dissociate and daptomycin inserts into the membrane, possibly followed by 
oligomerization, leakage and cell death (Straus & Hancock, 2006). A very recent study 
examined oligomerization of daptomycin both in solution and in association with 
membranes by fluorescence resonance energy transfer (FRET) analysis. It was 
demonstrated that daptomycin indeed forms oligomers associated with bacterial membrane 
vesicles, but not in solution at antimicrobially relevant concentrations. The conditions 
necessary for oligomerization resembled those required for antibacterial activity, 
suggesting that the oligomer represents the functional membrane lesion (Muraih et al., 
2011).  
Oligomerization on membrane vesicles correlates with the presence of 
phosphatidylglycerol, an essential and major anionic component of bacterial membranes. It 
has been suggested that binding of daptomycin to the negatively charged 
phosphatidylglycerol is mediated by Ca2+ ions (Muraih et al., 2011). A connection between 
the lipid composition of membranes and the antimicrobial activity of daptomycin has also 
been observed in vivo. A reduced level of phosphatidylglycerol, which is due to mutations 
in pgsA encoding the corresponding synthase, increases resistance of B. subtilis to 
daptomycin, while susceptibility to cell wall biosynthesis inhibitors like vancomycin is not 
affected (Hachmann et al., 2009, Hachmann et al., 2011). In contrast, deletion of mprF, 
which encodes the enzyme catalyzing formation of the positively charged lysyl-
phosphatidylglycerol, results in increased sensitivity to daptomycin (Hachmann et al., 
2009). In addition, enhanced translocation of the cationic lysyl-phosphatidylglycerol to the 
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outer membrane leaflet, which thereby introduces additional positive charges into the 
membrane, correlates with a more resistant phenotype in S. aureus (Jones et al., 2008). 
Conversely, mutations in mprF, which are usually expected to lead to decreased lysyl-
phosphatidylglycerol content, occur early during resistance development in S. aureus 
(Friedman et al., 2006). The exact consequences of these mutations, especially whether 
they are loss- or gain-of-function mutations, need to be investigated and compared to the 
effects of intended mprF alterations.  
Besides changes in susceptibility, modifications in the membrane lipid composition also 
influence the binding behavior of daptomycin to the cell surface. Daptomycin is normally 
concentrated on newly formed division septa and in a helical pattern along the long axis of 
B. subtilis cells (Hachmann et al., 2009), which is a pattern characteristic for anionic 
phospholipids (Barák et al., 2008). Depletion of phosphatidylglycerol leads to an overall 
weaker binding of daptomycin and loss of the helical localization pattern (Hachmann et al., 
2009). 
Investigation of resistance development and mechanisms can help to understand the MOA 
of antibiotics. A common feature of the resistance mechanisms mentioned above, either 
decreased levels of phosphatidylglycerol in B. subtilis or increased lysyl-
phosphatidylglycerol synthesis and translocation in S. aureus, is reduction of the overall 
negative net charge of the cell envelope. These data suggest that the Ca2+-daptomycin 
complex functions similar to cationic antimicrobial peptides. Composition and charge of 
the cell membrane seem to be important for the biological activity of Ca2+-bound 
daptomycin. Presumably, it preferentially interacts with and inserts into membrane regions 
enriched in anionic lipids.  
Another way to gain information about the MOA of antibiotics is the comparison of 
induction patterns to expression profiles provoked by well-known antimicrobial 
compounds. A list of studies providing such expression profiles as well as a discussion 
about the potential and limitations of such approaches has been presented in detail in 
section 5.1. Oligomerization and pore formation in bacterial membranes seem to be an 
important step in the MOA of daptomycin, but transcriptome studies suggest an additional 
mechanism involving the inhibition of cell wall biosynthesis. In S. aureus daptomycin 
induces a set of genes that is also induced by the proton ionophore carbonyl cyanide m-
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chlorophenylhydrazone, which is in agreement with the membrane interfering properties of 
both compounds. But additional induction of a typical cell wall stress stimulon, including 
the VraSR TCS, resembles expression profiles provoked by cell wall antibiotics such as 
vancomycin, oxacillin, bacitracin and D-cycloserine (Muthaiyan et al., 2008, Utaida et al., 
2003). The homologous LiaRS TCS, the main regulatory system responding to daptomycin 
treatment in B. subtilis (Chapter 2, Table 1 and (Hachmann et al., 2009)), is usually 
strongly induced by cell wall active compounds like bacitracin, nisin, ramoplanin or 
vancomycin (Mascher et al., 2004), which inhibit cell wall biosynthesis, especially by 
interfering with different steps of the lipid II cycle. These induction profiles suggest that 
daptomycin, in addition to membrane perforation, also interferes with cell wall 
biosynthesis. Since antibiotics with a similar induction profile preferentially block steps of 
the lipid II cycle, it seems likely that daptomycin also acts via such a mechanism. 
Nevertheless, an actual target within the cell wall biosynthesis pathway has not yet been 
identified (Schneider et al., 2009). 
5.2.2 Friulimicin B 
Friulimicin B primarily provokes an ECF σ factor-dependent response, while the TCS 
LiaRS, which usually responds to cell wall biosynthesis inhibitors, is not induced at all 
(chapter 2, Table 1 and Fig. 5.1). This induction pattern suggests that friulimicin B 
generally interferes with cell envelope integrity rather than interacting with a specific 
target within the cell wall biosynthesis pathway. But a detailed biochemical MOA study 
revealed that friulimicin B inhibits cell wall biosynthesis (Schneider et al., 2009). 
Friulimicin B does not affect membrane integrity but specifically forms a complex with the 
lipid carrier undecaprenol-monophosphate in a Ca2+-dependent manner, thereby blocking 
formation of lipid I. The lipid carrier undecaprenol-monophosphate is also involved in 
transport of other cell envelope components such as teichoic acids, indicating that 
friulimicin B might block multiple pathways (Schneider et al., 2009). Recently, the role of 
Ca2+ ions for the antimicrobial activity of friulimicin B has been investigated by a model 
membrane approach. It was demonstrated that friulimicin B interacts with membranes 
containing undecaprenol-monophosphate in the presence of Ca2+ ions (Reder-Christ et al., 
2011), thereby confirming the above stated MOA in which undecaprenol-monophosphate 
constitutes the target of friulimicin B (Schneider et al., 2009). It has also been suggested 
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that Ca2+ ions form a bridge between the negatively charged friulimicin B and the 
phosphate moiety of the lipid carrier. Moreover, it has been postulated that Ca2+ ions also 
influence the secondary structure of friulimicin B, probably shifting the antibiotic into a 
conformation suitable for target binding (Reder-Christ et al., 2011).  
Although friulimicin B is structurally very similar to daptomycin, the data mentioned 
above clearly demonstrate that it acts via a completely different molecular MOA. The fact 
that first failures in treatment of S. aureus infections with daptomycin have already been 
reported underlines the urgent need for antibiotics with novel MOAs (Jones et al., 2008). A 
common feature of cell wall antibiotics like vancomycin, ramoplanin or bacitracin, which 
interfere with the lipid II cycle, is induction of the LiaRS TCS in B. subtilis (Jordan et al., 
2008, Mascher et al., 2004, Salzberg et al., 2011). Although the lack of LiaRS induction by 
friulimicin B suggests a different MOA for this antibiotic, it nevertheless also interferes 
with the lipid II cycle, albeit by inhibition of a different step. Most cell wall-active 
antibiotics specifically interact with the lipid II complex, thereby inhibiting the later lipid-
linked steps of cell wall biosynthesis (Breukink & de Kruijff, 2006, Schneider & Sahl, 
2010). In contrast, friulimicin B prevents the first step of the lipid II cycle, the formation of 
lipid I, by binding to undecaprenol-monophosphate (Schneider et al., 2009). The only 
antibiotic known that also interferes with this step is tunicamycin. Although both 
antibiotics prevent lipid I formation, their molecular MOA is completely different. 
Tunicamycin mimics UDP-activated sugars, which leads to a competitive and reversible 
inhibition of MraY, the enzyme catalyzing formation of lipid I (Bettinger & Young, 1975, 
Brandish et al., 1996). In contrast, friulimicin B forms a tight complex with undecaprenol-
monophosphate, which results in the depletion of one of the substrates necessary for lipid I 
formation, while the activity of MraY is not affected (Schneider et al., 2009). To our 
knowledge, the response to tunicamycin has not been investigated on a genome-wide level. 
Nevertheless, it has been shown that the LiaRS TCS of B. subtilis responds to the presence 
of tunicamycin (Mascher et al., 2004). Our data show that the LiaRS system is not induced 
by friulimicin B (chapter 2, Table 1 and Fig. 5.1), although both antibiotics cause 
inhibition of lipid I synthesis. These data suggest that friulimicin B has a completely novel 
and unique MOA. So far, there is no antibiotic on the market or even known that shares 
this MOA, making friulimicin B an exceptionally promising drug candidate for clinical use 
against Gram-positive bacteria including MRSA. Moreover, the lipid carrier undecaprenol-
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monophosphate is a target that cannot be altered as easily as proteins or the D-Ala-D-Ala 
terminus of the pentapeptide of lipid II, the latter being a common mechanism for 
resistance against the last resort antibiotic vancomycin (Schneider et al., 2009, Walsh et 
al., 1996). 
The data presented in chapter 2 and discussed above clearly show that global expression 
profiling is indeed a powerful and efficient tool to characterize novel antimicrobial 
compounds. As has been demonstrated for the lipopeptide antibiotics daptomycin and 
friulimicin B (chapter 2 and Fig. 5.1), even closely related compounds can induce a distinct 
set of genes which reflects completely different MOAs. Thereby, in-depth expression 
profiling can provide valuable hints regarding the MOA of novel compounds, which have 
to be validated by detailed biochemical MOA studies. 
5.3 The stress response of Bacillus subtilis to rhamnolipids 
Rhamnolipids are biosurfactants produced by the soil bacterium P. aeruginosa. In addition 
to their industrial importance, rhamnolipids also show antimicrobial activity, especially 
against Gram-positive species (Itoh et al., 1971, Lang et al., 1989). We investigated the 
transcriptome of B. subtilis after exposure to rhamnolipids by genome-wide DNA 
microarray analysis and further determined the response by hierarchical clustering analysis 
and phenotypic characterization (chapter 3). The most striking finding of this study was the 
simultaneous induction of two usually independent stress responses: the cell envelope 
stress response, including the TCS LiaRS and the ECF σ factor σM, and the CssRS-
mediated secretion stress response.  
Although rhamnolipids clearly display antimicrobial activity, their exact MOA is still 
unclear. In general, it has been suggested that they influence the permeability of biological 
membranes due to their properties as chemical detergents (Lang et al., 1989). Indeed, 
rhamnolipids have been shown to alter surface hydrophobicity and increase membrane 
permeability followed by an elevated level of released extracellular proteins (Vasileva-
Tonkova et al., 2011). The toxic effects of rhamnolipids are more drastic for Gram-positive 
species, such as B. subtilis, than for Gram-negative bacteria. Therefore, the composition of 
the Gram-negative cell envelope, most likely the outer membrane, seems to have a 
protective function against this biosurfactant (Vasileva-Tonkova et al., 2011). 
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Induction of the cell envelope stress response in B. subtilis (chapter 3, Table 3 and Fig. 2) 
correlates well with the proposed interference of rhamnolipids with cell membrane 
integrity. Such an expression pattern with strong induction of the LiaRS TCS and a (weak) 
ECF σ factor-dependent response has been also observed for the membrane interfering 
antibiotic daptomycin (Fig. 5.1 and (Hachmann et al., 2009)) and cell wall biosynthesis 
inhibitors like bacitracin and vancomycin (Cao et al., 2002b, Mascher et al., 2003). Often, 
signal transducing systems detect a harmful compound and alter gene expression to protect 
the cell and ensure its survival.  Such a role has been postulated for σW of B. subtilis, which 
controls expression of an antibiosis regulon providing protection against certain antibiotics 
(Butcher & Helmann, 2006). Induction of the LiaRS TCS does not always protect the cell 
against damage caused by the inducing compound. A protective role of the LiaRS TCS has 
been only demonstrated for a few antibiotics, for example daptomycin, and some oxidative 
stress generating agents (Hachmann et al., 2009, Wolf et al., 2010). While rhamnolipids 
strongly induce the LiaRS TCS (chapter 3, Table 3), our concentration-dependent lysis 
curve experiments showed that the effect on susceptibility is rather low. A ∆liaF mutant 
strain, in which the lia locus is strongly and constitutively expressed, is slightly more 
resistant against rhamnolipids. However, a Lia “OFF” strain, in which the RR LiaR is 
deleted, does not show any alterations in growth behavior after rhamnolipid treatment 
compared to the wild type (chapter 3, Fig. 3).  
In contrast, ECF σ factors clearly contribute to resistance against rhamnolipids. Deletion of 
σ
M significantly increases sensitivity (chapter 3, Fig. 3), showing that this ECF σ factor and 
its target genes provide protection against cell damage caused by rhamnolipids. Moreover, 
combination of σM and σW deletions enhances the observed phenotype (chapter 3, Fig. 3). 
Such an effect based on the regulatory overlap of several ECF σ factors in B. subtilis has 
been observed before. While often hardly any phenotype can be discovered for single ECF 
σ factor mutant strains, combined deletions of multiple ECF σ factors revealed increased 
sensitivity against several antibiotics and detergents (Hachmann et al., 2009, Mascher et 
al., 2007). 
In the case of the cell wall antibiotic daptomycin, susceptibility of B. subtilis can be further 
increased by simultaneous deletion of liaIH and one to three ECF σ factors (σM, σW and 
σ
X) (Hachmann et al., 2009), thereby deleting the major systems orchestrating the cell 
envelope stress response in this organism (Jordan et al., 2008). We tested if such an 
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additive effect can be also seen for rhamnolipids, but did not observe any differences in 
growth behavior after deleting LiaR in addition to σM and σW (chapter 3, Fig. 3). 
Altogether, these data show that the main protection against cell envelope damage caused 
by rhamnolipids comes from induction of ECF σ factors. For other cell wall antibiotics, 
such as bacitracin or vancomycin, a similar protective role has been also observed for ECF 
σ factors but not for the LiaRS system (Mascher et al., 2007, Wolf et al., 2010). 
Our microarray analysis also revealed induction of genes not belonging to a typical cell 
envelope stress stimulon. Rhamnolipids caused increased expression of htrA and htrB 
(chapter 3, Table 3 and Fig. 1), both encoding membrane-bound serine proteases. 
Transcription of these two genes is controlled by the TCS CssRS, which is usually 
activated upon heat and secretion stress (Darmon et al., 2002). Severe secretion stress can 
be caused by overexpression of extracellular proteins, such as the α-amylase AmyQ or the 
alkaline phosphatase PhoA (Darmon et al., 2006, Hyyryläinen et al., 2001). Induction of 
the CssRS TCS by rhamnolipids suggests that these compounds also cause some kind of 
secretion stress, possibly either by interfering with secretion machineries or protein 
folding. In E. coli accumulation of misfolded proteins within extracellular compartments 
induces the cell envelope stress response consisting of the TCSs BaeRS and CpxAR as 
well as the ECF σ factor σE (Raffa & Raivio, 2002, Ruiz & Silhavy, 2005). CssRS of B. 
subtilis constitutes a homolog of the CpxAR TCS of E. coli (Hyyryläinen et al., 2001). 
Therefore, CssRS might represent a TCS that responds to similar effects of cell envelope 
interfering compounds that trigger the corresponding response in the Gram-negative E. 
coli. The TCSs of both organisms are induced by accumulation of misfolded secretory 
proteins and control expression of genes encoding extracellular chaperones or proteases, 
showing that both systems are, at least partially, functionally equivalent. It is possible that 
the elevated amount of released protein caused by rhamnolipids, which is possibly due to 
increased membrane permeability instead of enhanced protein secretion (Vasileva-
Tonkova et al., 2011), triggers the secretion stress response in B. subtilis. 
Although the CssRS TCS is clearly induced by rhamnolipids (chapter 3, Table 3 and Fig. 
1), we did not observe any differences in growth inhibition between a CssRS deletion and 
wild type strain (chapter 3, Fig. 3). These data demonstrate that the CssRS TCS does not 
confer resistance against the effects caused by rhamnolipids. Other studies have shown that 
CssRS is required to combat the severe effects of “real” secretion stress in the form of 
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overexpressed AmyQ (Hyyryläinen et al., 2001). These findings together with our results 
suggest that secretion stress generated by rhamnolipids is not crucial for growth inhibition 
by this biosurfactant. Instead, it might be a consequence of increased membrane 
permeability caused by rhamnolipids, which might increase the level of extracellular 
proteins or impair functionality of secretion machineries and membrane-anchored proteins 
responsible for maintenance of the secretom. 
Taken together, the stress stimulon provoked by rhamnolipids in B. subtilis suggests that 
the major MOA of rhamnolipids is indeed related to the membrane, as is demonstrated by 
induction of a typical cell envelope stress response. Nevertheless, there has to be a second 
impact leading to induction of the secretion stress response, which has not yet been 
observed for other cell envelope interfering antimicrobial compounds. 
5.4 Characterization of the novel ECF41 σ factors 
Typically, the activity of an ECF σ factor is controlled by direct protein-protein interaction 
with an anti-σ factor. Inactivation of this anti-σ factor results in the release and therefore 
activation of the ECF σ factor (Helmann, 2002). In addition to such classical and well 
investigated ECF σ factors, a comprehensive survey and subsequent classification of these 
proteins identified a number of novel groups with unique features and unknown signaling 
mechanisms (Staroń et al., 2009). One of these groups is ECF41, whose detailed 
characterization is presented in chapter 4 of this thesis. Our analysis revealed that this 
group of ECF σ factors is widely distributed in bacteria. It consists of more than 400 
proteins deriving from ten different phyla. The unusual genomic context of the ECF41 σ 
factors is highly conserved. It differs from the classical locus organization in the lack of 
genes encoding obvious anti-σ factors. Instead, a gene encoding either a 
carboxymuconolactone decarboxylase (CMD), an oxidoreductase or an epimerase is 
located in direct vicinity of the ECF41 genes. In contrast to often large regulons of other 
ECF σ factors, we found that ECF41 proteins regulate expression of only a single 
transcript, which is often comprised of the ECF41 σ factor and/or the neighboring gene 
mentioned above. This transcriptional unit is preceded by a distinct and highly conserved 
group-specific promoter motif, which is recognized by the corresponding ECF41 σ factor. 
Moreover, the ECF41 proteins carry a large C-terminal extension that is not present in 
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other ECF σ factors. We demonstrated experimentally in two different organisms that this 
extension is involved in regulation of σ factor activity. These results lead us to postulate 
that this extension functions as a fused anti-σ factor-like domain, thereby constituting a 
completely novel mechanism of ECF σ factor-dependent signal transduction (chapter 4). 
5.4.1 Biological function of ECF41 σ factors and their targets 
A good approach to assign a physiological function to an ECF σ factor is the analysis of its 
regulon. In general, the function of the target genes reflects the contribution of an ECF σ 
factor to counteracting specific stress situations, as has been shown for σR of S. coelicolor, 
which mediates a thiol-oxidative stress response (Paget et al., 2001), or σW of B. subtilis, 
controlling an antibiosis regulon (Butcher & Helmann, 2006). Therefore, analysis of the 
function of ECF41-dependent target genes could provide some hints for the physiological 
role of this novel group of ECF σ factors. 
The target gene of the ECF41 σ factor in both B. licheniformis and R. sphaeroides encodes 
a CMD protein. The prototypical function of these enzymes is degradation of aromatic 
compounds, which has been demonstrated for proteins from Rhodococcus opacus and 
Bradyrhizobium japonicum (Eulberg et al., 1998, Lorite et al., 1998).  They catalyze the 
decarboxylation of γ-carboxymuconolactone to β-ketoadipate enol-lactone within the 
protocatechuate branch of the β-ketoadipate pathway. Importantly, all CMD proteins 
linked to ECF41 σ factors carry a highly conserved CxxC motif (Fig. 5.2), which 
distinguishes them from the classical γ-CMD proteins involved in metabolism of aromatic 
compounds.  
An already characterized protein originally annotated as CMD protein, which carries such 
a CxxC motif, is MdrA from the archaeon Methanosarcina acetivorans. This protein is 
encoded in an operon with putative oxidative stress genes. It shows disulfide reductase 
activity and iron-sulfur cluster formation, both dependent on the CxxC motif. It has been 
suggested that MdrA plays a role in the oxidative stress response of this organism, possibly 
mediating repair of proteins containing disulfide bonds or iron-sulfur clusters, which were 
damaged by oxidative stress (Lessner & Ferry, 2007). The CMD protein family also 
includes alkylhydroperoxidases, with AhpD of M. tuberculosis being the best understood 
example. AhpD contains a CxxC motif crucial for its catalytic function. Besides 
alkylhydroperoxidase activity, AhpD serves as a reducing partner for the peroxiredoxin 
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AhpC. Together, these two proteins constitute important elements of the antioxidant 
defense system of M. tuberculosis (Hillas et al., 2000, Koshkin et al., 2003). Based on 
these two investigated examples, it can be proposed that the function of CMD proteins 
containing a conserved CxxC motif is counteracting oxidative stress. 
 
Figure 5.2. Multiple sequence alignment of selected CMD proteins. The alignment was constructed using 
ClustalW (Thompson et al., 1994). Identical amino acids are shaded in black, similar amino acids in grey. 
Cysteine residues of the highly conserved CxxC motif are highlighted in red. The CMD proteins are grouped 
into proteins linked to ECF41 σ factors and γ-CMD proteins with a (putative) function in the protocatechuate 
metabolism. The name of the CMD proteins is given at the beginning of each line. They derive from the 
following organisms: BLi04370 (YdfG) from B. licheniformis, RSP_0606 from R. sphaeroides, SCO2743 
from S. coelicolor, GYMC10_0387 from Geobacillus sp. Y412MC10, bll7811 from B. japonicum, 
Oter_3133 from Opitutus terrae, Acid345_3513 from Koribacter versatilis, Krac_12621 from Ktedonobacter 
racemifer, GAU_2974 from Gemmatimonas aurantiaca, Snas_2023 from Stackebrandtia nassauensis, PcaL 
from R. opacus, PcaC from B. japonicum, Bpro_1856 from Polaromonas sp. JSP666, PputGB1_4433 from 
Pseudomonas putida and Rpic12D_2061 from Ralstonia pickettii. Note that PcaL constitutes a fusion protein 
and only the CMD domain is included in the alignment. 
Results from investigations of M. tuberculosis σJ, the only ECF41 σ factor that has been 
studied in addition to Ecf41Bli and Ecf41Rsp, also suggest a general role of the ECF41 σ 
factors in response to oxidative stress. The genome of M. tuberculosis harbors two ECF41-
encoding genes, sigJ and sigI, which are both so-called “orphans” not associated with COE 
genes (chapter 4, Table S1). Only sigI is preceded by the typical ECF41-dependent 
promoter sequence, and it has been shown to be the only target recognized by σJ 
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(Homerova et al., 2008). This reveals a cascade in which one ECF41 σ factor activates 
transcription of another member of this group. Although a number of similar putative 
promoter sequences can be found in the genome of M. tuberculosis, several approaches 
failed to assign them as relevant targets of σI or σJ (Homerova et al., 2008, Rodrigue et al., 
2007). This supports our results showing that ECF41 σ factors, unlike other ECF σ factors, 
do not control expression of a large regulon (chapter 4). The only known phenotype 
associated with σJ is a weakly increased sensitivity to H2O2 in a mutant strain (Hu et al., 
2004). However, we performed sensitivity tests and did not observe any differences in 
growth behavior of mutant and wild type strains of both B. licheniformis and R. 
sphaeroides in the presence of oxidative stress producing agents, including H2O2, cumene 
hydroperoxide, t-butyl hydroperoxide and paraquat (data not shown). Moreover, we 
performed a phenotype microarray analysis with R. sphaeroides wild type, Ecf41Rsp 
deletion and overexpression strains. Despite about 1200 different tested conditions, 
including the presence of oxidative stress agents, antimicrobial compounds and a wide 
range of metabolic substrates, this analysis did not reveal any reproducible phenotypes 
(supplementary material and data not shown). All the above mentioned approaches are 
based on growth behavior under stress conditions coupled with genetic alterations. Since 
they did not provide any hints for the function of the ECF41 group, biochemical 
characterization of the target gene products could shed some light on their physiological 
role.  
Knowledge of the exact function of the COE gene products, which can be either CMD 
proteins, oxidoreductases or epimerases, would also allow drawing conclusions regarding 
the signal leading to activation of the ECF41 σ factors. In general, the COE proteins are 
predicted to catalyze redox reactions or chemical conversions. Therefore, instead of a 
compound causing oxidative or another kind of stress, the inducing stimulus could also be 
an alternative nutrient source, for whose metabolism the COE genes encode an important 
enzyme. The presence of a specific substrate might somehow be sensed by the ECF41 σ 
factor, which in turn triggers the expression of corresponding metabolic enzymes. This 
hypothesis is in good agreement with the observation that ydfG, which is the ECF41-
dependent target gene encoding a CMD protein in B. licheniformis, is expressed at the 
transition from the exponential to the stationary growth phase (Fig. 4.4 B). In addition,  an 
increase of the sigJ mRNA level in M. tuberculosis has been observed during stationary 
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phase (Hu & Coates, 2001). A characteristic feature of this growth phase is nutrient 
depletion. One important strategy for survival under these conditions is the use of 
alternative nutrients, including compounds that require unusual degradation pathways and 
specialized signal transducing systems controlling the expression of the corresponding 
enzymes dependent on substrate availability. The ECF41 σ factors and their target genes 
could be involved in regulation and accomplishment of such specialized degradative 
reactions. 
Differentiation is another possibility to deal with the deteriorating conditions during 
stationary phase. Especially bacteria with very complex life cycles, such as some 
Actinobacteria that even show multicellular differentiation, often contain a particularly 
large number of signal transducing systems (Bentley et al., 2002, Flärdh & Buttner, 2009). 
Based on the phylogenetic analysis of ECF41 proteins, these σ factors are especially 
abundant within the Actinobacteria (Table 4.4 and Fig. 4.1), which makes species from this 
phylum particularly interesting for further studies. Many of them, especially the 
Streptomyces species, contain multiple copies of the ECF41 gene in the genome (chapter 4, 
Table S1). This conspicuous abundance of ECF41 σ factors within one genome indicates 
an important function in the often elaborated lifestyles of these species. On the one hand, 
functional and regulatory redundancy has to be considered during experimental 
investigations when more than one ECF41 gene is present in a single genome. On the other 
hand, an important function of these transcriptional regulators, which is indicated by their 
high abundance, could simplify the search for a specific phenotype associated with ECF41 
σ factors. 
5.4.2 Regulatory role of the C-terminal extension in signal transduction 
The most interesting feature of the ECF41 proteins is a large C-terminal extension, which 
is exclusively present in this group of ECF σ factors. Within this extension, we identified 
three highly conserved motifs (Fig. 4.3). To investigate a possible function of this 
extension in signal transduction, we determined the impact of mutations and truncations of 
this extension on promoter activation. Exchange of the conserved motifs of Ecf41Bli against 
alanine residues caused only minor alterations in target promoter activation (Fig. 4.6), 
whereas C-terminal truncations of the ECF41 proteins revealed more drastic effects (Fig. 
4.7). Partial truncation of the extension results in strongly increased target promoter 
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activity. The most obvious effect can be observed for the partly truncated variant Ecf41Bli 
(204), which increased promoter activity ~20-fold relative to the full-length protein (Fig. 
4.7). In contrast, loss of the whole extension (variant 167) completely abolished σ factor 
activity (Fig. 4.7). Moreover, these truncations also alter the affinity of Ecf41Bli to RNAP. 
The shortest variant (167) hardly co-purifies with RNAP, which is in good agreement with 
its inability to activate the target promoter. In contrast, the highly active variant (204) co-
purifies with RNAP to a much lesser extent then the full-length protein (Fig. 4.8). These 
data demonstrate an important regulatory role of this extension, but the effects cannot be 
explained solely by altered affinity for RNAP. Considering that an obvious anti-σ factor is 
missing in the direct genomic context of the ECF41 genes, the extension could possibly 
constitute a fused anti-σ factor-like domain. But besides a mere inhibitory function, parts 
of the C-terminal extension are also required for ECF41-dependent transcription, since its 
entire deletion completely abolished σ factor activity (Fig. 4.7). Such a behavior is very 
unusual, because regions σ2 and σ4 alone are normally sufficient for transcription initiation 
by other ECF σ factors. This suggests that the signal transduction of ECF41 σ factors is 
based on a completely novel and so far unknown signal transducing cascade, which will be 
the subject of further investigations. At this time, it can be only speculated about the exact 
molecular mechanism of ECF41 σ factor activation. 
A feasible approach to gain indications regarding a possible mechanism how the extension 
influences σ factor activity is comparison of its sequence and structure to other already 
investigated proteins. A BLAST search (Altschul et al., 1990), which is based on sequence 
similarity alone, did not reveal any proteins other than ECF41 members. In order to 
identify structurally similar proteins, we first predicted the secondary structure of ECF41 σ 
factors using the secondary structure prediction server Jpred 3 (Cole et al., 2008). The 
secondary structure predicted for Ecf41Rsp as well as an alignment of ECF41 proteins and 
classical ECF σ factors representative for the Jpred 3 analysis is shown in Fig. 5.3. The σ2 
and σ4 domains consist of several α-helices as has already been demonstrated for σ
70 
proteins (Campbell et al., 2002). The C-terminal extension is predicted to form both α-
helices and β-sheets of different lengths (Fig. 5.3). The highly conserved motifs are mainly 
located in regions without a distinct secondary structure. Especially the WLPEP motif, 
whose amino acid sequence is exceptionally highly conserved, lies within an unstructured 
region connecting the σ2 and σ4 domains (Fig. 5.3).  
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Figure 5.3. Predicted secondary structure of group ECF41 proteins. The multiple sequence alignment of 
selected ECF σ factors was constructed using ClustalW (Thompson et al., 1994). Identical amino acids at the 
same position are shaded in black, similar amino acids in grey. The secondary structure for Ecf41Rsp was 
predicted using Jpred 3 (Cole et al., 2008) available at http://www.compbio.dundee.ac.uk/www-jpred/. α-
helices are shown as cylindrical forms, β-sheets as arrows. The σ2 and σ4 domains and the C-terminal 
extension are marked. Conserved motives of ECF41 σ factors are highlighted by black lines. The ECF σ 
factors derive from the following organisms: Ecf41Bli from B. licheniformis, Ecf41Rsp and RSP_2681 from R. 
sphaeroides, MSMEG_5444 from Mycobacterium smegmatis, gll0669 from Gleobacter violaceus, 
Franean1_1629 from Frankia sp. EAN1pec, PHZ_c2577 from Phenylobacterium zucineum, Ajs_2746 from 
Acidovorax sp. J42, Bphyt_2345 from Burkholderia phytofirmans, Reut_B5467 from Ralstonia eutropha, 
SigM and SigW from B. subtilis and RpoE and FecI from E. coli. 
Based on this highly conserved secondary structure, we predicted a three-dimensional 
model (Fig. 5.4), which provides some interesting hints for possible signal transducing 
mechanisms and further investigations. 
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Figure 5.4. Hypothetical three-dimensional model of ECF41 σ factors. HHpred (Söding et al., 2005) was 
used to search the PDB database (Berman et al., 2000) for proteins with known structure similar to Ecf41Rsp. 
The σ2 and σ4 domains were modeled on the already well-known structure of other ECF σ factors. The best 
hit for the C-terminal extension of Ecf41Rsp was limonene-1,2-epoxide hydrolase of Rhodococcus 
erythropolis with 15% similarity. The three-dimensional model was predicted with the program Modeller 
(Šali & Blundell, 1993) and graphically presented using the UCSF Chimera package from the Resource for 
Biocomputing, Visualization, and Informatics at the University of California, San Francisco (Pettersen et al., 
2004). The modeling was performed in collaboration with Gregor Witte. 
The hypothetical three-dimensional model of ECF41 σ factors consists of three domains 
with a distinct fold connected by unstructured linker regions (Fig. 5.4). The σ2 and σ4 
domains are modeled on the already well-known structure of other ECF σ factors. The 
modeling of the C-terminal extension of Ecf41Rsp from R. sphaeroides is based on the 
known structure of limonene-1,2-epoxide hydrolase from Rhodococcus erythropolis 
(Arand et al., 2003). Similarly, the same analysis performed for Ecf41Bli from B. 
licheniformis revealed similarity to a protein of unknown function from Burkholderia 
pseudomallei (data not shown), which carries a nuclear transport factor 2 (NTF2)-like 
domain, thereby showing structural similarity to mammalian NTF2 (Bullock et al., 1996). 
While these two proteins are not functionally related to each other or to σ factors, they both 
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have the same secondary structure and it has been shown that they form dimers (Arand et 
al., 2003, Bullock et al., 1996).  
In general, an ECF σ factor is regulated through direct protein-protein interaction with an 
anti-σ factor. Without a stimulus, this anti-σ factor keeps the ECF σ factor inactive. In the 
presence of a suitable stimulus, the anti-σ factor gets inactivated and releases the ECF σ 
factor, which initiates transcription of its target genes (Butcher et al., 2008, Helmann, 
2002). The most common mechanisms for the inactivation of anti-σ factors are either 
regulated proteolysis or conformational changes (Campbell et al., 2008, Heinrich & 
Wiegert, 2009). ECF41 σ factors are not associated with obvious anti-σ factors, but carry a 
large C-terminal extension involved in regulation of σ factor activity (Fig. 4.3 and 4.7). 
Therefore, we suggest that this extension functions as a fused anti-σ factor-like domain. 
Based on the hypothetical three-dimensional model of ECF41 proteins (Fig. 5.4) as well as 
σ factor activation mechanisms described in the literature, three possible signal transducing 
principles involving the C-terminal extension can be proposed for ECF41 σ factors: (i) 
intermolecular interaction, (ii) intramolecular interaction, and (iii) proteolysis of the 
extension. These three possibilities will be discussed in detail in the following sections. 
5.4.2.1 Intermolecular interaction 
Intermolecular interaction could be a conceivable mechanism for regulation of ECF41 σ 
factor activity. One attractive hypothesis is that ECF41 proteins exist as dimers in the cell, 
thereby keeping themselves inactive. Thereby, the C-terminal extension could constitute a 
dimerization interface. This hypothesis is supported by the fact that the proteins, on which 
the three-dimensional structure of the C-terminal extension is modeled (see above and Fig. 
5.4), form dimers (Arand et al., 2003, Bullock et al., 1996). In case of the ECF41 σ factors, 
a suitable stimulus could trigger conformational changes and dissociation, resulting in a 
monomeric form that is able to interact with RNAP and promoter DNA. To test this 
hypothesis, we carried out initial protein-protein interaction studies based on a bacterial 
two-hybrid system. These assays showed that the ECF41 σ factors of both B. licheniformis 
and R. sphaeroides interact (weakly) with themselves (Fig. 5.5), which indicates possible 
oligomerization. Nevertheless, this indirect indication needs to be validated by further 
interaction studies. 
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Figure 5.5. Oligomerization of ECF41 σ factors. The genes of ecf41Bli and ecf41Rsp were cloned into 
pUT18, pUT18C, pKT25 and pKT25N, thereby generating either N- or C-terminal fusions to the T18 or T25 
fragment of adenylate cyclase from Bordetella pertussis. The bacterial two-hybrid assay was performed 
according to (Karimova et al., 2000). Blue color indicates protein-protein interaction. The positive control is 
based on the derivatives pKT25-zip and pUT18-zip, in which the leucine zipper GCN4 is genetically fused to 
the T25 and T18 fragment, respectively. The negative control is based on the empty vectors.  
5.4.2.2 Intramolecular interaction 
The inhibitory effect of the extension could also occur through intramolecular interaction. 
For example, the C-terminal extension might interact with the σ2 or σ4 domain, thereby 
preventing binding of the ECF41 σ factor to RNAP or promoter DNA. An appropriate 
stimulus could induce a conformational change resulting in an active σ factor. Such a 
conformational change that abolishes the inhibitory function could be triggered, for 
example, by disulfide bond formation, as has already been demonstrated for soluble anti-σ 
factors such as RsrA of S. coelicolor (Kang et al., 1999, Zdanowski et al., 2006). Instead 
of actual dissociation of an anti-σ/σ factor complex, a conformational change could 
uncover or rearrange parts of the ECF41 protein important for σ factor function. 
Intramolecular interaction combined with an inhibitory effect has also been observed for 
σ
70 of E. coli. While this primary σ factor does not need to be activated, specific binding of 
free σ70 to promoter DNA is inhibited by its N-terminal region 1.1. It is proposed that this 
autoinhibitory region sterically blocks the access of promoter DNA to the DNA-binding 
domains. Interaction of σ70 with the RNAP core enzyme induces a movement of region 1.1 
that probably unmasks the DNA-binding domains, thereby allowing this σ factor the 
recognition of target promoters only as part of the RNAP holoenzyme (Callaci et al., 1999, 
Dombroski et al., 1993a, Dombroski et al., 1993b). In case of ECF41 σ factors, the C-
terminal extension could play such an inhibitory role by blocking the binding to target 
promoter DNA. Instead of RNAP holoenzyme formation, the so far unknown inducing 
signal for group ECF41 could trigger a conformational change resulting in free and thereby 
functional DNA-binding domains. In this context the highly conserved WLPEP motif of 
ECF41 σ factors could be of importance. It is located between the σ2 and σ4 domains, a 
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region which usually does not exhibit much sequence and structure conservation (Fig. 5.3 
and chapter 4, Fig. S1). Its exceptionally high conservation and exclusive presence in 
ECF41 σ factors suggest an important function of the amino acids within this motif. It 
could serve as an interaction interface, possibly being affected by the C-terminal extension. 
Alternatively, the WLPEP motif could also be important for positioning and stabilization 
of the σ2 and σ4 domains, thereby supporting binding to DNA or RNAP. A stabilizing 
function is in good agreement with the fact that exchange of the WLPEP motif of Ecf41Bli 
against alanine residues results in a weak but significant decrease in target promoter 
activation (Fig. 4.6). RNAP pull-down or bandshift assays with a corresponding derivative 
of the ECF41 σ factor could reveal if the WLPEP motif influences binding to RNAP or 
promoter DNA. It would be also interesting to test if the exchange of this motif against 
alanine residues also weakens the strong promoter activation by the truncated and highly 
active Ecf41Bli variant (204).  
5.4.2.3 Proteolysis 
Proteolysis of the C-terminal extension could also be a possibility for activation of ECF41 
σ factors. Such a mechanism can be found for σ factors regulating sporulation in B. 
subtilis. At least two examples are known, in which the σ factor is synthesized as an 
inactivate precursor and then activated by proteolysis. Membrane-bound pro-σE, the 
precursor of σE, whose expression is induced early during sporulation, is most likely 
processed to its active state by the putative protease SpoIIGA (Piggot & Hilbert, 2004). 
Pro-σK is the precursor of σK, which is responsible for expression of late sporulation genes 
in the mother cell. Pro-σK carries 20 N-terminal residues that promote association of this σ 
factor to the mother cell membrane and inhibit binding to RNAP and promoter DNA. 
Cleavage of these 20 residues and thereby activation of this σ factor via SpoIVFB occurs 
tightly regulated at later sporulation stages (Piggot & Hilbert, 2004, Zhang et al., 1998, 
Zhou & Kroos, 2004). With regard to the ECF41 σ factors, cleavage of a certain C-
terminal part responsible for the inhibitory function of this extension could lead to an 
active ECF41 protein. In this case, the N-terminal part of the extension, which we found to 
be required for σ factor activity (Fig. 4.7), would be still present. The signal triggering 
such a proteolysis could be either perceived directly by a protease or another protein, 
which in turn activates a corresponding protease. In another conceivable scenario, the C-
terminal extension could constitute the sensor, which may change its conformation after 
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signal perception and expose a protease recognition site. Nevertheless, a protease or other 
protein involved in such a mechanism still needs to be identified.  
5.5 Conclusions 
The aim of this thesis was the investigation of cell envelope stress responses with a special 
focus on the role and mechanistic details of ECF σ factor-dependent signal transduction. 
Genome-wide expression profiling, usually performed on model organisms after treatment 
with specific antimicrobial compounds, is a good and often utilized approach to identify 
the regulatory networks orchestrating stress responses. Moreover, such studies can also 
provide valuable indications regarding the MOA of antibiotics. This significantly 
contributes to the knowledge of the MOA of novel antimicrobial compounds and can be 
even used to speculate about their clinical relevance and success. 
ECF σ factors play a major role in mediating cell envelope stress responses. For some ECF 
σ factors, the function and signal transducing mechanisms are already well understood. But 
a classification of these proteins performed by Staroń and colleagues (Staroń et al., 2009) 
identified a number of novel groups of ECF σ factors and provides a valuable resource for 
the detailed characterization of ECF σ factor-dependent gene regulation. Chapter 4 of this 
thesis presented the first analysis of such a novel group. The unique features of this group, 
especially the regulatory C-terminal extension, nicely illustrate the great diversity of ECF σ 
factor-dependent signal transduction und encourage the investigation of further groups 
with yet unknown signaling mechanisms. Just recently, a novel ECF σ factor of 
Myxococcus xanthus, named CorE, has also been shown to carry a short C-terminal 
extension while an obvious anti-σ factor is missing. This extension contains several 
cysteine residues important for stimulus perception and controls copper-dependent DNA 
binding and thereby activity of CorE. While this short extension of CorE resembles the 
function of an anti-σ domain, the exact mechanism of signal transduction is still unclear 
(Gómez-Santos et al., 2011). Although CorE-like proteins and ECF41 σ factors do not 
belong to the same group of ECF σ factors, their regulation presumably involves a fused 
anti-σ domain rather than a second protein functioning as an anti-σ factor. These studies 
demonstrate that there is still a great potential for the discovery of completely novel and 
complex ECF σ factor-dependent signal transducing mechanisms.  
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Supplementary material 
Detailed experimental procedures and additional figures for 
chapter 2 
Strains, media and growth conditions. B. subtilis strains were routinely grown in LB 
medium at 37°C with aeration, except where stated otherwise. Erythromycin (1 µg/ml) 
plus lincomycin (25 µg/ml) for MLS resistance were used for the selection of strain 
BFS2469, tetracycline (10 µg/ml) was used for selection of strain TMB389. Friulimicin B 
was obtained from MerLion Pharmaceuticals GmbH, and other drugs from their respective 
manufacturers.  
RNA preparation. B. subtilis 168 wild type strain was grown aerobically at 37°C in LB 
medium to mid-log phase. The culture was split and induced with friulimicin B or 
daptomycin (1 µg/ml each) with one sample remaining as the uninduced control. After 10 
min of induction 30 ml of each sample were mixed with 15 ml cold killing buffer (20 mM 
Tris-HCl pH 7.0, 5 mM MgCl2, 20 mM NaN3), harvested by centrifugation and frozen in 
liquid nitrogen. For cell disruption, the pellet was resuspended in 200 µl killing buffer, 
immediately dropped into the Teflon vessel (filled and pre-cooled with liquid nitrogen), 
and then disrupted with a Mikro-Dismembrator U (Sartorius). The resulting cell powder 
was resuspended in 3 ml of lysis solution (4 M guanidine-thiocyanate, 0.025 M Na-acetat 
pH 5.2, 0.5% N-lauroylsarcosinate) and the RNA was extracted twice by 
phenol/chloroform/isoamylalcohol 25/24/1 followed by chloroform/isoamylalcohol 24/1 
extraction and ethanol precipitation. RNA samples were DNase-treated with the RNase-
free DNase kit (Qiagen) according to the manufacturer’s instructions and purified using 
RNeasy mini columns (Qiagen). The quality control of the RNA preparations was 
performed with the RNA 6000 Nano LabChip Kit (Agilent Technologies) on the Agilent 
2100 Bioanalyzer according to the manufacturer’s instructions. 
DNA microarray analysis. The RNA samples obtained from three independent 
cultivations were used for independent cDNA synthesis and DNA array hybridization. 
Generation of the Cy3/Cy5-labeled cDNAs and hybridization to B. subtilis whole-genome 
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DNA microarrays (Eurogentec) were performed as described (Jürgen et al., 2005). The 
slides were scanned with a ScanArray Express scanner (PerkinElmer). Quantitation of the 
signal and background intensities was carried out using the ScanArray Express image 
analysis software. 
Transcriptome data analysis. Data was analyzed using the GeneSpring software (Agilent 
Technologies). Raw signal intensities were first transformed by intensity dependent 
LOWESS normalization. The normalized array data were subjected to a statistical analysis 
using Cyber-T, a program based on a t-test combined with a Bayesian statistical framework 
(Baldi & Long, 2001). The software is accessible through a web interface at 
http://cybert.microarray.ics.uci.edu. The mRNA abundance was considered to be 
significantly different between the untreated control samples and the samples obtained 
after treatment with the respective antibiotic if (i) the Cyber-T Bayesian P value was < 
0.001 and (ii) the average fold change was at least 3 in three independent experiments. The 
potential and known functions of the encoded proteins were initially inferred from the 
SubtiList (http://genolist.pasteur.fr/SubtiList/) or BSORF databases  
(http://bacillus.genome. ad.jp/). An in-depth analysis of the identified marker genes (as 
listed in Table 2) was performed using the SMART (Letunic et al., 2006, Schultz et al., 
1998) and MicrobesOnline (Alm et al., 2005) databases, at http://smart.embl-
heidelberg.de/ and http://www.microbesonline.org/, respectively. 
Quantitative real time RT-PCR. Measurement of transcript abundance was performed by 
quantitative real-time RT-PCR using iScript one-step RT-PCR kit with SYBR Green (Bio-
Rad) according to the manufacturer’s procedure with minor modifications: In brief, 100 ng 
of DNA-free total RNA was used in a total reaction volume of 20 µl with 0.3 µM of each 
primer (see Table 1). The amplification reaction was carried out in an MyiQ Cycler 
(BioRad) using the following program: reverse transcription at 50°C for 10 min, followed 
by a 95°C denaturing/activation step for 5 min, followed by 45 cycles (95°C for 10 sec), 
(60°C for 30 sec). After a subsequent denaturation (95°C for 1 min) and annealing (55°C 
for 1 min) the setpoint temperature was increased in 80 cycles (10 sec each) by 
0.5°C/cycle, starting from 55°C, to determine the melting temperatures of the PCR 
products. Expression of rpsJ and rpsE was monitored as constitutive reference. These 
genes were chosen due to their stable expression behaviour under various growth and 
stress conditions in B. subtilis (data not shown). Expression of liaI and genes encoding 
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ECF σ factors was calculated as fold changes using the formula: Fold change = 2-∆∆Ct; with 
-∆∆Ct = (Ct(gene x)-Ct(constitutive gene))condition I – (Ct(gene x)-Ct(constitutive gene))condition II (Talaat et al., 
2002). 
Concentration-dependent killing curve/β-galactosidase assays. These experiments were 
performed as described (Mascher et al., 2004). In brief, strain BFS2470 was grown in LB 
medium with MLS selection to OD600 ~ 0.5 and daptomycin/friulimicin B were added to a 
final concentration ranging from 0.01 to 50 µg/ml. An uninduced culture was used as a 
negative control. The cultures were incubated with aeration at 37°C. A sample was taken 
after 30 min for β-galactosidase assay and the turbidity of the remaining culture was 
measured for at least 5 hours to monitor the concentration-dependent effects of the 
antibiotics on growth. 
L-[
35
S]methionine labelling of proteins and 2D-PAGE analysis. B. subtilis 168 wild 
type strain was grown aerobically at 37°C in Belitsky minimal medium (Stülke et al., 
1993) to mid-log phase. 10 and 30 minutes after addition of daptomycin or friulimicin B 
(1,5 and 1,0 µg/ml, respectively) the cells as well as untreated control cells were labelled 
with 15 µCi/ml [35S]-methionine. After 5 minutes incorporation of radioactive methionine, 
the reaction was stopped by adding an excess of nonradioactive methionine (1mM) and 
chloramphenicol (100µg/ml) to stop translation. Samples were taken and the cytoplasmic 
protein fraction isolated as described earlier (Bandow et al., 2003). 2D-PAGE using 
Immobiline dry strips (IPG, Amersham Biosciences) (pH 4-7) loaded with 80 µg protein 
extract as well as visualization of radiolabelled proteins and dual channel imaging using 
Delta2D software (Decodon) were carried out as described (Bernhardt et al., 1999, 
Bernhardt et al., 2003). 
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Figure S1. Killing curves and concentration-dependent induction of the liaI promoter in B. subtilis 
cultures treated with daptomycin and friulimicin B. (A) Killing curves daptomycin. LB medium was 
inoculated from a fresh overnight culture of B. subtilis W168 and incubated at 37°C with aeration. Cell 
density was monitored by measuring OD600 at regular intervals. At mid-logarithmic growth phase (OD600 ~ 
0.5) the culture was split and induced with different concentrations of daptomycin (■, uninduced control; □, 
0.5 µg/ml; , 1 µg/ml; , 2 µg/ml; , 5 µg/ml;  10 µg/ml; , 50 µg/ml). (B) Friulimicin killing curves, 
using the same experimental conditions as above. (C) Induction of the liaI promoter. Strain BFS2470 (B. 
subtilis W168 liaI::pMUTIN) was grown in LB medium as described above and induced with different 
concentrations of daptomycin  (grey bars) and friulimicin  (striped bars), respectively, for 30 min, with one 
sample remaining as the uninduced control. The cells  were harvested and β-galactosidase assays were 
performed as described in the detailed experimental procedures. The PliaI activity, expressed in Miller Units 
(Miller, 1972), is shown on the y-axis.  
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Figure S2. Proteome analysis. Protein expression profiles of B. subtilis 168 before (green image) and after 
10 or 30 min of the exposure (red image) to friulimicin B (left) and daptomycin (right), respectively, are 
shown. 
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Supplementary material provided on CD 
The following supplementary material can be found on the enclosed CD. 
Chapter 2 
Table S1 daptomycin. Excel file containing the complete microarray dataset for 
daptomycin. The normalized array data were analyzed using the software Cyber-T (Baldi 
& Long, 2001), which is available at http://cybert.microarray.ics.uci.edu. The output of this 
analysis  including several statistical parameters is given in form of an excel table. 
Table S2 friulimicin B. Excel file containing the complete microarray dataset for 
friulimicin B, which was analyzed as described above for daptomycin. 
Chapter 3 
Table S1. Excel file of the complete microarray dataset containing rhamnolipid induction 
ratios for each gene of B. subtilis. The ratio values are averages from three independent 
microarray experiments and calculated from intensity data using the Rosetta Resolver 
software (version 7.2.1, Rosetta biosoftware).  
Chapter 4 
Table S1. Excel file containing the non-redundant dataset with 373 proteins extracted from 
the MiST2 database (Ulrich & Zhulin, 2010) in October 2010. The dataset was analyzed 
regarding the genomic context and occurrence of the ECF41-dependent promoter motif. 
Pfam domains of the COE proteins were identified using the SMART database (Letunic et 
al., 2006, Schultz et al., 1998). Abbreviations: ECF, gene encoding the ECF41 σ factor; 
COE, gene encoding a carboxymuconolactone decarboxylase, oxidoreductases or 
epimerase; CMD, gene encoding a carboxymuconolactone decarboxylase; Ox, gene 
encoding an oxidoreductases; Epi, gene encoding an epimerase; Hypo, gene encoding a 
hypothetical protein. 
Figure. S1. Genbank file containing an alignment of ECF41 proteins. The alignment 
containing 373 ECF41 protein sequences was constructed using ClustalW (Thompson et 
al., 1994). 
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PM_deletion_versus_wt. Word document containing results of the phenotypic microarray 
analysis performed for R. sphaeroides strains YSD239 (ΔRSP_0606-ecf41Rsp) and 2.4.1 
(wt). 
PM_overexpression_versus_wt. Word document containing results of the phenotypic 
microarray analysis performed for R. sphaeroides strains TMR003 (pIND4 ecf41Rsp aa1-206) 
and 2.4.1 (wt). 
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